0001755672-26-000004 | 10-K | XBRL Viewer

1,203

1,227

1,211

136

132

283

180

233

^[1]

(181)

(284)

(397)

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Income (Loss) from Continuing Operations After Taxes

1,204

893

926

Provision for (benefit from) income taxes on continuing operations

484

421

147

Income (loss) from Continuing Operations before Income Taxes

1,688

1,314

1,073

1,203

1,227

1,211

180

233

253

Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

(136)

(132)

(283)

180

233

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges

181

284

397

Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] | EIDP

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

1,203

1,227

1,211

(136)

(171)

(283)

180

233

253

Non-operating (benefits) costs - net

181

284

397

174

151

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges

Significant items

658

315

579

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Corporate

Corporate Expenses

138

115

110

Corporate | EIDP

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Corporate Expenses

138

115

110

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

1,203

1,227

1,211

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

3,986

3,491

Segments | EIDP

Geographic Areas, Revenues from External Customers [Abstract]

$ 3,986

$ 3,491

[1]	Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.

Geographic Information (Tables)

12 Months Ended

Dec. 31, 2025

Net Sales by Geographic Area


	Net Sales
	For the Year Ended December 31,
(In millions)	2025		2024		2023
United States	$	8,269	$	7,866	$	7,783
Canada	755		794		807
EMEA	3,110		3,124		3,367
Latin America 1	3,928		3,776		3,906
Asia Pacific	1,339		1,348		1,363
Total	$	17,401	$	16,908	$	17,226

1.Net sales for Brazil for the years ended December 31, 2025, 2024 and 2023 were $2,900 million, $2,618 million and $2,523 million, respectively.

Net Property By Geographic Area


	Net Property
	As of December 31,
(In millions)	2025		2024		2023
United States	$	2,879	$	2,878	$	2,922
Canada	100		101		119
EMEA	573		522		548
Latin America	586		514		608
Asia Pacific	82		84		90
Total	$	4,220	$	4,099	$	4,287

Long-Term Debt and Available Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Short-Term Borrowings and Finance Lease Obligations


Short-Term Borrowings and Finance Lease Obligations
(In millions)	December 31, 2025		December 31, 2024
364-Day Revolving Credit Facility	$	—	$	—
Other loans - various currencies	112		250
Long-term debt payable within one year	782		500
Finance lease obligations payable within one year	—		—
Total short-term borrowings and finance lease obligations	$	894	$	750

Long-Term Debt


Long-Term Debt
	December 31, 2025				December 31, 2024
(In millions)	Amount		Weighted Average Rate		Amount		Weighted Average Rate
Promissory notes and debentures:
Maturing in July 2025	$	—	—	%	$	500	1.70	%
Maturing in May 2026	600		4.50	%	600		4.50	%
Maturing in July 2030	500		2.30	%	500		2.30	%
Maturing in May 2032	500		5.125	%	—		—	%
Maturing in May 2033	600		4.80	%	600		4.80	%
Other loans:
Foreign currency loans, various rates and maturities	182		12.70	%	161		12.70	%
Medium-term notes, varying maturities through 2041	102		3.76	%	104		4.41	%
Finance lease obligations	—				—
Less: Unamortized debt discount and issuance costs	16				12
Less: Long-term debt due within one year	782				500
Total long-term debt	$	1,686			$	1,953

Committed and Available Credit Facilities

Committed and Available Credit Facilities at December 31, 2025

(In millions)

Effective Date

Committed Credit

Credit Available

Maturity Date

Interest

Revolving Credit Facility

June 2024

2,850

June 2029

Floating Rate

Revolving Credit Facility

June 2024

1,900

June 2027

Floating Rate

364-Day Revolving Credit Facility

February 2025

750

February 2026

Floating Rate

Total committed and available credit facilities

5,500

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

Geographic Areas, Revenues from External Customers [Abstract]

Geographic Information

12 Months Ended

Dec. 31, 2025

Geographic Information [Text Block]

GEOGRAPHIC INFORMATION

Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.


	Net Sales
	For the Year Ended December 31,
(In millions)	2025		2024		2023
United States	$	8,269	$	7,866	$	7,783
Canada	755		794		807
EMEA	3,110		3,124		3,367
Latin America 1	3,928		3,776		3,906
Asia Pacific	1,339		1,348		1,363
Total	$	17,401	$	16,908	$	17,226

1.Net sales for Brazil for the years ended December 31, 2025, 2024 and 2023 were $2,900 million, $2,618 million and $2,523 million, respectively.


	Net Property
	As of December 31,
(In millions)	2025		2024		2023
United States	$	2,879	$	2,878	$	2,922
Canada	100		101		119
EMEA	573		522		548
Latin America	586		514		608
Asia Pacific	82		84		90
Total	$	4,220	$	4,099	$	4,287

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) - Pension Plan

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Net Periodic Benefit, Discount Rate

5.59%

4.97%

5.17%

Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase

^[1]

2.87%

2.83%

Expected long-term rate of return on plan assets

4.56%

4.57%

4.55%

[1]	The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (m)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Fair Value Measurements Fair Value Measurement Recurring Basis (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Derivative Asset

$ 32

$ 91

Derivative Liability, Foreign Currency

111

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Marketable Securities

^[1]

Available-for-sale securities

^[1],[2]

Total assets at fair value

^[1]

251

Total Liabilities at fair value

^[1]

111

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[1],[3]

Derivative Liability, Foreign Currency

^[1],[3]

104

Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Derivative Asset

^[1],[3]

Derivative Liability, Foreign Currency

^[1],[3]

$ 9

$ 7

[1]	Reflects significant other observable inputs
[2]	Represents the company's investments in debt securities that are classified as available-for-sale, which are included in the Consolidated Balance Sheets.
[3]	See Note 19 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.

Segment Reporting Reconciliation of Profitability (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

$ 17,401

$ 16,908

$ 17,226

9,172

9,529

9,920

17,401

16,908

17,226

9,118

9,512

9,895

Other Expenses

^[1]

4,297

3,905

3,840

3,986

3,491

Seed [Member] | Segments

9,898

9,545

9,472

4,533

4,876

4,982

Other Expenses

^[1]

2,729

2,450

2,373

Crop Protection [Member] | Segments

2,636

2,219

2,117

7,503

7,363

7,754

4,585

4,636

4,913

Other Expenses

^[1]

1,568

1,455

1,467

$ 1,350

$ 1,272

$ 1,374

[1]	Other expenses consist primarily of selling, general and administrative expenses and research and development expense, net of depreciation add-back.

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Lease, Cost [Table Text Block]

Leases (Tables)

12 Months Ended

Dec. 31, 2025

Leases [Abstract]


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Operating lease cost	$	161	$	176	$	169
Finance lease cost
Amortization of right-of-use assets	—		1		1

Total finance lease cost	$	—	$	1	$	1
Short-term lease cost	37		27		23
Variable lease cost	7		8		11

Total lease cost	$	205	$	212	$	204

Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	166	$	188	$	169

Financing cash outflows from finance leases	$	—	$	1	$	1

Schedule of Lease Assets and Liabilities [Table Text Block]


(In millions)	December 31, 2025		December 31, 2024
Operating Leases
Operating lease right-of-use assets 1	$	411	$	414
Current operating lease liabilities 2	122		134
Noncurrent operating lease liabilities 3	293		342
Total operating lease liabilities	$	415	$	476

Finance Leases
Property, plant, and equipment, gross	$	14	$	14
Accumulated depreciation	(14)		(14)
Property, plant, and equipment, net	$	—	$	—
Short-term borrowings and finance lease obligations	—		—
Long-term debt	—		—
Total finance lease liabilities	$	—	$	—

1.Included in other assets in the Consolidated Balance Sheets.

2. Included in accrued and other current liabilities in the Consolidated Balance Sheets.

3. Included in other noncurrent obligations in the Consolidated Balance Sheets.

Lease Term and Discount Rate [Table Text Block]


Lease Term and Discount Rate	December 31, 2025		December 31, 2024
Weighted-average remaining lease term (years)
Operating leases	6.20		6.44
Finance leases	0		0.38
Weighted average discount rate
Operating leases	3.85	%	3.32	%
Finance leases	—	%	3.29	%

Maturities of Lease Liabilities [Table Text Block]


Maturity of Lease Liabilities at December 31, 2025	Operating Leases
(In millions)
2026	$	136
2027	95
2028	71
2029	51
2030	33
2031 and thereafter	87
Total lease payments	$	473
Less: Interest	58
Present value of lease liabilities	$	415

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Income (Loss) from Continuing Operations After Taxes	$ 1,204	$ 863	$ 941
Net Income attributable to continuing operations - Noncontrolling Interest	11	12	12
Income (loss) from continuing operations attributable to Corteva common stockholders	1,193	851	929
(Loss) income from discontinued operations attributable to Corteva common stockholders	(99)	56	(194)
Net (Loss) Income attributable to common stockholders	$ 1,094	$ 907	$ 735

Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 19
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-19

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Crop Protection Strategy Operations Program [Member]

Restructuring and Asset Related Charges (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Severance and related benefit costs 1	$	11	$	91	$	—
Asset related charges 2,3	13		101		214
Decommissioning and demolition costs 2	60		10		—
Contract termination charges 2	66		30		3
Total restructuring and asset related charges - net 4	$	150	$	232	$	217

1.Reflects corporate related charges.

2.Reflects charges which are substantially all associated with the Crop Protection segment.

3.Asset-related charges includes impairment charges related to operating lease assets and property, plant and equipment.

4.This amount excludes charges relating to spare parts write-offs included in cost of goods sold for the year ended December 31, 2023, in the company's Consolidated Statement of Operations.

The following table summarizes changes to liability balances related to the Crop Protection Operations Strategy Restructuring Program for the years ended December 31, 2024 and 2025, respectively:


(In millions)	Severance and Related Benefit Costs		Asset Related Charges1		Decommissioning and Demolition Costs		Contract Termination Charges		Total
Balance at December 31, 2023	$	—	$	—	$	—	$	—	$	—
Charges to income from continuing operations	91		101		10		30		232
Payments	(21)		—		(10)		(30)		(61)
Asset write-offs	—		(101)		—		—		(101)
Balance at December 31, 2024	$	70	$	—	$	—	$	—	$	70
Charges to income from continuing operations	11		13		60		66		150
Payments	(49)		—		(52)		(12)		(113)
Asset write-offs	—		(13)		—		—		(13)
Balance at December 31, 2025	$	32	$	—	$	8	$	54	$	94

1.Asset-related charges includes impairment charges related to operating lease assets and property, plant and equipment.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Property, Plant and Equipment [Abstract]

Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Cash and Cash Equivalents	$ 4,521	$ 3,106
Marketable Securities	9	63
Accounts and notes receivable - net	6,371	5,676
Inventories	5,667	5,432
Other current assets	767	820
Total current assets	17,335	15,097
Investments in nonconsolidated affiliates	160	134
Property, Plant and Equipment	9,551	9,074
Less: Accumulated Depreciation	5,331	4,975
Net Property, Plant and Equipment	4,220	4,099
Goodwill	10,465	10,408
Other intangible assets	8,301	8,876
Deferred Income Taxes	320	401
Other Assets	2,044	1,810
Total Assets	42,845	40,825
Short-term borrowings and finance lease obligations	894	750
Accounts Payable	4,398	4,039
Income Taxes Payable	155	207
Deferred Revenue	3,579	3,287
Accrued and other current liabilities	3,099	2,103
Total current liabilities	12,125	10,386
Long-term Debt	1,686	1,953
Deferred Income Tax Liabilities	251	478
Pension and other post employment benefits - noncurrent	2,434	2,271
Other noncurrent obligations	1,963	1,707
Total Noncurrent Liabilities	$ 6,334	$ 6,409
Common Stock, Shares, Issued	672,163	685,595
Common stock	$ 7	$ 7
Additional Paid in Capital	27,001	27,196
Retained earnings (accumulated deficit)	(67)	55
Accumulated other comprehensive income (loss)	(2,797)	(3,469)
Total stockholders' equity attributable to the company	24,144	23,789
Noncontrolling Interests	242	241
Total Equity	24,386	24,030
Total Liabilities and Equity	42,845	40,825
EIDP
Cash and Cash Equivalents	4,521	3,106
Marketable Securities	9	63
Accounts and notes receivable - net	6,371	5,676
Inventories	5,667	5,432
Other current assets	767	820
Total current assets	17,335	15,097
Investments in nonconsolidated affiliates	160	134
Property, Plant and Equipment	9,551	9,074
Less: Accumulated Depreciation	5,331	4,975
Net Property, Plant and Equipment	4,220	4,099
Goodwill	10,465	10,408
Other intangible assets	8,301	8,876
Deferred Income Taxes	320	401
Other Assets	2,044	1,810
Total Assets	42,845	40,825
Short-term borrowings and finance lease obligations	894	750
Accounts Payable	4,398	4,039
Income Taxes Payable	155	207
Deferred Revenue	3,579	3,287
Accrued and other current liabilities	3,223	2,096
Total current liabilities	12,249	10,379
Long-term Debt	1,686	1,953
Deferred Income Tax Liabilities	251	478
Pension and other post employment benefits - noncurrent	2,434	2,271
Other noncurrent obligations	1,963	1,707
Total Noncurrent Liabilities	6,334	6,409
Common stock	0	0
Additional Paid in Capital	24,610	24,464
Retained earnings (accumulated deficit)	2,207	2,930
Accumulated other comprehensive income (loss)	(2,797)	(3,469)
Total stockholders' equity attributable to the company	24,259	24,035
Noncontrolling Interests	3	2
Total Equity	24,262	24,037
Total Liabilities and Equity	42,845	40,825
EIDP \| Corteva [Member]
Due from Parent	0	(129)
$4.50 Series Preferred Stock [Member] \| EIDP
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 2024	169	169
$3.50 Series Preferred Stock [Member] \| EIDP
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2025 and December 31, 2024	$ 70	$ 70

Background and Basis of Presentation (Notes)	12 Months Ended
Background and Basis of Presentation (Notes)	Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 - BACKGROUND AND BASIS OF PRESENTATION Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two operating segments: Seed and Crop Protection. See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's operating segments. Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EIDP) and the term “EIDP” used herein means EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) and its consolidated subsidiaries or EIDP, Inc. excluding its consolidated subsidiaries, as the context may indicate. Principles of Consolidation and Basis of Presentation The consolidated financial statements contained in this Annual Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the company, its majority owned subsidiaries over which the company exercises control. The Consolidated Financial Statements and other financial information included in this Annual Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations. On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation of the agriculture business (the “Corteva Separation”) of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The Corteva Separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock of Corteva, Inc. Prior to the Corteva Separation, subsequent to the Merger, Historical Dow and EIDP engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products ("Internal Reorganization"). On April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow common stock to holders of DowDuPont's common stock (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”). On April 1, 2019, Historical Dow entities, which held certain assets and liabilities aligned with Historical Dow’s agriculture business and the assets and liabilities associated with its specialty products business, respectively, were transferred and conveyed to DowDuPont. On April 1, 2019 and May 1, 2019, EIDP’s materials science and specialty products entities, along with their respective assets and liabilities, were conveyed to Dow and DowDuPont, respectively. On May 2, 2019, DowDuPont conveyed Historical Dow agricultural entities to EIDP. On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On May 31, 2019, DowDuPont contributed EIDP to Corteva, Inc. and on June 1, 2019, the Corteva Separation was completed. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements. Since 2018, Argentina has been considered a highly-inflationary economy under U.S. GAAP and, therefore, the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 3 percent to the company's annual net sales and approximately 1 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets and translates the financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the Consolidated Financial Statements). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. As of December 31, 2025, the company holds these foreign government bonds with an amortized cost of $30 million as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 19 - Financial Instruments, to the Consolidated Financial Statements, for additional information. As of December 31, 2025, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to its operations and financial reporting.

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2025

Property, Plant and Equipment [Table Text Block]


(In millions)	December 31, 2025		December 31, 2024
Land and land improvements	$	449	$	425
Buildings	1,867		1,715
Machinery and equipment	6,849		6,472
Construction in progress	386		462
Total property, plant and equipment	$	9,551	$	9,074
Accumulated depreciation	(5,331)		(4,975)
Total property, plant and equipment - net	$	4,220	$	4,099

Property, Plant and Equipment - Depreciation Expense [Table Text Block]


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Depreciation expense	$	559	$	542	$	528

Stock-Based Compensation Stock Options (Details) - Share-based Payment Arrangement, Option [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding at beginning of period	3,257
Stock options granted during the period	288
Stock options exercised during the period	(1,606)
Stock options forfeited/expired during the period	(58)
Stock options outstanding at end of period	1,881	3,257
Stock options exercisable at end of period	1,299
Stock options outstanding, weighted average exercise price beginning of period	$ 43.97
Stock options granted, weighted average price	64.70
Stock options exercised during the period, weighted average exercise price	40.40
Stock options forfeited/expired, weighted average price	58.31
Stock options outstanding, weighted average exercise price end of period	49.74	$ 43.97
Stock options exercisable, weighted average exercise price	$ 44.95
Stock options outstanding, weighted average remaining contractual term	5 years 29 days	4 years 5 months 15 days
Stock options exercisable, weighted average remaining contractual term	3 years 8 months 12 days
Stock options outstanding, intrinsic value	$ 32,565	$ 43,761
Stock options exercisable, intrinsic value	28,689
Unrecognized Pretax Compensation Expense Related to Stock Options	$ 7,000
Remaining Weighted-Average Recognition Period	1 year 1 month 20 days
OIP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of stock options	$ 42,000	20,000	$ 14,000
Tax Benefit from Compensation Benefit	$ (8,000)	$ (4,000)	$ (3,000)

Earnings Per Share Share Count Information (Details) - shares
shares in Thousands

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Earnings Per Share [Line Items]

Weighted Average Number of Shares Outstanding, Basic

680,000

693,700

709,000

Dilutive effect of equity compensation plans

^[1]

1,400

2,300

2,900

Weighted Average Number of Shares Outstanding, Diluted

681,400

696,000

711,900

Stock options and restricted stock units excluded from EPS

^[2]

2,300

3,100

2,300

[1]

Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

[2]

These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; or (ii) the

performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Leases Supplemental Balance Sheet Information (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Leases [Abstract]

Operating Lease, Right-of-Use Asset

^[1]

$ 411

$ 414

Current operating lease liabilities

^[2]

122

134

Noncurrent operating lease liabilities

^[3]

293

342

Total operating lease liabilities

415

476

Finance Lease, Right-of-Use Asset, Gross

Finance Lease, Right-Of-Use Asset, Accumulated Depreciation

(14)

Finance Lease, Right-of-Use Asset

Finance lease obligations payable within one year

Finance Lease, Liability, Noncurrent

Finance Lease, Liability

$ 0

Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]

Accrued and other current liabilities

Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]

Other Assets

Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]

Other noncurrent obligations

[1]	Included in other assets in the Consolidated Balance Sheets.
[2]	Included in accrued and other current liabilities in the Consolidated Balance Sheets.
[3]	Included in other noncurrent obligations in the Consolidated Balance Sheets.

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Net income (loss)	$ 1,105	$ 919	$ 747
Cumulative Translation Adjustments	867	(1,014)	425
Unrealized Gain (Loss) on Investments	6	(6)	0
Derivative Instruments	(23)	71	(135)
Total other comprehensive income (loss)	672	(792)	129
Comprehensive Income (Loss)	1,777	127	876
Comprehensive Income Attributable to Noncontrolling Interest- net of tax	11	12	12
Comprehensive Income (Loss) Attributable to Company	1,766	115	864
EIDP
Net income (loss)	1,105	949	732
Cumulative Translation Adjustments	867	(1,014)	425
Unrealized Gain (Loss) on Investments	6	(6)	0
Derivative Instruments	(23)	71	(135)
Total other comprehensive income (loss)	672	(792)	129
Comprehensive Income (Loss)	1,777	157	861
Comprehensive Income Attributable to Noncontrolling Interest- net of tax	1	2	2
Comprehensive Income (Loss) Attributable to Company	1,776	155	859
Pension Plan
Adjustments to other benefit plans	(152)	127	(190)
Pension Plan \| EIDP
Adjustments to other benefit plans	(152)	127	(190)
Other Benefit Plans
Adjustments to other benefit plans	(26)	30	29
Other Benefit Plans \| EIDP
Adjustments to other benefit plans	$ (26)	$ 30	$ 29

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table summarizes changes in the carrying amount of goodwill by segment for the years ended December 31, 2024 and 2025, respectively.


(In millions)	Seed		Crop Protection		Total




Balance at December 31, 2023	$	5,422	$	5,183	$	10,605
Currency translation adjustment	(96)		(139)		(235)
Other goodwill adjustments 1	—		38		38
Balance at December 31, 2024	$	5,326	$	5,082	$	10,408
Currency translation adjustment	(14)		71		57

Balance at December 31, 2025	$	5,312	$	5,153	$	10,465

1.Includes measurement period adjustments related to the acquisitions of Stoller and Symborg, which were not material.

The company performed annual qualitative testing on all of its reporting units in 2025 and 2024, determining that no goodwill impairments existed in either year. As of December 31, 2025, accumulated impairment losses on goodwill were $4,503 million.

Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:


	December 31, 2025						December 31, 2024
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (finite-lived):
Germplasm	$	6,291	$	(1,587)	$	4,704	$	6,291	$	(1,336)	$	4,955
Customer-related	2,394		(1,024)		1,370		2,350		(863)		1,487
Developed technology	1,860		(1,283)		577		1,838		(1,161)		677
Trademarks/trade names	2,056		(466)		1,590		2,056		(380)		1,676

Other 1	368		(313)		55		388		(312)		76
Total other intangible assets with finite lives	$	12,969	$	(4,673)	$	8,296	$	12,923	$	(4,052)	$	8,871

Intangible assets not subject to amortization (indefinite-lived):
In-process research and development	5		—		5		5		—		5
Total other intangible assets with indefinite lives	5		—		5		5		—		5
Total other intangible assets	$	12,974	$	(4,673)	$	8,301	$	12,928	$	(4,052)	$	8,876

1.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for finite-lived intangible assets was $644 million, $685 million, and $683 million for the years ended December 31, 2025, 2024 and 2023, respectively.

Total estimated amortization expense for the next five fiscal years is as follows:


(In millions)
2026	$	637
2027	576
2028	555
2029	531
2030	521

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp Loss	Noncontrolling Interest [Member]	EIDP	EIDP Corteva [Member]	EIDP Preferred Stock [Member]	EIDP Common Stock [Member]	EIDP Additional Paid-in Capital [Member]	EIDP Retained Earnings [Member]	EIDP Accumulated Other Comp Loss	EIDP Noncontrolling Interest [Member]	EIDP Due from Parent
Beginning Balance at Dec. 31, 2022	$ 25,541	$ 7	$ 27,851	$ 250	$ (2,806)	$ 239	$ 24,749		$ 239	$ 0	$ 24,284	$ 3,031	$ (2,806)	$ 1	$ 0
Net income (loss)	747			735		12	732					730		2
Other comprehensive income (loss)	129				129		129						129
Share based compensation	26		28				26				28	(2)
Retained Earnings, Share-based Payment Arrangement, Dividend Equivalent Units Accrual				(2)
Common Dividends	(439)			(439)
Dividends, Preferred Stock							(10)					(10)
Repurchase of common stock	(756)		(171)	(585)
Issuance of Corteva stock	40		40				40				40
Other - net	(9)					(9)	(6)				(3)	(2)		(1)
Ending Balance at Dec. 31, 2023	$ 25,279	7	27,748	(41)	(2,677)	242	25,660		239	0	24,349	3,747	(2,677)	2	0
Common Stock, Dividends, Per Share, Declared	$ 0.62
Net income (loss)	$ 919			907		12	949					947		2
Other comprehensive income (loss)	(792)				(792)		(792)						(792)
Due from Parent							(129)								(129)
Share based compensation	45		47				45				47	(2)
Retained Earnings, Share-based Payment Arrangement, Dividend Equivalent Units Accrual				(2)
Common Dividends	(458)			(229)
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings			(229)
Dividends, Preferred Stock							(10)					(10)
Repurchase of common stock	(1,009)		(430)	(579)
Issuance of Corteva stock	60		60				60				60
Dividend to Parent							(1,750)					(1,750)
Other - net	(14)			(1)		(13)	4				8	(2)		(2)
Ending Balance at Dec. 31, 2024	$ 24,030	7	27,196	55	(3,469)	241	24,037		239	0	24,464	2,930	(3,469)	2	(129)
Common Stock, Dividends, Per Share, Declared	$ 0.66
Net income (loss)	$ 1,105			1,094		11	1,105					1,104		1
Other comprehensive income (loss)	672				672		672						672
Due from Parent							129								129
Share based compensation	55		57				55				57	(2)
Retained Earnings, Share-based Payment Arrangement, Dividend Equivalent Units Accrual				(2)
Common Dividends	(475)			(359)
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings			(116)
Dividends, Preferred Stock							(10)					(10)
Repurchase of common stock	(1,071)		(221)	(850)
Issuance of Corteva stock	88		88				88				88
Dividend to Parent								$ (1,815)				(1,815)
Other - net	(18)		(3)	(5)		(10)	1				1
Ending Balance at Dec. 31, 2025	$ 24,386	$ 7	$ 27,001	$ (67)	$ (2,797)	$ 242	$ 24,262		$ 239	$ 0	$ 24,610	$ 2,207	$ (2,797)	$ 3	$ 0
Common Stock, Dividends, Per Share, Declared	$ 0.70

Commitments and Contingent Liabilities Litigation - Chemours Separation (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($) lawsuits	Dec. 31, 2029 USD ($)	Dec. 31, 2028 USD ($)	Sep. 30, 2028 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2022 USD ($)
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29.00%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%
Accounts and Notes Receivable [Member] \| Corteva [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 188
Accounts and Notes Receivable [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Indemnification Assets	138				$ 43
Other Assets [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Indemnification Assets	470				280
Accrued and Other Current Liabilities [Member] \| Corteva [Member]
Loss Contingencies [Line Items]
Estimated Litigation Liability	874				228
PFAS [Member]
Loss Contingencies [Line Items]
MOU Terms for Withdrawals	125
Withdrawal Amount after Year 6		$ 200
Threshold to waive MOU escrow account funding obligation						$ 100
MOU Escrow Account Balance	$ 105
PFAS [Member] \| Forecast [Member]
Loss Contingencies [Line Items]
Escrow Account Balance			$ 700
PFAS [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term	20 years
Qualified Spend and Escrow Account Contribution Threshold	$ 4,000
PFAS [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Escrow Account Deposit Percentage	50.00%
PFAS [Member] \| Corteva [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold	$ 600
PFAS [Member] \| Corteva and DuPont
Loss Contingencies [Line Items]
Corteva and DuPont stray liability sharing percentage for PFAS	50.00%
Amount credited to each company's threshold	$ 150
Escrow Account Deposit Percentage	50.00%
PFAS [Member] \| Corteva and DuPont \| Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold	$ 2,000
Corteva and Dupont stray liability threshold for PFAS	$ 300
PFAS [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Annual escrow deposit							$ 100
PFAS [Member] \| DuPont de Nemours and Corteva [Member]
Loss Contingencies [Line Items]
Annual escrow deposit							$ 100
PFAS [Member] \| No later than September 30 of each subsequent year through and including 2028 \| Chemours [Member] \| Subsequent Event
Loss Contingencies [Line Items]
Annual escrow deposit, remainder of period				$ 50
PFAS [Member] \| No later than September 30 of each subsequent year through and including 2028 \| Chemours [Member] \| Subsequent Event \| Maximum [Member]
Loss Contingencies [Line Items]
Total Escrow Deposit Amount				500
PFAS [Member] \| No later than September 30 of each subsequent year through and including 2028 \| Corteva and DuPont \| Subsequent Event
Loss Contingencies [Line Items]
Annual escrow deposit, remainder of period				50
PFAS [Member] \| No later than September 30 of each subsequent year through and including 2028 \| Corteva and DuPont \| Subsequent Event \| Maximum [Member]
Loss Contingencies [Line Items]
Total Escrow Deposit Amount				$ 500
Asbestos Issue
Loss Contingencies [Line Items]
Pending Lawsuits, Number \| lawsuits	900
Asbestos Issue \| Chemours [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 87				38
Estimated Litigation Liability	$ 88				$ 38

Consolidated Balance Sheets (Parentheticals) - USD ($)	12 Months Ended
Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Common Stock, Par Value	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,666,667,000	1,666,667,000
Common Stock, Shares, Outstanding	672,163,000	685,595,000
Corteva [Member]
Common Stock, Par Value	$ 0.01
EIDP
Common Stock, Par Value	$ 0.30	$ 0.30
Common Stock, Shares Authorized	1,800,000,000	1,800,000,000
Common Stock, Shares, Outstanding	200	200
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Shares Authorized	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 4.50	$ 4.50
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Shares Authorized	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 3.50	$ 3.50

Background and Basis of Presentation (Policies)	12 Months Ended
Background and Basis of Presentation (Policies)	Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	Principles of Consolidation and Basis of Presentation

Background and Basis of Presentation (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of Reportable Segments	2
Percentage of Annual Net Sales	3.00%
Percentage of Segment Operating EBITDA	1.00%
Debt Securities, AFS, Amortized Cost, Maturity after year one to five years	$ 30
Percentage deterioration of the official Peso to USD exchange rate	10.00%

Fair Value Measurements

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

FAIR VALUE MEASUREMENTS

The table below summarizes the basis used to measure certain assets and liabilities relating to marketable securities and derivative assets and liabilities at fair value on a recurring basis.


Significant Other Observable Inputs	December 31, 2025		December 31, 2024
(In millions)	Level 2 1		Level 2 1
Assets at fair value:
Marketable securities	$	1	$	63
Debt securities:
Foreign government bonds 2	30		97
Derivatives relating to: 3
Foreign currency	28		71
Commodity contracts	4		20

Total assets at fair value	$	63	$	251
Liabilities at fair value:
Derivatives relating to: 3
Foreign currency	$	41	$	104
Commodity contracts	9		7
Total liabilities at fair value	$	50	$	111

1.Reflects significant other observable inputs.

2.Represents the company's investments in debt securities that are classified as available-for-sale, which are included in the Consolidated Balance Sheets.

3.See Note 19 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.

For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 19 - Financial Instruments, to the Consolidated Financial Statements, for further information on the types of instruments used by the company for risk management.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2025 and 2024.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.

Fair Value Measurements on a Nonrecurring Basis

As part of the Crop Protection Operations Strategy Restructuring Program, the company plans to exit its production activities at its site in Pittsburg, California, as well as cease operations in select manufacturing lines at other locations. During the year ended December 31, 2023, the company recognized a pre-tax non-cash impairment charge of $152 million to restructuring and asset related charges – net, in the Consolidated Statement of Operations, consisting of a charge of $92 million and $60 million relating to operating lease assets and property, plant and equipment, respectively, which were classified as Level 3 measurements using unobservable inputs.

See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

Income Tax Disclosure [Text Block]

Commitments and Contingent Liabilities Litigation - Ohio / New York / Other Natural Resource Damages / Netherlands / Fayatteville (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2025 USD ($)	Dec. 31, 2025 USD ($) lawsuits	Dec. 31, 2024 lawsuits
OHIO \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits		2
Litigation Settlement Amount		$ 110,000,000
OHIO \| PFOA Matters: Drinking Water Actions [Member] \| Corteva Contribution to Ohio NRD Settlement
Loss Contingencies [Line Items]
Litigation Settlement Amount		16,000,000
Payments for Legal Settlements		13,000,000
NEW YORK \| Baker Class Action [Member]
Loss Contingencies [Line Items]
Litigation Settlement Amount	$ 22,000,000
Litigation Settlement, Amount Awarded to Other Party, Supplemental Payment	$ 1,000,000
Period for supplemental payment	5 years
DELAWARE \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Collective Threshold for Payments to Fund the NRST Trust		50,000,000
Supplemental Payment Threshold		$ 25,000,000
NETHERLANDS \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits			4
NORTH CAROLINA \| PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners		2,400

Geographic Information Net Property by Country (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	$ 4,220	$ 4,099	$ 4,287
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	2,879	2,878	2,922
CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	100	101	119
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	573	522	548
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	82	84	90
Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	$ 586	$ 514	$ 608

Leases Lease Costs (Details) - USD ($) $ in Millions	12 Months Ended
Leases Lease Costs (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating Lease, Cost	$ 161	$ 176	$ 169
Finance Lease, Right-of-Use Asset, Amortization	0	1	1
Finance Lease, Cost	0	1	1
Short-term Lease, Cost	37	27	23
Variable Lease, Cost	7	8	11
Total Lease Cost	$ 205	$ 212	$ 204

EIDP Income Taxes (Notes)

12 Months Ended

Dec. 31, 2025

INCOME TAXES

Domestic and foreign components of income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	324	$	(414)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Current tax expense (benefit)
Federal	$	87	$	285	$	143
State and local	26		45		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	777	$	590
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		412		152
Net income (loss) from continuing operations after taxes	$	1,204	$	863	$	941

The table below provides the updated disclosure requirements of ASU 2023-09, which was adopted on a prospective basis for the year ended December 31, 2025. See Note 3 - Recent Accounting Guidance, to the Consolidated Financial Statements, for a description of the relevant disclosure requirements.

The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2025
($ In millions)	$		%
U.S. Federal statutory tax rate	$	354	21.0	%
State and local income tax, net of federal (national) income tax effect 1	5		0.3	%
Foreign tax effects
Argentina
Statutory tax rate differential	(17)		(1.0)	%
Withholding tax	18		1.1	%
Exchange gains/losses	(31)		(1.8)	%
Changes in valuation allowances	73		4.3	%
Other	(3)		(0.2)	%
Brazil

Withholding tax	37		2.2	%
Changes in valuation allowances 2	153		9.1	%
Other	(4)		(0.2)	%
India
Statutory tax rate differential	17		1.0	%
Agriculture exemption	(41)		(2.4)	%
Withholding tax	31		1.8	%
Other	1		0.1	%
Switzerland
Statutory tax rate differential	(91)		(5.4)	%
Cantonal income tax, net	59		3.5	%
Other	(1)		(0.1)	%
Other foreign jurisdictions	49		2.9	%
Effect of cross-border tax laws (net of related foreign tax credits)
Global Intangible Low-Taxed Income (GILTI)	24		1.4	%
Other	12		0.7	%
Tax credits
U.S. research and development credit	(47)		(2.8)	%
Other foreign tax credits	(52)		(3.1)	%
Changes in valuation allowances 3	74		4.4	%
Nontaxable or nondeductible items	31		1.8	%
Changes in unrecognized tax benefits	(19)		(1.1)	%
Other
Capital loss 3	(77)		(4.6)	%
Legal entity tax characterization 4	(49)		(2.9)	%
Other	(22)		(1.3)	%
Effective tax rate	$	484	28.7	%

1.State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.

2.For the year ended December 31, 2025, the company established a valuation allowance recorded against the net deferred tax asset position of a legal entity in Brazil (Crop Protection business) in the amount of $132 million.

3.For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.

4.For the year ended December 31, 2025, a U.S. federal deferred tax benefit was recorded associated with a change in a legal entity's U.S. tax characterization in the amount of $(49) million.

As previously disclosed for the years ended December 31, 2024 and 2023, prior to the adoption of ASU 2023-09, the effective income tax rate differs from the statutory federal income tax rate as follows:


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.8		(1.8)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.7)		(5.9)
Exchange gains/losses 3	1.7		2.0
State and local incomes taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(7.9)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.5)
Tax settlements and expiration of statute of limitations	(1.7)		(0.3)

Impact of Brazil valuation allowance 6	9.4		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	0.1		(0.1)
Effective tax rate on income from continuing operations	32.3	%	13.9	%

1. Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results.

2. Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.

3. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, to the Consolidated Financial Statements, under the heading "Foreign Currency Risk."

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

Significant jurisdictions in which income taxes were paid (net of refunds received) are shown below:


Income Taxes Paid, Net	For the Year Ended December 31,
(In millions)	2025
US Federal	$	195
US State and Local	49
Brazil	72
India	42
Switzerland, Federal	59
Switzerland, Geneva	46
Other Foreign	287
Total	$	750

Significant components of the company's net deferred tax asset (liability) were attributable to:


Deferred Tax Balances	December 31, 2025				December 31, 2024
(In millions)	Assets		Liabilities		Assets		Liabilities
Property	$	—	$	347	$	—	$	278
Operating loss and tax credit carryforwards 1	631		—		552		—
Accrued employee benefits	678		—		671		—
Other accruals and reserves	767		—		590		—
Intangibles	—		1,828		—		1,950
Inventory	275		—		184		—
Research and development capitalization	689		—		761		—
Investments	53		—		69		—
Unrealized exchange gains/losses	—		4		—		50
Other – net	42		—		40		—
Subtotal	$	3,135	$	2,179	$	2,867	$	2,278
Valuation allowances 2	(887)		—		(666)		—
Total	$	2,248	$	2,179	$	2,201	$	2,278
Net deferred tax asset (liability)	$	69			$	(77)

1. Primarily related to tax loss and credit carryforwards from operations in the United States, Argentina, Brazil, Switzerland, and Spain.

2. During the year ended December 31, 2025, the company established a valuation allowance recorded against the net deferred tax asset position of a legal entity in Brazil (Crop Protection business) in the amount of $132 million. During the year ended December 31, 2024, the company established a valuation allowance against the net deferred tax asset position of a legal entity in Brazil (Seed business) in the amount of $120 million.

Details of the company’s operating loss and tax credit carryforwards are shown in the following table:


Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	December 31, 2025		December 31, 2024
Operating loss carryforwards
Expire within 5 years	$	290	$	222
Expire after 5 years or indefinite expiration	213		226
Total operating loss carryforwards	$	503	$	448
Tax credit carryforwards
Expire within 5 years	$	25	$	13
Expire after 5 years or indefinite expiration	103		91
Total tax credit carryforwards	$	128	$	104
Total operating loss and tax credit carryforwards	$	631	$	552

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:


Total Gross Unrecognized Tax Benefits	For the Year Ended December 31,
(In millions)	2025		2024		2023
Total unrecognized tax benefits as of beginning of period	$	263	$	390	$	357
Decreases related to positions taken on items from prior years	(1)		(4)		—
Increases related to positions taken on items from prior years	94		13		23
Increases related to positions taken in the current year	9		12		16
Settlement of uncertain tax positions with tax authorities	(24)		(140)		(4)
Decreases due to expiration of statutes of limitations	(5)		(5)		(2)
Exchange (gain) loss	(1)		(3)		—
Total unrecognized tax benefits as of end of period	$	335	$	263	$	390
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	243	$	176	$	173
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations	$	(9)	$	(4)	$	1
Total accrual (receivable) for interest and penalties associated with unrecognized tax benefits at end of period	$	(15)	$	(2)	$	11

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. As of December 31, 2025 and 2024, the company has an advance deposit balance of $95 million and $100 million, respectively, to a foreign taxing authority, partially as a prerequisite to petition the court related to an open tax examination. These payments are accounted for as a prepaid asset, included in other assets in the Consolidated Balance Sheets.

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:


Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2025			Earliest Open Year
Jurisdiction
Argentina			2018
Brazil			2018
Canada			2017
China			2015
France			2023
India			2023
Italy			2019
Spain			2020
Switzerland			2020
United States:
Federal income tax			2012
State and local income tax			2012

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be indefinitely invested amounted to $4,158 million at December 31, 2025. Distributions of profits from non-U.S. subsidiaries are subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply; these taxes are partially offset by U.S. foreign tax credits. The company is asserting indefinite reinvestment related to certain investments in foreign subsidiaries. Determination of the amount of unrecognized deferred tax liability related to indefinitely reinvested profits is not feasible primarily due to our legal entity structure and the complexity of U.S. and local tax laws.

For periods between the Merger on August 31, 2017, and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent federal and/or state corporate income tax

liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or Tax Matters Agreement. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements for further information related to indemnifications between Corteva, DuPont and Dow.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law, enacting changes in a wide array of policy areas, including federal tax law. The impacts of OBBBA are included in the financial statements for the year ended December 31, 2025, including the reinstatement of expensing of domestic research and development expenditures.

On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act of 2022 (“the Act”). The Act includes tax provisions, among other things, which implement (i) a 15 percent minimum tax on book income of certain large corporations and (ii) a one percent excise tax on net stock repurchases. The Act did not have a material impact on the company’s financial position, results of operations or cash flows.

In December 2021, the Organization for Economic Cooperation and Development ("OECD") released the Pillar Two Model rules (also referred to as the global minimum tax or Global Anti-Base Erosion "GloBE" rules), which were designed to ensure multinational enterprises pay a certain level of tax within every jurisdiction in which they operate. Several jurisdictions in which we operate have enacted these rules. For the year ended December 31, 2025, there is no material tax charge associated with these rules. The company will continue to monitor and evaluate legislative developments.

Income Tax Disclosure [Text Block]

INCOME TAXES

Refer to page F-23 of the Corteva, Inc. Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EIDP. Since the reconciliation to the U.S. statutory rate for the year ended December 31, 2025 is the same for both Corteva, Inc. and EIDP, such information is omitted from the table below.


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	363	$	(434)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,314	$	1,073
Current tax expense (benefit)
Federal	$	87	$	292	$	138
State and local	26		47		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	786	$	585
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		421		147
Net income (loss) from continuing operations	$	1,204	$	893	$	926


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.6		(1.9)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.5)		(6.0)
Exchange gains/losses 3	1.7		2.0
State and local income taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(8.0)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.6)
Tax settlements and expiration of statute of limitations	(1.6)		(0.4)
Impact of Brazil valuation allowance 6	9.1		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	—		0.2
Effective tax rate	32.0	%	13.7	%

2. Includes a tax charge of $46 million for the year ended December 31, 2023 associated with intellectual property realignment.

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

The entire disclosure for income tax.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

Accounts and Notes Receivable, Net Customer Financing (Details) - Factoring Agreement [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade Receivables Sold That Remained Outstanding with an element of recourse	$ 17	$ 15
Loss on Sale of Accounts Receivable	5	9	$ 17
Trade Receivables Sold	$ 166	$ 131	$ 112

DEI Document - USD ($)	12 Months Ended
DEI Document - USD ($)	Dec. 31, 2025	Feb. 05, 2026	Jun. 30, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jun. 03, 2019
Document Information [Line Items]
Document Annual Report	true
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2025
Entity Registrant Name	Corteva, Inc.
Entity Incorporation, State or Country Code	DE
Entity Central Index Key	0001755672
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
ICFR Auditor Attestation Flag	true
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Document Financial Statement Error Correction [Flag]	false
Aggregate market value			$ 50,600,000,000
Entity Common Stock, Shares Outstanding		672,524,000
Common Stock, Par Value	$ 0.01	$ 0.01		$ 0.01			$ 0.01
Entity Small Business	false
Entity Shell Company	false
Document Transition Report	false
Entity File Number	001-38710
Entity Tax Identification Number	82-4979096
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Documents Incorporated by Reference [Text Block]	Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2026 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy).
Auditor Location	Philadelphia, Pennsylvania
Auditor Name	PricewaterhouseCoopers LLP
Common Stock, Shares, Outstanding	672,163,000			685,595,000	701,260,000	713,419,000
Other Address
Document Information [Line Items]
Entity Address, Address Line One	1000 N. West Street, Suite 900,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19801
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CTVA
Security Exchange Name	NYSE
EIDP
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2025
Entity Registrant Name	EIDP, Inc.
Entity Incorporation, State or Country Code	DE
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
ICFR Auditor Attestation Flag	true
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Document Financial Statement Error Correction [Flag]	false
Entity Common Stock, Shares Outstanding		200
Common Stock, Par Value	$ 0.30	$ 0.30		$ 0.30
Entity Small Business	false
Entity Shell Company	false
Entity File Number	1-815
Entity Tax Identification Number	51-0014090
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Common Stock, Shares, Outstanding	200			200
EIDP \| Other Address
Document Information [Line Items]
Entity Address, Address Line One	1000 N. West Street, Suite 900,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19801
EIDP \| $3.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$3.50 Series Preferred Stock
Trading Symbol	CTAPrA
Security Exchange Name	NYSE
EIDP \| $4.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$4.50 Series Preferred Stock
Trading Symbol	CTAPrB
Security Exchange Name	NYSE

Stock-Based Compensation Stock Compensation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 78	$ 64	$ 54
Tax Benefit from Compensation Benefit	$ (15)	$ (12)	$ (10)
OIP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant	20,000,000
Shares authorized for future grants	8,000,000

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Revenue Disaggregation of Revenue - Geo (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

$ 17,401

$ 16,908

$ 17,226

17,401

16,908

17,226

EMEA

3,110

3,124

3,367

Latin America

^[1]

3,928

3,776

3,906

Asia Pacific

1,339

1,348

1,363

Seed [Member] | Segments

Seed [Member] | North America [Member]

9,898

9,545

9,472

^[2]

6,271

6,033

5,768

Seed [Member] | EMEA

Seed [Member] | Latin America

^[3]

1,560

1,581

1,622

Seed [Member] | Asia Pacific

1,614

1,523

1,637

Crop Protection [Member] | Segments

453

408

445

Crop Protection [Member] | North America [Member]

7,503

7,363

7,754

Crop Protection [Member] | EMEA

^[2]

2,753

2,627

2,822

Crop Protection [Member] | Latin America

^[3]

1,550

1,543

1,745

Crop Protection [Member] | Asia Pacific

2,314

2,253

2,269

$ 886

$ 940

$ 918

[1]	Net sales for Brazil for the years ended December 31, 2025, 2024 and 2023 were $2,900 million, $2,618 million and $2,523 million, respectively.
[2]	Represents U.S. & Canada.
[3]	Europe, Middle East, and Africa ("EMEA")

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Segment Reporting (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Income (Loss) from Continuing Operations After Taxes

$ 1,204

$ 863

$ 941

Provision for (benefit from) income taxes on continuing operations

484

412

152

Income (loss) from Continuing Operations before Income Taxes

1,688

1,275

1,093

136

132

283

180

233

^[1]

(181)

(284)

(397)

Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]

Depreciation and amortization

1,203

1,227

1,211

(136)

(132)

(283)

180

233

Non-operating (benefits) costs - net

181

284

397

174

151

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges

Significant items

658

315

579

Corporate

Corporate Expenses

138

115

110

Commitments and Contingencies Disclosure [Abstract]

$ 3,986

$ 3,491

[1]	Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.

Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target	0.00%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target	200.00%
RSUs and PSUs - OIP [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period	$ 64.49	$ 54.56	$ 62.22
Fair Value of RSUs and PSUs vested during the period	$ 73	$ 63	$ 58
Unrecognized Pretax Compensation Expense Related to RSUs and PSUs	$ 65
Remaining Weighted-Average Recognition Period	1 year 25 days
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity award conversion ratio	1
RSU Requisite Service Period	6 months
Restricted Stock Units and Performance Deferred Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested RSUs and PSUs at beginning of period	3,643,000
PSUs granted during the period	1,344,000
RSUs and PSUs vested during the period	(1,352,000)
RSUs and PSUs forfeited during the period	(272,000)
Nonvested RSUs and PSUs at end of period	3,363,000	3,643,000
Weighted average grant date fair value, nonvested RSUs and PSUs beginning of period	$ 55.12
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period	64.49
Weighted Average Grant Date Fair Value, vested RSUs and PSUs during the period	53.99
Weighted Average Grant Date Fair Value, RSUs and PSUs forfeited during the period	58.04
Weighted average grant date fair value, nonvested RSUs and PSUs end of period	$ 59.10	$ 55.12
Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSUs granted during the period	292,890
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period	$ 64.71
Management [Member] \| Restricted Stock Units (RSUs) [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU Award Vesting Period	3 years
Management [Member] \| Restricted Stock Units (RSUs) [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU Award Vesting Period	5 years
OIP [Member] \| Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU Award Vesting Period	3 years

Commitments and Contingent Liabilities (Tables)

12 Months Ended

Dec. 31, 2025

Supplier Finance Program


(In millions)
Confirmed obligations outstanding at December 31, 2023	$	115
Invoices confirmed during the year	571
Confirmed invoices paid during the year	(598)
Confirmed obligations outstanding at December 31, 2024	$	88
Invoices confirmed during the year	690
Confirmed invoices paid during the year	(657)
Confirmed obligations outstanding at December 31, 2025	$	121

Schedule of Environmental Loss Contingencies


	As of December 31, 2025
(In millions)	Indemnification asset		Accrual balance 3		Potential exposure above amount accrued 3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity 1,2	$	254	$	264	$	204
Other discontinued or divested businesses obligations 1	33		71		201

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont 2	50		55		55

Environmental remediation liabilities not subject to indemnity	—		112		86

Indemnification liabilities related to the MOU 4	—		60		7
Total	$	337	$	562	$	553

1.Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page F-37, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $22 million related to the Superfund sites.

3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $49 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page F-43 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the North Carolina Department of Environmental Quality ("NC DEQ").

4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-36, under the header "Chemours Separation Agreement (Performance Chemicals).

EIDP Basis of Presentation (Notes)	12 Months Ended
EIDP Basis of Presentation (Notes)	Dec. 31, 2025
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 - BACKGROUND AND BASIS OF PRESENTATION Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two operating segments: Seed and Crop Protection. See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's operating segments. Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EIDP) and the term “EIDP” used herein means EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) and its consolidated subsidiaries or EIDP, Inc. excluding its consolidated subsidiaries, as the context may indicate. Principles of Consolidation and Basis of Presentation The consolidated financial statements contained in this Annual Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the company, its majority owned subsidiaries over which the company exercises control. The Consolidated Financial Statements and other financial information included in this Annual Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations. On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation of the agriculture business (the “Corteva Separation”) of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The Corteva Separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock of Corteva, Inc. Prior to the Corteva Separation, subsequent to the Merger, Historical Dow and EIDP engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products ("Internal Reorganization"). On April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow common stock to holders of DowDuPont's common stock (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”). On April 1, 2019, Historical Dow entities, which held certain assets and liabilities aligned with Historical Dow’s agriculture business and the assets and liabilities associated with its specialty products business, respectively, were transferred and conveyed to DowDuPont. On April 1, 2019 and May 1, 2019, EIDP’s materials science and specialty products entities, along with their respective assets and liabilities, were conveyed to Dow and DowDuPont, respectively. On May 2, 2019, DowDuPont conveyed Historical Dow agricultural entities to EIDP. On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On May 31, 2019, DowDuPont contributed EIDP to Corteva, Inc. and on June 1, 2019, the Corteva Separation was completed. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements. Since 2018, Argentina has been considered a highly-inflationary economy under U.S. GAAP and, therefore, the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 3 percent to the company's annual net sales and approximately 1 percent to each of the company's annual Seed and Crop Protection segment operating EBITDA. The company remeasures net monetary assets and translates the financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the Consolidated Financial Statements). The Argentina government has offered USD-denominated bonds to importers, the proceeds from which could be used to pay off outstanding intercompany payables. As of December 31, 2025, the company holds these foreign government bonds with an amortized cost of $30 million as part of its strategy to manage its net monetary asset exposure in Argentina. Refer to the “Debt Securities” section in Note 19 - Financial Instruments, to the Consolidated Financial Statements, for additional information. As of December 31, 2025, a further 10 percent deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of our net monetary assets or pre-tax earnings. The company will continue to assess the implications to its operations and financial reporting.
EIDP
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION Corteva, Inc. owns 100 percent of the outstanding common stock of EIDP. EIDP is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EIDP are outlined below: •Preferred Stock - EIDP has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest at the Corteva, Inc. level. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Separation remains issued and outstanding as to EIDP and was unaffected by the Corteva Separation. •Related Party Loan - EIDP engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remained on EIDP's consolidated financial statements at the standalone level (including the associated interest) through its repayment date in the fourth quarter of 2023. •Master In-House Banking Agreement - A Master In-House Banking Agreement exists to which EIDP is a party, along with Corteva and certain consolidated subsidiaries, as more fully described in EIDP Note 2 – Related Party Transactions, of the EIDP Consolidated Financial Statements. Through the third quarter of 2024, EIDP earned interest on Corteva, Inc.’s borrowings under the Master In-House Banking Agreement; however, beginning in the fourth quarter of 2024 no interest has been recognized by EIDP and the amount due from Corteva, Inc. is classified within equity of EIDP due to a change in repayment intent related to the arrangement. Such transactions are eliminated in consolidation at the Corteva, Inc. level. •Dividends - The Board of Directors of EIDP authorizes and declares a quarterly dividend to Corteva, Inc., from which the proceeds are intended to be used to fund Corteva, Inc. share repurchases and common stock dividends during the subsequent quarter. •Capital Structure - At December 31, 2025, Corteva, Inc.'s capital structure consists of 672,163,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EIDP only, and not to Corteva, Inc., and are presented to show differences between EIDP and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: •Note 1 - Background and Basis of Presentation - refer to page F-11 of the Corteva, Inc. Consolidated Financial Statements •Note 2 - Summary of Significant Accounting Policies - refer to page F-12 of the Corteva, Inc. Consolidated Financial Statements •Note 3 - Recent Accounting Guidance - refer to page F-16 of the Corteva, Inc. Consolidated Financial Statements •Note 4 - Revenue - refer to page F-17 of the Corteva, Inc. Consolidated Financial Statements •Note 5 - Restructuring and Asset Related Charges - Net - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements •Note 6 - Supplementary Information - refer to page F-21 of the Corteva, Inc. Consolidated Financial Statements. In addition, EIDP earned interest on a related party loan receivable from Corteva, Inc. through the third quarter of 2024; refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements, below •Note 7 - Income Taxes - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 3 - Income Taxes, of the EIDP Consolidated Financial Statements, below •Note 8 - Earnings Per Share of Common Stock - Not applicable for EIDP •Note 9 - Accounts and Notes Receivable - Net - refer to page F-29 of the Corteva, Inc. Consolidated Financial Statements •Note 10 - Inventories - refer to page F-30 of the Corteva, Inc. Consolidated Financial Statements •Note 11 - Property, Plant and Equipment - refer to page F-30 of the Corteva, Inc. Consolidated Financial Statements •Note 12 - Goodwill and Other Intangible Assets - refer to page F-30 of the Corteva, Inc. Consolidated Financial Statements •Note 13 - Leases - refer to page F-31 of the Corteva, Inc. Consolidated Financial Statements •Note 14 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page F-33 of the Corteva, Inc. Consolidated Financial Statements. In addition, EIDP had a related party loan payable to Corteva, Inc. which was repaid during the fourth quarter of 2023; refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements, below •Note 15 - Commitments and Contingent Liabilities - refer to page F-35 of the Corteva, Inc. Consolidated Financial Statements •Note 16 - Stockholders' Equity - refer to page F-45 of the Corteva, Inc. Consolidated Financial Statements •Note 17 - Pension Plans and Other Post-Employment Benefits - refer to page F-47 of the Corteva, Inc. Consolidated Financial Statements •Note 18 - Stock-Based Compensation - refer to page F-56 of the Corteva, Inc. Consolidated Financial Statements •Note 19 - Financial Instruments - refer to page F-58 of the Corteva, Inc. Consolidated Financial Statements •Note 20 - Fair Value Measurements - refer to page F-63 of the Corteva, Inc. Consolidated Financial Statements •Note 21 - Geographic Information - refer to page F-64 of the Corteva, Inc. Consolidated Financial Statements •Note 22 - Segment Information - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 4 - Segment Information, of the EIDP Consolidated Financial Statements, below

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with each VIE does not provide it the power to direct the VIE's significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2025 and 2024, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates in Financial Statement Preparation

The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash equivalents represent highly liquid investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.

Restricted Cash Equivalents

Restricted cash equivalents primarily relates to a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 6 - Supplementary Information, to the Consolidated Financial Statements, for further information.

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.

Fair Value Measurements

Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The company uses the following hierarchy to classify assets and liabilities measured at fair value:


Level 1	–	Quoted market prices in active markets for identical assets or liabilities.

Level 2	–	Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs).

Level 3	–	Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation

The company's worldwide operations utilize the USD or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: (i) extension of the parent or foreign subsidiaries operating in a highly-inflationary environment (USD functional currency) and (ii) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories

The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of both December 31, 2025 and 2024, approximately 60 percent and 40 percent of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 10 - Inventories, to the Consolidated Financial Statements, for further information.

The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.

Goodwill and Other Intangible Assets

The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter at the reporting unit level, which is defined as the operating segment or one level below the operating segment. One level below the operating segment, or component, is a business in which discrete financial information is available and regularly reviewed by segment management. The company aggregates certain components into reporting units based on economic similarities. The company’s reporting units are Seed and Crop Protection.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach). Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis include future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. See Note 12 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are no longer considered held and used, they are removed from the Consolidated Balance Sheets.

Acquisitions

Acquisitions are recorded using the acquisition method of accounting which recognizes and measures the identifiable assets acquired and liabilities assumed as of the acquisition date at fair value, where applicable. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired and liabilities assumed is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred. The company includes the operating results of acquired entities from their respective dates of acquisition.

Leases

The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.

Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. The company recognizes lease expense for these leases on a straight-line basis over the lease term.

The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 13 - Leases, to the Consolidated Financial Statements, for further information.

Impairment of Long-Lived Assets

The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset group. The company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments

Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction

matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 19 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Revenue Recognition

The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine the revenue recognition for an arrangement considered to be a contract with a customer, the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 4 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.

Cost of Goods Sold

Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold.

Research and Development

Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.

Selling, General and Administrative Expenses

Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Litigation and Other Contingencies

Accruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs

Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

Insurance/Self-Insurance

The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes

The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or accounts and notes receivable - net, and the long-term portion is included in other noncurrent obligations or other assets in the Consolidated Balance Sheets.

Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.

Earnings per Common Share

The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.

Financial Instruments Derivatives (Details) - Designated as Hedging Instrument [Member] € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2025 EUR (€)	May 31, 2025 EUR (€)	Mar. 31, 2025 EUR (€)	Jul. 31, 2024 EUR (€)	May 31, 2024 EUR (€)	Feb. 29, 2024 EUR (€)	Mar. 31, 2020 EUR (€)
Commodity Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Beginning Balance	$ (49)	$ (71)	$ 55
Additions and revaluations of derivatives designated as cash flow hedges	3	(29)	(87)
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred	55	51	(39)
Ending Balance	9	(49)	(71)
After-tax net gain to be reclassified from AOCL into earnings over the next twelve months	19
Derivative, Remaining Maturity				2 years
Foreign Exchange Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Beginning Balance	13	1	10
Additions and revaluations of derivatives designated as cash flow hedges	5	19	(36)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(13)	(7)	27
Ending Balance	5	$ 13	$ 1
After-tax net gain to be reclassified from AOCL into earnings over the next twelve months	$ 5
Derivative, Remaining Maturity				2 years
Foreign Exchange Contract [Member] \| Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount \| €				€ 500	€ 1,200	€ 1,700	€ 500	€ 500	€ 1,200	€ 450

EIDP Income Taxes Rate Reconciliation (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Effective Income Tax Rate Reconciliation [Line Items]

21.00%

(2.80%)

^[1]

0.30%

^[2]

4.40%

Effective Income Tax Rate Reconciliation, Percent

(1.30%)

28.70%

Continuing Operations [Member]

Effective Income Tax Rate Reconciliation [Line Items]

Effective tax rates on international operations - net

21.00%

^[3]

(4.80%)

1.80%

Acquisitions, divestitures, and ownership restructuring activities

^[4]

1.10%

(3.60%)

(4.70%)

(5.90%)

^[5]

1.70%

2.00%

Impact of Swiss Tax Changes

1.30%

0.90%

^[6]

0.00%

(7.90%)

Excess tax benefits (tax deficiency) from stock-compensation

0.20%

0.50%

Tax settlements and expiration of statue of limitations

(1.70%)

(0.30%)

Repatriation of Foreign Earnings

^[7]

9.40%

0.00%

^[8]

1.70%

2.90%

Deferred Other Tax Expense (Benefit)

0.10%

(0.10%)

$ (62)

Continuing Operations [Member] | Brazil Valuation Allowance [Member] | Seed [Member]

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | Intellectual Property Realigment

120

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | Tax Currency Change

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | EIDP

$ (24)

Effective Income Tax Rate Reconciliation [Line Items]

Effective tax rates on international operations - net

21.00%

^[9]

4.60%

(1.90%)

Acquisitions, divestitures, and ownership restructuring activities

^[10]

(1.10%)

3.60%

(4.50%)

(6.00%)

^[11]

1.70%

2.00%

Impact of Swiss Tax Changes

1.30%

0.90%

^[12]

0.00%

(8.00%)

Excess tax benefits (tax deficiency) from stock-compensation

(0.20%)

(0.60%)

Tax settlements and expiration of statue of limitations

(1.60%)

(0.40%)

Repatriation of Foreign Earnings

^[13]

1.70%

2.90%

Effective Income Tax Rate Reconciliation, Percent

0.00%

0.20%

32.00%

13.70%

Deferred Other Tax Expense (Benefit)

$ (62)

Continuing Operations [Member] | EIDP | Brazil Valuation Allowance [Member]

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | EIDP | Brazil Valuation Allowance [Member] | Seed [Member]

^[14]

9.10%

0.00%

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | EIDP | Intellectual Property Realigment

$ 120

Effective Income Tax Rate Reconciliation [Line Items]

Continuing Operations [Member] | EIDP | Tax Currency Change

$ 46

Effective Income Tax Rate Reconciliation [Line Items]

Earnings Per Share [Text Block]

$ (24)

[1]	State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.
[2]	For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.
[3]	Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results.
[4]	Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.
[5]	Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, to the Consolidated Financial Statements, under the heading "Foreign Currency Risk."
[6]	Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.
[7]	For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position ofa legal entity in Brazil (Seed business).
[8]	Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.
[9]	Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results.
[10]	Includes a tax charge of $46 million for the year ended December 31, 2023 associated with intellectual property realignment.
[11]	Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, under the heading Foreign Currency Risk.
[12]	Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.
[13]	Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.
[14]	For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of a legal entity in Brazil (Seed business).

Earnings Per Share of Common Stock (Notes)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

EARNINGS PER SHARE OF COMMON STOCK

The following tables provide earnings per share calculations for the periods indicated below:


Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	863	$	941
Net income (loss) attributable to continuing operations noncontrolling interests	11		12		12

Income (loss) from continuing operations available to Corteva common stockholders	$	1,193	$	851	$	929


Income (loss) from discontinued operations available to Corteva common stockholders	(99)		56		(194)
Net income (loss) available to common stockholders	$	1,094	$	907	$	735


Earnings (Loss) Per Share Calculations - Basic	For the Year Ended December 31,
(Dollars per share)	2025		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	1.75	$	1.23	$	1.31
Earnings (loss) per share of common stock from discontinued operations	(0.15)		0.08		(0.27)
Earnings (loss) per share of common stock	$	1.60	$	1.31	$	1.04


Earnings (Loss) Per Share Calculations - Diluted	For the Year Ended December 31,
(Dollars per share)	2025		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	1.75	$	1.22	$	1.30
Earnings (loss) per share of common stock from discontinued operations	(0.15)		0.08		(0.27)
Earnings (loss) per share of common stock	$	1.60	$	1.30	$	1.03


Share Count Information	For the Year Ended December 31,
(Shares in millions)	2025	2024	2023
Weighted-average common shares - basic	680.0	693.7	709.0
Plus dilutive effect of equity compensation plans 1	1.4	2.3	2.9

Weighted-average common shares - diluted	681.4	696.0	711.9
Potential shares of common stock excluded from EPS calculations 2	2.3	3.1	2.3

1.Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; or (ii) the

performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Pension Plans and Other Post Employment Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Defined Benefit Plan, Assumptions [Table Text Block]

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:


Weighted-Average Assumptions used to Determine Benefit Obligations	December 31, 2025		December 31, 2024
Discount rate	5.31	%	5.59	%
Rate of increase in future compensation levels 1	2.82	%	2.87	%

1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:


Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	For the Year Ended December 31,
	2025		2024		2023
Discount rate	5.59	%	4.97	%	5.17	%
Rate of increase in future compensation levels 1	2.87	%	2.87	%	2.83	%
Expected long-term rate of return on plan assets	4.56	%	4.57	%	4.55	%

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:


Weighted-Average Assumptions used to Determine Benefit Obligations	December 31, 2025		December 31, 2024
Discount rate	5.14	%	5.50	%

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the table below:


Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	For the Year Ended December 31,
	2025		2024		2023
Discount rate	5.50	%	4.92	%	5.09	%

As of December 31, 2025, 2024 and 2023, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments.

Schedule of Pension Plans and Other Postemployment Benefits [Table Text Block]

Summarized information on the company's pension and other post-employment benefit plans is as follows:


Change in Projected Benefit Obligations, Plan Assets and Funded Status
	Defined Benefit Pension Plans				Other Post-Employment Benefits
(In millions)	For the Year Ended December 31,				For the Year Ended December 31,
	2025		2024		2025		2024
Change in benefit obligations:
Benefit obligation at beginning of the period	$	12,222	$	13,440	$	812	$	925
Service cost	13		16		—		—
Interest cost	627		648		40		42
Plan participants' contributions	1		2		16		18
Actuarial (gain) loss	383		(580)		15		(51)
Benefits paid	(1,228)		(1,241)		(112)		(120)

Plan amendments	1		—		—		(1)
New plans/merger	1		—		—		—

Effect of foreign exchange rates	37		(63)		1		(1)

Benefit obligations at end of the period	$	12,057	$	12,222	$	772	$	812

Change in plan assets:
Fair value of plan assets at beginning of the period	$	10,630	$	11,755	$	—	$	—
Actual return on plan assets	805		116		—		—
Employer contributions	40		50		96		101
Plan participants' contributions	1		2		16		18
Benefits paid	(1,228)		(1,241)		(112)		(120)


Effect of foreign exchange rates	27		(52)		—		1

Fair value of plan assets at end of the period	$	10,275	$	10,630	$	—	$	—
Funded status
U.S. plan with plan assets	$	(1,463)	$	(1,268)	$	—	$	—
Non-U.S. plans with plan assets	(32)		(41)		—		—
All other plans 1,2	(287)		(283)		(772)		(812)
Funded status at end of the period	$	(1,782)	$	(1,592)	$	(772)	$	(812)

1.As of December 31, 2025 and 2024, $112 million and $131 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.

2.Includes pension plans maintained around the world where funding is not customary.


	Defined Benefit Pension Plans				Other Post-Employment Benefits
	December 31,				December 31,
(In millions)	2025		2024		2025		2024
Amounts recognized in the Consolidated Balance Sheets:
Other assets	$	10	$	2	$	—	$	—
Accrued and other current liabilities	(32)		(32)		(98)		(103)
Pension and other post-employment benefits	(1,760)		(1,562)		(674)		(709)

Net amount recognized	$	(1,782)	$	(1,592)	$	(772)	$	(812)
Pre-tax amounts recognized in accumulated other comprehensive income (loss):
Net gain (loss)	$	(518)	$	(320)	$	244	$	276
Prior service benefit (cost)	14		17		13		14
Pre-tax balance in accumulated other comprehensive income (loss) at end of year	$	(504)	$	(303)	$	257	$	290

Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]


Pension Plans with Projected Benefit Obligations in Excess of Plan Assets	December 31, 2025		December 31, 2024
(In millions)	December 31, 2025		December 31, 2024
Projected benefit obligations	$	11,821	$	12,094
Fair value of plan assets	$	10,028	$	10,500

Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]


Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	December 31, 2025		December 31, 2024
(In millions)	December 31, 2025		December 31, 2024
Accumulated benefit obligations	$	11,806	$	11,995
Fair value of plan assets	$	10,027	$	10,414

Schedule of Net Benefit Costs [Table Text Block]


(In millions)	Defined Benefit Pension Plans						Other Post-Employment Benefits
	For the Year Ended December 31,						For the Year Ended December 31,
Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)	2025		2024		2023		2025		2024		2023
Net Periodic Benefit (Credit) Cost:
Service cost	$	13	$	16	$	18	$	—	$	—	$	1
Interest cost	627		648		690		40		42		49
Expected return on plan assets	(622)		(531)		(605)		—		—		—
Amortization of unrecognized loss (gain)	—		1		—		(17)		(13)		(10)
Amortization of prior service (benefit) cost	(4)		(4)		(3)		(1)		(1)		(2)

Settlement loss	—		2		—		—		—		—
Net periodic benefit (credit) cost - Total	$	14	$	132	$	100	$	22	$	28	$	38


Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net gain (loss)	$	(199)	$	164	$	(255)	$	(15)	$	51	$	49
Amortization of unrecognized (gain) loss	—		1		—		(17)		(13)		(10)
Prior service benefit (cost)	(1)		—		—		—		1		—
Amortization of prior service (benefit) cost	(4)		(4)		(3)		(1)		(1)		(2)

Settlement loss	—		2		—		—		—		—

Effect of foreign exchange rates	1		(1)		8		—		—		1



Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva	$	(203)	$	162	$	(250)	$	(33)	$	38	$	38
Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)	$	(217)	$	30	$	(350)	$	(55)	$	10	$	—

Schedule of Expected Benefit Payments [Table Text Block]


Estimated Future Benefit Payments at December 31, 2025	Defined Benefit Pension Plans		Other Post-Employment Benefits
(In millions)
2026	$	1,199	$	98
2027	1,162		91
2028	1,126		85
2029	1,088		79
2030	1,048		73
Years 2031-2035	4,644		293
Total	$	10,267	$	719

Schedule of Allocation of Plan Assets [Table Text Block]


Allocation for Plan Assets	December 31, 2025		December 31, 2024
Asset Category
U.S. equity securities	8	%	9	%
Non-U.S. equity securities	5		5
Fixed income securities	67		67
Hedge funds	—		—
Private market securities	13		12
Real estate	7		7
Cash and cash equivalents	—		—
Total	100	%	100	%


Basis of Fair Value Measurements	Total		Level 1		Level 2		Level 3
For the year ended December 31, 2025
(In millions)
Cash and cash equivalents	$	876	$	876	$	—	$	—
U.S. equity securities 1	837		836		1		—
Non-U.S. equity securities	417		417		—		—
Debt – government-issued	1,540		—		1,540		—
Debt – corporate-issued	3,728		—		3,728		—
Debt – asset-backed	440		—		440		—
Hedge funds	5		—		2		3
Private market securities	5		—		—		5
Real estate funds	4		—		—		4


Other	62		—		—		62
Subtotal	$	7,914	$	2,129	$	5,711	$	74
Investments measured at net asset value
Debt - government issued	$	42
Debt - corporate-issued	3
U.S. equity securities	23
Non-U.S. equity securities	22
Hedge funds	3
Private market securities	1,750
Real estate funds	647

Total investments measured at net asset value	$	2,490
Other items to reconcile to fair value of plan assets
Pension trust receivables 2	79
Pension trust payables 3	(208)
Total	$	10,275

1.The Corteva pension plans directly held no Corteva, Inc. common stock at December 31, 2025.

2.Primarily receivables for investment securities sold.

3.Primarily payables for investment securities purchased.


Basis of Fair Value Measurements
For the year ended December 31, 2024
(In millions)	Total		Level 1		Level 2		Level 3
Cash and cash equivalents	$	1,030	$	1,030	$	—	$	—
U.S. equity securities 1	1,030		1,026		1		3
Non-U.S. equity securities	389		388		—		1
Debt – government-issued	1,628		—		1,628		—
Debt – corporate-issued	3,540		—		3,540		—
Debt – asset-backed	590		—		590		—
Hedge funds	5		—		2		3
Private market securities	3		—		—		3
Real estate funds	101		—		—		101


Other	51		—		—		51
Subtotal	$	8,367	$	2,444	$	5,761	$	162
Investments measured at net asset value
Debt - government issued	$	39
Debt - corporate-issued	3
U.S. equity securities	21
Non-U.S. equity securities	20
Hedge funds	11
Private market securities	1,810
Real estate funds	642
Total investments measured at net asset value	$	2,546
Other items to reconcile to fair value of plan assets
Pension trust receivables 2	79
Pension trust payables 3	(362)
Total	$	10,630

1.The Corteva pension plans directly held $132 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2024.

2.Primarily receivables for investments securities sold.

3.Primarily payables for investment securities purchased.

Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]


Fair Value Measurement of Level 3 Pension Plan Assets	U.S. equity securities		Non-U.S. equity securities		Debt – corporate-issued		Hedge funds		Private market securities		Real estate funds		Other		Total
(In millions)
Balance at January 1, 2024	$	1	$	2	$	2	$	3	$	6	$	52	$	55	$	121
Actual return on assets:
Relating to assets sold during the year ended December 31, 2024	—		3		(14)		—		—		—		—		(11)
Relating to assets held at December 31, 2024	2		—		14		—		(3)		(68)		(2)		(57)
Purchases, sales and settlements, net	—		(4)		—		—		—		1		(2)		(5)
Transfers in or out of Level 3, net	—		—		(2)		—		—		116		—		114
Balance at December 31, 2024	$	3	$	1	$	—	$	3	$	3	$	101	$	51	$	162
Actual return on assets:
Relating to assets sold during the year ended December 31, 2025	(1)		(1)		—		—		—		—		—		(2)
Relating to assets held at December 31, 2025	1		—		—		—		2		(3)		9		9
Purchases, sales and settlements, net	(3)		—		—		—		—		—		2		(1)
Transfers in or out of Level 3, net	—		—		—		—		—		(94)		—		(94)
Balance at December 31, 2025	$	—	$	—	$	—	$	3	$	5	$	4	$	62	$	74

Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Fair Value, Inputs, Level 3 [Member]

$ 10,275

$ 10,630

$ 11,755

162

121

(2)

(11)

(57)

(1)

(5)

Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]

(94)

114

(14)

Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]

(2)

Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]

Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]

(3)

Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]

101

(3)

(68)

Derivative, Asset [Member] | Fair Value, Inputs, Level 3 [Member]

(94)

116

(2)

(2)

Defined Benefit Plan, Equity Securities, US | Fair Value, Inputs, Level 3 [Member]

^[1]

^[2]

(1)

(3)

Defined Benefit Plan, Equity Securities, Non-US | Fair Value, Inputs, Level 3 [Member]

$ 2

(1)

(4)

$ 0

[1]	The Corteva pension plans directly held no Corteva, Inc. common stock at December 31, 2025.
[2]	The Corteva pension plans directly held $132 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2024.

Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details) $ in Millions	Dec. 31, 2025 USD ($)
Debt Instrument [Line Items]
Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount	$ 696
Letters of Credit Outstanding, Amount	$ 248

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

Restructuring and Asset Related Charges Asset Impairments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Non-cash accelerated prepaid royalty amortization	$ 0	$ 55	$ 72

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Earnings Per Share of Common Stock EPS Calculation - Diluted (Details) - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ 1.75	$ 1.22	$ 1.30
Diluted earnings (loss) per share of common stock from discontinued operations	(0.15)	0.08	(0.27)
Diluted (loss) earnings per share of common stock	$ 1.60	$ 1.30	$ 1.03

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(13))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Cash and Cash Equivalents

Commitments and Contingent Liabilities Litigation - PFOA and NW Water District Settlement (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($) lawsuits	Jun. 01, 2023 USD ($)
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| lawsuits	10,100
MDL Settlement [Member]
Loss Contingencies [Line Items]
Litigation Settlement Amount	$ 59
MDL Settlement [Member] \| Corteva [Member]
Loss Contingencies [Line Items]
Payments for Legal Settlements	$ 8
Nationwide Water District Settlement
Loss Contingencies [Line Items]
Loss Contingency, Estimate of Possible Loss		$ 1,185
Number of water district opt-outs	900
Water Districts remaining in Settlement Class	93.00%

Commitments and Contingent Liabilities Litigation - Corteva Separation (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
PFAS [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
De minimis threshold	$ 1
DuPont de Nemours and Dow \| Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	104	$ 47
DuPont de Nemours and Dow \| Other Assets [Member]
Loss Contingencies [Line Items]
Indemnification Assets	263	143
DuPont de Nemours and Dow \| Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	26	9
DuPont de Nemours and Dow \| Other Noncurrent Obligations [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	$ 154	149
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29.00%
Corteva [Member] \| Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 188
Corteva [Member] \| Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Estimated Litigation Liability	$ 874	$ 228
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Basis of Consolidation

Use of Estimates

Use of Estimates in Financial Statement Preparation

Cash equivalents represent highly liquid investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.

Restricted Cash

Restricted Cash Equivalents

Marketable Securities

Fair Value Measurements

The company uses the following hierarchy to classify assets and liabilities measured at fair value:


Level 1	–	Quoted market prices in active markets for identical assets or liabilities.

Level 2	–	Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs).

Level 3	–	Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation

Inventories

The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.

Goodwill and Other Intangible Assets

Business Combination

Acquisitions

Leases

Impairment of Long-Lived Assets

Derivative Instruments

Environmental Matters

Revenue Recognition

Selling, General and Administrative Expenses

Research and Development

Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Litigation

Litigation and Other Contingencies

Severance Costs

Insurance and Self Insurance

Insurance/Self-Insurance

Income Taxes

Earnings Per Share, Policy [Policy Text Block]

Earnings per Common Share

Commitments and Contingent Liabilities Litigation - Bayer (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($)
Bayer
Loss Contingencies [Line Items]
Litigation Resolution	$ 610

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Financial Instruments Disclosure [Text Block]

Financial Instruments

12 Months Ended

Dec. 31, 2025

Disclosure Text Block [Abstract]

FINANCIAL INSTRUMENTS

Time Deposits and Money Market Funds

At December 31, 2025 and 2024, the company held investments in held-to-maturity securities at amortized cost, which approximates fair value. At these periods, the company held additional held-to-maturity securities, as well as available-for-sale securities, consisting of investments in foreign government bonds which are discussed further in the "Debt Securities" section. Reclassifications of prior year held-to-maturity balances have been made in the current year to disaggregate between those that are time deposits and foreign government bonds.

The following table summarizes investments in time deposits and money market funds classified as held-to-maturity securities at December 31, 2025 and 2024:


Held-to-Maturity Securities		Amortized Cost
(in millions)	Balance Sheet Location	December 31, 2025		December 31, 2024
Time deposits and money market funds	Cash equivalents 1	$	3,431	$	2,179
Time deposits	Marketable securities 2	$	1	$	8

1.Maturity at time of purchase was three months or less.

2.Maturity at time of purchase was more than three months to less than one year.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit losses in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The aggregate notional amounts for the company's derivative instruments that are designated and not designated as hedging instruments was a net buy (sell) position of $1,280 million and $(1,056) million at December 31, 2025 and 2024, respectively.

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against

changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign

exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive income (loss):


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Beginning balance	$	(49)	$	(71)	$	55
Additions and revaluations of derivatives designated as cash flow hedges	3		(29)		(87)
Clearance of hedge results to earnings	55		51		(39)
Ending balance	$	9	$	(49)	$	(71)

At December 31, 2025, an after-tax net gain of $19 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months.

Foreign Currency Contracts

The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive

income (loss):


(In millions)	For the Year Ended December 31,
(In millions)	2025		2024		2023
Beginning balance	$	13	$	1	$	10
Additions and revaluations of derivatives designated as cash flow hedges	5		19		(36)
Clearance of hedges results to earnings	(13)		(7)		27
Ending balance	$	5	$	13	$	1

At December 31, 2025, an after-tax net gain of $5 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges

Foreign Currency Contracts

In March 2025, the company designated €1.7 billion of forward contracts to exchange Euro as net investment hedges. Of these hedges, €1.2 billion expired and were settled in May 2025, while the remaining €500 million expired and were settled in December 2025. The purpose of these forward contracts was to mitigate foreign exchange exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in EUR/USD exchange rates.

In May 2024, the company designated €500 million of forward contracts to exchange Euro as net investment hedges. An additional tranche of €500 million of forward contracts to exchange Euro were executed in July 2024 and also designated as net investment hedges. These hedges expired and were settled in December 2024. The company had previously designated €1.2 billion and €450 million of forward contracts to exchange Euro as net investment hedges, which expired and were settled in May 2024 and March 2023, respectively.

Prior to maturity, the company had elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses commodity contracts to offset a portion of the company’s exposure to commodity price fluctuations so that gains and losses on the contracts offset changes in the commodity price over the relevant aggregate period. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.

Fair Value of Derivative Instruments

Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets.

The presentation of the company's derivative assets and liabilities is as follows:


		December 31, 2025
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting 1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	5	$	—	$	5
Commodity contracts	Other current assets	1		—		1
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	23		(21)		2
Commodity contracts	Other current assets	3		—		3
Total asset derivatives		$	32	$	(21)	$	11

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	1	$	—	$	1
Commodity contracts	Accrued and other current liabilities	3		—		3
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	40		(21)		19
Commodity contracts	Accrued and other current liabilities	6		—		6
Total liability derivatives		$	50	$	(21)	$	29


		December 31, 2024
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting 1		Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	—	$	—	$	—
Commodity contracts	Other current assets	8		—		8
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	71		(45)		26
Commodity contracts	Other current assets	12		—		12
Total asset derivatives		$	91	$	(45)	$	46

Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	—	$	—	$	—
Commodity contracts	Accrued and other current liabilities	2		—		2
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	104		(45)		59
Commodity contracts	Accrued and other current liabilities	5		—		5
Total liability derivatives		$	111	$	(45)	$	66

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments


	Amount of Gain (Loss) Recognized in OCI 1 - Pre-Tax
	For the Year Ended December 31,
(In millions)	2025		2024		2023
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts	$	(94)	$	48	$	—
Cash flow hedges:
Foreign currency contracts	5		29		(54)
Commodity contracts	5		(59)		(123)
Total derivatives designated as hedging instruments	$	(84)	$	18	$	(177)

1.OCI is defined as other comprehensive income (loss).


(in millions)	Amount of Gain (Loss) Recognized in Income - Pre-Tax 1
	For the Year Ended December 31,
	2025		2024		2023
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts 2	$	6	$	9	$	(41)
Commodity contracts 2	(72)		(74)		49
Total derivatives designated as hedging instruments	(66)		(65)		8
Derivatives not designated as hedging instruments:
Foreign currency contracts 3	73		(130)		(28)
Foreign currency contracts 2	(103)		23		(77)
Commodity contracts 2,4	—		(34)		(20)
Commodity contracts 3	—		(2)		2
Total derivatives not designated as hedging instruments	(30)		(143)		(123)
Total derivatives	$	(96)	$	(208)	$	(115)

1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.

2.Recorded in cost of goods sold, in the Consolidated Statement of Operations.

3.Recognized in other income (expense) - net, in the Consolidated Statement of Operations. Note that the net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the Consolidated Financial Statements for additional information.

4.The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the Consolidated Statement of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.

Debt Securities

At December 31, 2025 and 2024, the company held investments in held-to-maturity debt securities consisting of foreign government bonds. The company's investments in held-to-maturity securities are held at amortized cost, which approximates fair value. These foreign government bonds are held by certain foreign subsidiaries in which the USD is the functional currency.


Held-to-Maturity Securities		Amortized Cost
(in millions)	Balance Sheet Location	December 31, 2025		December 31, 2024
Foreign government bonds	Marketable securities 1	$	—	$	55

1.Maturity at time of purchase was more than three months to less than one year.

The company also held debt securities, which consisted of foreign government bonds classified as available-for-sale securities, at December 31, 2025 and 2024. The company's investments in available-for-sale securities are recorded at fair value with unrealized gains and losses recorded in accumulated other comprehensive income (loss), within the Consolidated Statements of Equity, or current period earnings if an allowance for credit losses has been established, within the Consolidated Statements of Operations.


Available-for-Sale Securities		Fair Value
(in millions)	Balance Sheet Location	December 31, 2025		December 31, 2024
Foreign government bonds	Marketable securities 1	$	8	$	—
Foreign government bonds	Other assets 2	$	22	$	97

1.Maturity at time of purchase was more than three months to less than one year.

2.Maturity at time of purchase was more than one year.

At December 31, 2025, available for sale debt securities with a contractual maturities of less than one year and of one to five years included gross unrealized gains (losses) of $— million and $— million, respectively.

The estimated fair value of the available-for-sale securities as of December 31, 2025 and 2024 was determined using Level 2 inputs within the fair value hierarchy. Level 2 measurements were based on the closing price at the end of the period quoted market prices in active markets for identical assets and liabilities.

Commitments and Contingent Liabilities

12 Months Ended

Dec. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

NOTE 15 - COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees

Indemnifications

In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.

Obligations for Supplier Finance Programs

The company enters into supplier finance programs with various finance providers in which the company agrees to pay these finance providers the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the finance provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At December 31, 2025 and 2024, the outstanding obligations under supplier finance programs was approximately $121 million and $88 million, respectively, and included within accounts payable in the Consolidated Balance Sheets.

The rollforward of the company’s outstanding obligations confirmed as valid under its supplier finance programs for the years ended December 31, 2024 and 2025 is as follows:


(In millions)
Confirmed obligations outstanding at December 31, 2023	$	115
Invoices confirmed during the year	571
Confirmed invoices paid during the year	(598)
Confirmed obligations outstanding at December 31, 2024	$	88
Invoices confirmed during the year	690
Confirmed invoices paid during the year	(657)
Confirmed obligations outstanding at December 31, 2025	$	121

Obligations for Customers and Other Third Parties

The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At December 31, 2025 and 2024, the company had directly guaranteed $71 million and $64 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. The maximum future payments include $5 million and $4 million of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables at December 31, 2025 and 2024, respectively. See Note 9 - Accounts and Notes Receivable - Net, to the Consolidated Financial Statements, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance

customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $234 million and $223 million at December 31, 2025 and 2024, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Indemnifications under Separation Agreements

The company has entered into various agreements where the company is indemnified for certain liabilities. The term of this indemnification is generally indefinite, with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable.

Chemours Separation Agreement (Performance Chemicals)

Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution.

In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. Additionally, in January 2021, a binding memorandum of understanding as described below replaced the potential future liability sharing arrangements established in the 2017 amendment to the Chemours Separation Agreement. At December 31, 2025 and December 31, 2024, the indemnification assets from Chemours were $138 million and $43 million, respectively, within accounts and notes receivable - net and $470 million and $280 million, respectively, within other assets in the interim Consolidated Balance Sheets. These indemnification assets are regularly assessed for collectability and the company has concluded that these assets are recoverable. The liabilities subject to Chemours indemnification are considered stray liabilities under the Corteva Separation Agreement. Therefore, if Chemours fails to indemnify the company, these stray liabilities are subject to proportionate cost sharing between Corteva and DuPont, on a 29 percent and 71 percent basis, respectively, as further described in this footnote below.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EIDP, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims proceeded (the “Arbitration”).

On January 22, 2021, Chemours, DuPont, Corteva and EIDP entered into a binding memorandum of understanding resolving legal disputes originating from the Delaware Litigation and Arbitration, and establishing a cost sharing arrangement and escrow account supporting and managing potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaced a prior 2017 amendment to the Chemours Separation Agreement. According to the terms of the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of the escrow account) in the aggregate. DuPont’s and Corteva’s 50 percent share under the MOU will be limited to $2 billion, including qualified expenses and escrow account contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50 percent of the first $300 million (up to $150 million each), and thereafter DuPont bears 71 percent and Corteva bears the remaining 29 percent. Under the terms of the MOU, Corteva’s estimated aggregate share of the potential $2 billion is approximately $600 million.

In order to support and manage any potential future PFAS liabilities, the parties also agreed to establish an escrow account (“MOU Escrow Account”). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50

percent of the deposits and DuPont and Corteva together will make 50 percent of the deposits necessary to restore the balance of the escrow account to $700 million, pursuant to the terms of the Letter Agreement. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029, pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend.

In April 2024, Corteva, EIDP, DuPont, and Chemours received a final judgment resolving all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population (the “Nationwide Water District Settlement”). In connection with the Nationwide Water District Settlement, the MOU was supplemented to waive funding due to the MOU Escrow Account by Chemours, DuPont and Corteva for 2023 provided that each party fully funds its portion of the Nationwide Water District Settlement and said settlement is consummated. The funding obligation to the MOU Escrow Account with respect to 2024 and due September 30, 2024 was to be waived if (i) between October 1, 2023 and September 30, 2024, the parties had entered into settlement agreements resolving liabilities under the MOU that in the aggregate exceed $100 million; (ii) each company had fully funded its respective share, in accordance with the MOU, of such settlements; and (iii) such settlements were consummated. No such waiver was triggered for the 2024 escrow funding obligation due September 30, 2024 and, therefore, the company made its required contribution.

The company made its annual installment deposits due to the MOU Escrow Account through December 31, 2025. The MOU escrow account contains $105 million as of December 31, 2025, representing the aggregate contributions from Chemours, DuPont and Corteva, less withdrawals to fund related settlements.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties dismissed the pending arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

The Chemours Separation Agreement obligates Chemours to defend and indemnify EIDP in legacy asbestos cases. As of December 31, 2025, there were approximately 900 pending lawsuits, with most being allegations of personal injury from Historical DuPont contractors. At December 31, 2025 and 2024, the company has a litigation accrual of $88 million and $38 million, respectively, and related indemnification assets of $87 million and $38 million, respectively, recorded.

Corteva Separation Agreement

On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement ("TMA"), the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow assets, employees, certain liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) and provides for indemnification obligation among the parties. Under the Corteva Separation Agreement, DuPont indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution, Dow indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that relate to the Historical Dow business, and Corteva indemnifies DuPont and Dow for certain liabilities.

Under the Corteva Separation Agreements, certain legacy EIDP liabilities from discontinued and/or divested operations and businesses of EIDP (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. Costs and liabilities have been shared based on the terms of the Corteva Separation Agreement. All future stray liabilities are allocated to Corteva and DuPont proportionally on the basis of 29 percent and 71 percent, respectively, subject to a $1 million de minimis requirement.

On November 1, 2025, DuPont spun off its electronics business, Qnity Electronics, Inc. ("Qnity"). DuPont, Corteva and Qnity entered into a letter agreement, effective November 1, 2025, affirming that DuPont is not novated from its obligations with respect to Corteva for legacy liabilities allocated to Qnity in its spin-off ("Qnity Letter Agreement"). Additionally, under the Qnity Letter Agreement, Corteva has certain third-party beneficiary rights to enforce indemnity and payment obligations of DuPont's with respect to legacy liabilities allocated to Qnity subject to: (i) DuPont's consent; or (ii) Corteva's receipt of a judgment that includes payment obligations for legacy liabilities attributable to Qnity, and either DuPont does not use commercially reasonable efforts to enforce the payment obligation against Qnity, or DuPont files for bankruptcy.

At December 31, 2025 and 2024, the aggregate indemnification assets from DuPont and Dow were $104 million and $47 million, respectively, within accounts and notes receivable - net and $263 million and $143 million, respectively, within other assets in the Consolidated Balance Sheets. At December 31, 2025 and December 31, 2024, the aggregate indemnification liabilities were $26 million and $9 million, respectively, within accrued and other current liabilities and $154 million and $149 million, respectively, within other noncurrent obligations in the Consolidated Balance Sheets.

Discontinued Operations Activity

For the years ended December 31, 2025 and 2024, the company recorded benefits (charges) of $(99) million and $56 million, to income (loss) from discontinued operations after income taxes, in the Consolidated Statement of Operations. The after-tax charge recognized during the year ended December 31, 2025 was driven by charges relating to the MOU with Chemours and DuPont, comprised of a litigation charge associated with the NJ Statewide Settlement as well as PFAS environmental remediation activities primarily at Chemours' Fayetteville Works facility, along with other environmental matters. The after-tax benefit recognized during the year ended December 31, 2024 was driven by charges pursuant to the MOU with Chemours and DuPont relating to PFAS remediation activities primarily at Chemours' Fayetteville Works facility and litigation activity, which were more than offset by a favorable adjustment of certain prior year tax positions for previously divested businesses, the derecognition of an indemnification liability associated with the Water District Settlement Fund contribution, and insurance proceeds related to legacy matters.

Litigation

The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EIDP businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the Corteva Separation from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, for which the ultimate liability could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company. At December 31, 2025 and 2024, current accrued litigation was $874 million and $228 million, respectively, within accrued and other current liabilities. A current indemnification asset of $188 million was recorded within accounts and notes receivable - net at December 31, 2025 in relation to the current accrued litigation. See the "Chemours Separation Agreement (Performance Chemicals)" and the "Corteva Separation Agreement" sections for further details on the indemnifications.

Bayer Dispute

In August 2022, Bayer filed a breach of contract/declaratory judgment lawsuit in Delaware state court against Corteva relating to an agrobacterium cross-license agreement and Enlist E3® soybeans. Bayer alleged that Corteva practiced two Bayer patents in developing Enlist E3® soybeans, and therefore, is entitled pursuant to the terms of the cross-license agreement to royalties for sales between 2019 through 2029, along with interest. In January 2025, the court issued several rulings precluding Corteva's invalidity and inequitable conduct defenses, while also aligning on key aspects of Corteva's patent claim construction. In May 2025, the Delaware state court granted Corteva’s motion for partial summary judgment agreeing that U.S. Supreme Court precedent precludes the collection of royalties after patent expiration. Bayer’s motion for reconsideration was denied in June 2025. In July 2025, a stipulated order allowed Bayer to appeal the summary judgment finding, while also allowing Corteva’s cross-appeal of the dismissal of its invalidity and inequitable conduct defenses.

In August 2022, Corteva filed a lawsuit against Bayer CropScience LLP and Monsanto Company (collectively “Bayer”) in federal court in Delaware for alleged infringement of Corteva’s patented AAD-1 herbicide resistance technology used in Enlist® corn. The complaint for this lawsuit was amended to include additional patents that are closely related to this patented technology for soybeans. Corteva seeks to enjoin Bayer from continuing to infringe, as well as appropriate monetary damages. Bayer has filed an answer to the complaint and has asserted various affirmative defenses including invalidity. In August 2023, the court issued a decision adopting Corteva’s claim construction for all five disputed patent terms subject to this litigation.

In December 2023, the Patent Trial and Appeal Board ("PTAB") authorized an Inter Partes Review (“IPR”) proceeding initiated by Bayer to review the patentability of three patents subject to the AAD-1 litigation. Inari joined the IPR proceeding. In

December 2024, the PTAB issued a decision invalidating these patents on the basis they were unpatentable. Corteva appealed this decision and Corteva's AAD-1 lawsuit remains stayed during pendency of the IPR appeal. Corteva holds numerous additional patents covering its Enlist® traits or Enlist® weed control system. Therefore, the IPR process is not expected to impact its ability to license and protect Enlist E3® traits.

In October 2022, Corteva filed a lawsuit against Bayer in Delaware state court seeking a declaration that, under the terms of Corteva’s licensing agreement and the law, Bayer is not entitled to collect patent royalties on the Roundup Ready® Corn 2 trait after Bayer’s U.S. patent protection expires, and therefore is no longer required to pay royalties under the licensing agreement and entitled to recover relevant royalties paid. In September 2024, the court granted Bayer’s motion for summary judgment. Corteva’s appeal was heard by the Delaware Supreme Court, en banc, in May 2025. Additionally, Corteva initiated arbitration of two additional agreements with Bayer seeking similar relief. The Delaware Supreme Court stayed the appeal proceedings pending resolution discussions between Corteva and Bayer.

As of January 2026, the parties agreed to settle the agrobacterium cross-license agreement dispute. In addition, Corteva and Bayer resolved several other disputes regarding post-patent royalties and other matters, including post-patent regulatory support, resulting in the termination or amendment of the related licenses, as applicable. As part of the resolution of these matters, the cross-license agreement has been terminated and Corteva has agreed to a payment of $610 million and to drop its AAD-1 patent claims against Bayer. Also as a result of the resolution of this litigation and the related license terminations and amendments, potential royalty obligations for Corteva's Enlist E3® soybeans, as well as future royalty payments due to Bayer under other licensing agreements in dispute were terminated. The settlement agreements support Corteva's product out-licensing growth in competitive corn, cotton and canola markets, including for the out-licensing of above and below ground triple-stack corn technology. In conjunction with resolution of these matters, the companies also agreed to new cotton licensing arrangements at terms reflective of market rates. There is no remaining litigation between the parties.

Federal Trade Commission Investigation

On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its Crop Protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl, rimsulfuron and other related products in order to determine whether Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has fully cooperated with all requests related to this subpoena. On September 29, 2022, the FTC, along with ten state attorneys general in California, Colorado, Illinois, Indiana, Iowa, Minnesota, Nebraska, Oregon, Wisconsin, and Texas, filed a lawsuit against Corteva and another competitor alleging the parties engaged in unfair methods of competition, unlawful conditioning of payments, unreasonably restrained trade, and have an unlawful monopoly (the “FTC lawsuit”). In December 2022, attorneys general in Tennessee and Washington joined the FTC lawsuit and the Arkansas state attorney general filed a separate lawsuit against Corteva and another competitor based on the allegations set forth in the FTC lawsuit. In July 2025, the Arkansas state attorney general amended the complaint to include methoxyfenozide, cyhalofop, picloram, triclopyr, and aminopyralid products. Several proposed private class action lawsuits were also filed in federal court alleging anticompetitive conduct based on the allegations set forth in the FTC lawsuit.

Virtually all of these private lawsuits were centralized into a multi-district litigation in the U.S. District Court for the Middle District of North Carolina. In January 2025, federal court for the multi-district litigation granted in part, and denied in part, Corteva's motion to dismiss. Specifically, the court order dismissed the plaintiff's federal damages claims and 13 of the 27 state consumer protection act claims. The plaintiffs amended their complaint to include methoxyfenozide products. The trials for these claims are expected to begin in 2027.

Lorsban® Lawsuits

As of December 31, 2024, there were asserted claims for personal injury against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the merger of Dow and Historical DuPont and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. As of December 31, 2025, an accrual has been established for the estimated resolution of certain claims.

Litigation related to legacy EIDP businesses unrelated to Corteva’s current businesses

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EIDP is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective.

Leach Settlement and Ohio MDL Settlement

EIDP has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EIDP, which alleged that PFOA from EIDP’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EIDP to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of December 31, 2025, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

PFOA Personal Injury Claims

In December 2024, the defendants reached a settlement of all of the currently filed and unfiled personal injury cases in the Ohio MDL for $59 million. The settlement was payable in two installments, with $8 million contributed in aggregate by Corteva. The final installment was paid upon the court dissolving the MDL in March 2025.

Other PFOA Matters

EIDP is a party to other PFOA lawsuits involving claims for property damage, medical monitoring and personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EIDP would prevail on the merits of these claims.

EIDP did not make film-forming foams, PFOS, or PFOS products. While EIDP made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EIDP’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EIDP has never made or sold PFOA as a commercial product.

Aqueous Film-Forming Foams. Approximately 10,100 cases filed against 3M and other defendants, including EIDP and Chemours, and some including Corteva and DuPont, alleging personal injury (primarily kidney, testicular, liver and thyroid cancer) from the use of aqueous film-forming foams (“AFFF”) or contamination, in most cases due to migration from military installations or airports, consolidated in a multi-district litigation proceeding in federal district court in South Carolina (“SC MDL”). Most of these recent cases also assert claims that the EIDP and Chemours separation constituted a fraudulent conveyance.

In August 2025, the SC MDL entered multiple case management orders requiring cases filed outside the SC MDL to be transferred to the SC MDL, establishing a 21-day window for unfiled cases to be filed, and allowing the filing of multi-plaintiff complaints. A significant number of new cases asserting personal injury were filed or transferred to the SC MDL. Many of the personal injury cases both inside and outside the SC MDL include and continue to include, as new cases are threatened, multiple plaintiffs. Therefore, the number of plaintiffs asserting such claims is substantially higher than the number of cases set forth above. The first bellwether personal injury trial is expected to be scheduled for 2026. Discussions between the parties on a resolution to these cases remain ongoing.

Nationwide Water District Settlement. On June 1, 2023, Corteva, EIDP, Inc., DuPont, and Chemours (collectively, the “settling companies”) entered into a binding agreement in principle to comprehensively resolve all drinking water claims related to PFAS of a defined class of U.S. public water systems that serve the vast majority of the United States population, including, but not limited to the AFFF claims in the SC MDL, under the Nationwide Water District Settlement, for $1.185 billion in the aggregate. PFAS, as defined in the settlement, includes PFOA and HFPO-DA, among a broad range of fluorinated organic substances. In April 2024, the settlement was deemed final resulting in the release of the previously restricted cash in the Water District Settlement Fund and derecognition of the associated liability. The Nationwide Water District Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by Corteva or EIDP.

The class represented by the Nationwide Water District Settlement is composed of all Public Water Systems, as defined in 42 U.S.C. § 300f, with a current detection of PFAS or that are currently required to monitor for PFAS under the Environmental Protection Agency’s Fifth Unregulated Contaminant Monitoring Rule (“UCMR 5”) or other applicable federal or state law (the “Class”). Approximately 88 percent of the U.S. is served by systems required to test under UCMR 5. The Class does not include water systems owned and operated by a State or the United States government; small systems that have not detected the presence of PFAS and are not currently required to monitor for it under federal or state requirements; and, unless they otherwise request to be included, water systems in the lower Cape Fear River Basin of North Carolina.

The total number of requests for exclusion (“opt-outs”) was approximately 900 water districts while most public water districts (approximately 93 percent of the Class) remain in the class settlement. The company has been served complaints from opt-outs, as well as water district and municipal authority claims not covered by the Nationwide Water District Settlement.

New Jersey. In late March 2019, the New Jersey State Attorney General filed four lawsuits against EIDP, Chemours, and others alleging that operations at and discharges from former EIDP sites in New Jersey (Chambers Works, Parlin, Pompton Lakes, and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims for remediation, fraudulent conveyance, as well as claims under the New Jersey Water Pollution Control Act and the New Jersey Industrial Site Recovery Act (“ISRA”).

On August 3, 2025, the company, together with Chemours and DuPont agreed to a proposed Judicial Consent Order with the State of New Jersey (the "NJ Statewide Settlement") to resolve all outstanding claims by the State of New Jersey pending against the companies related to the legacy use of a wide variety of substances of concern, including, but not limited to DNAPL (dense non-aqueous phase liquids), chemical solvents, and PFAS. Subject to a public notice and comment period and subject to court approval following that period, the NJ Statewide Settlement will also resolve legacy claims related to four Historical DuPont operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno) in the State, including claims under ISRA, alleged statewide PFAS contamination, including from the use of AFFF, claims of fraudulent conveyance, and claims for known natural resource damages from these Historical DuPont sites that the State of New Jersey and its departments have, or may have, in the future against the companies.

The NJ Statewide Settlement, after the expiration of the public notice and comment period, is subject to court approval. The court hearing for this approval occurred in January 2026 with a conclusion on the approval expected during the first half of 2026. The NJ Statewide Settlement includes aggregate cash payments to the State of New Jersey of $875 million, payable over a period of 25 years (net present value of approximately $500 million, using an 8 percent discount rate), responsibility for which will be allocated among the settling companies in accordance with the terms of the MOU. Of the $875 million, approximately $16 million is allocated to statewide natural resource damages unrelated to the four Historical DuPont sites, 25 percent of which relates to alleged statewide AFFF contamination. Accordingly, in the second quarter of 2025, the company recorded a pre-tax loss of $72 million ($58 million after-tax) within discontinued operations, reflecting the net present value of the company's share of the aggregate cash payment in accordance with the MOU. The settling companies have agreed to count the NJ Statewide Settlement against the MOU limit at net present value as of the date of the NJ Statewide Settlement. Entry into the NJ Statewide Settlement suspended the companies' 2025 MOU escrow funding obligations and funding of the initial payment under the NJ Statewide Settlement, expected in 2026, will be deemed to satisfy these obligations for 2025.

In addition to the cash payment, the NJ Statewide Settlement obligates certain settling companies to continue to undertake remediation at the four Historical DuPont sites, which will be determined in accordance with applicable law and the respective cost sharing arrangements between the settling companies, to the extent applicable. DuPont and Chemours will be responsible for the remediation at the sites under their current respective ownership. As part of the NJ Statewide Settlement, the companies have agreed to a binding third party review process of the remedial funding source ("RFS") for each of the four Historical DuPont sites (in the form of a surety bond or similar financial instrument) to ensure available funds for future remediation of these sites. This review process could identify additional required remediation, and an increase to the RFS for each of these sites.

The company and DuPont will also establish a reserve fund (in the form of a surety bond or similar financial instrument) in the amount of $475 million (the "Reserve Fund") with DuPont funding 71 percent and the company bearing the remaining 29 percent. The Reserve Fund is further financial security, separate from, and secondary to, the RFS, and the Reserve Fund will be accessible only in the event the RFS for a site has been exhausted and the party responsible for a site is not otherwise performing the required remediation. If a responsible party under the NJ Statewide Settlement defaults on their remediation or payment obligations (subject first to the cost sharing arrangements under the Corteva Separation Agreements, which provides that these obligations are "stray liabilities"), EIDP will become responsible for such obligations.

Under the NJ Statewide Settlement, no settling party admits any liability or wrongdoing or agrees to waive any defenses as to any such liability or wrongdoing.

Pursuant to a separate agreement among the company, DuPont, and Chemours, DuPont and the company will purchase Chemours' future interest, if any, in certain insurance proceeds. DuPont and the company will make the purchase by contributing a total of $150 million, with $106 million from DuPont and $44 million from the company, into an escrow fund, with funds to be released to pay Chemours' share of the NJ Statewide Settlement. DuPont and the company will pay Chemours, as additional contingent consideration, amounts received from the acquired insurance proceeds in excess of $150 million plus an accrued fee. The accrued fee will equal the lesser of (a) $35 million, and (b) $3 million plus interest (at prime minus 2 percent) on an initial balance of $150 million, as reduced by any amounts received by DuPont and Corteva from the acquired insurance proceeds, until DuPont and the company have so received $150 million, plus the accrued fee. The purchase price to be paid to Chemours, and the insurance proceeds recovered, by DuPont and the company from the insurance proceeds acquired from Chemours, are subject to the sharing percentages under the Letter Agreement.

Ohio. EIDP is a defendant in two lawsuits, including an action by the State of Ohio based on alleged damage to natural resources. The natural resources damage claim was preliminarily resolved in December 2023 for $110 million, with Corteva’s share of the settlement under the MOU being approximately $16 million of which $13 million has been paid. As of December 31, 2025, an accrual has been established. The second, a putative nationwide class action ("the Hardwick Class Action") brought on behalf of anyone who has detectable levels of PFAS in their blood serum seeks declaratory and injunctive relief, including the establishment of a “PFAS Science Panel.” In December 2023, the Sixth Circuit Court of Appeals dismissed the Hardwick Class Action due to lack of standing by Mr. Hardwick. With further opportunities for appeals expired, the plaintiffs filed a new case, narrowing their original claims, in June 2024. In January 2025, EIDP filed a motion to dismiss the new case on the grounds it remains similar to the original claim.

New York. EIDP is a defendant in a putative class action (the "Baker Class Action"), brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring, property damage and personal injury based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls. The lawsuits allege that EIDP and others supplied materials used at these facilities resulting in PFOA air and water contamination. A court approved settlement was reached between the plaintiffs and the other co-defendants regarding the Baker Class Action case. In September 2022, the class certification of the Baker Class Action was granted, with the court certifying three separate classes consisting of a private well property damage class, a medical monitoring class and a nuisance class. A settlement in principle of the Baker Class Action was reached in June 2025 for $22 million, plus funding $1 million annually to a medical monitoring fund for five years. As of December 31, 2025, an accrual for Corteva’s share of the expected settlement under the MOU was established.

EIDP is a defendant in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. This district submitted a timely opt-out request from the Nationwide Water District Settlement. EIDP and Chemours are also defendants in two lawsuits by a private water utility provider in New Jersey and New York alleging damages from PFAS releases into the environment, that impacted water sources that the utilities use to provide water, as well as product liability, negligence, nuisance, and trespass claims. The court dismissed the New York plaintiff's trespass claims and limited plaintiffs’ nuisance claims to abatement damages

Other Natural Resource Damage Cases. In addition to the natural resource damage cases in New Jersey and New York, natural resource damage lawsuits against EIDP, Chemours, and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water, have been filed by attorneys general in 31 states, the District of Columbia and three U.S. territories. Certain cases also name DuPont and Corteva as defendants and include claims of fraudulent conveyance. The complaints seek reimbursement for past and future costs to monitor and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources, as well as punitive damages. Due to overlapping AFFF allegations, virtually all of these cases have been transferred, or are pending transfer to the SC MDL. These cases are largely in the discovery phase.

On July 13, 2021, Chemours, DuPont, EIDP and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies' and the State's agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, if the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the Natural Resources and Sustainability Trust (the “NRS Trust”) in an amount equal to such other states’ recovery in excess of $50 million ("Supplemental Payment"). Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the

settlement are subject to the MOU and the Corteva Separation Agreement. Due to the settlement of natural resource damages claims with the State of Ohio, the one-time Supplemental Payment will be triggered when the further opportunity for appeals expires under the Ohio judicial consent order process. As of December 31, 2025, an accrual has been established for Corteva's share under the MOU. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims.

Canada. The Province of British Columbia, filed a class action against various defendants, including 3M, DuPont Canada, EIDP, and Chemours alleging harms caused by PFAS/AFFF. The class consists of all municipalities, regional districts, and other governance authorities and other persons in Canada that were responsible for a “Drinking Water System” from 1970 to the present. The plaintiff seeks to recover costs for the treatment and restoration of natural resources, as well as property, economic, and punitive damages. A putative class action was also filed in July 2024 on behalf of citizens of Quebec, Canada seeking class certification to recover for alleged PFAS and AFFF contamination of private wells and public water treatment facilities. In January 2024, a class action was also filed in Canada against 3M and other defendants, including EIDP and Chemours, alleging PFOS and PFOA environmental contamination and personal injury from use of AFFF. Additionally, several lawsuits on behalf of consumers of PFAS-infused products in the Province of British Columbia for personal injury and PFAS contamination in Manitoba, Canada have been filed.

Netherlands. In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees. In September 2023, the court entered a second interlocutory judgment, ruling, inter alia, that defendants were liable to the municipalities for PFOA emissions during a certain time period, and the removal costs of deposited emissions on the municipalities' land infringes their property rights by an objective standard. In June 2024, Chemours and these Dutch municipalities signed a letter of intent that included the implementation of a specific remediation plan for the restoration of restricted vegetable gardens in certain areas of those municipalities to be funded by Chemours, sampling and developing a program to address a recreational lake, and further settlement discussions, including a potential fund to cover certain other expenditures aimed at environmental-related activities. While the letter of intent contemplates the possibility of settlement, discussions between the parties related to the resolution to these matters remain ongoing. Although the company believes a loss is probable, it is not estimable at this time due to various reasons including, among others, the status of discussions between the parties. As of December 31, 2025, an accrual has been established for the estimated environmental remediation set forth in the letter of intent. Additionally, the Office of Public Prosecutor in the Netherlands opened a criminal investigation against certain Dutch subsidiaries of Chemours and Historical DuPont, as well as each subsidiary's directors, alleging unlawful PFOA and GenX emissions from Chemours' Dordrecht Works facility.

Carpet Mill Cases. The city of Centre, Alabama water district alleged defendants, including EIDP, Chemours, other chemical suppliers and large carpet mills, discharged PFAS in their industrial wastewater, and that this wastewater after treatment, resulted in PFAS contamination of drinking water supplies. The trial for the Centre, Alabama water district carpet mill case is set to begin January 2026. In July 2024, the town of Lyerly, Georgia filed a case making similar allegations as those brought in the Centre, Alabama case. Numerous carpet, textile and paper manufacturers, their alleged suppliers and former suppliers, including EIDP and Chemours, and certain municipal or utility defendants are also subject to several lawsuits in Georgia, Alabama and South Carolina, alleging negligence, nuisance and trespass related to the release of PFOA, and requesting injunctive relief related to PFOA contamination.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, EIDP introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. This Historical DuPont facility is now owned and operated by Chemours, which continues to manufacture and use GenX. The current natural resources damage claims in North Carolina allege that direct discharges from this legacy facility are a source of PFOA contamination.

At December 31, 2025, several actions, including personal injury, are pending in the North Carolina federal court against Chemours and EIDP relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority (“CFPUA”) and Brunswick County, that seek actual and punitive damages as well as injunctive relief. EIDP and Chemours filed a motion for summary judgment on this consolidated action in March 2025. Cumberland County, North Carolina, which is not part of the

forgoing consolidation action or the Nationwide Water District Settlement, filed an action for alleged PFOA contamination to its groundwater sources used in drinking water and seeking recovery for costs associated with water filtration, monitoring, and compliance costs. The pending mediation and trial for this matter are no longer scheduled.

In March 2023, CFPUA filed a Delaware Chancery Court action claiming the spin-off of Chemours and the Dow and Historical DuPont merger were unlawful and should be voided, so CFPUA is not precluded from recovering amounts it is entitled in its pending litigation. EIDP filed a motion to dismiss the Delaware Chancery Court action based upon failure to state a claim under Delaware law in June 2023, along with a counterclaim in October 2023. CFPUA’s motion to stay the case was granted in January 2024.

In a state court action approximately 2,400 private property owners near the Fayetteville Works facility seek compensatory and punitive damages for their claims of private nuisance, trespass, negligence, water monitoring and property damage allegedly caused by release of certain PFCs. In addition, several personal injury cases have been filed in the North Carolina federal court alleging thyroid disease, and prostate, breast and kidney cancers as a result of PFAS exposure.

Generally, site-related expenses related to GenX claims are subject to the cost sharing arrangements as defined in the MOU.

Environmental

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the Consolidated Balance Sheets. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see page F-36-37.

The accrued environmental obligations and indemnification assets include the following:


	As of December 31, 2025
(In millions)	Indemnification asset		Accrual balance 3		Potential exposure above amount accrued 3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity 1,2	$	254	$	264	$	204
Other discontinued or divested businesses obligations 1	33		71		201

Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont 2	50		55		55

Environmental remediation liabilities not subject to indemnity	—		112		86

Indemnification liabilities related to the MOU 4	—		60		7
Total	$	337	$	562	$	553

1.Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page F-37, under the header "Corteva Separation Agreement."

2.The company has recorded an indemnification asset related to these accruals, including $22 million related to the Superfund sites.

4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-36, under the header "Chemours Separation Agreement (Performance Chemicals).

Nebraska Department of Environment and Energy, AltEn Facility

The EPA and the Nebraska Department of Environment and Energy (“NDEE”) are pursuing investigations, response and removal actions, litigation and enforcement action related to an ethanol plant located near Mead, Nebraska that is owned and

operated by AltEn LLC (“AltEn”). The agencies have alleged violations under the Resource Conservation and Recovery Act (“RCRA”) and other federal and state laws stemming from AltEn’s lack of compliance with the terms and conditions of its operating permits and other regulatory requirements. Corteva is one of six seed companies, who were customers of AltEn (collectively, the "Facility Response Group"), participating in the NDEE’s Voluntary Cleanup Program to address certain interim remediation needs at the site. In March 2025, the Facility Response Group reached an agreement to settle its lawsuit against AltEn and certain of its affiliates to preserve certain contractual and common law indemnification claims. The settlement agreement, among other things, limits AltEn’s ability to dispose of the property or take any adverse action with respect to its property or assets. As of December 31, 2025, an accrual was established for Corteva’s estimated voluntary contribution to the solid waste and wastewater remedial action plans for the AltEn location.

California Department of Toxic Substances Control, Pittsburg Plant

The California Department of Toxic Substances Control (“DTSC”) has filed a state court lawsuit over challenging whether the Pittsburg plant’s high purity water system (“HPWS”), as operated by Dow and now Corteva, required a permit pursuant to the RCRA. Discussions between the parties remain ongoing and further litigation, including discovery, is stayed.

Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) - Pension Plan - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Fair Value, Inputs, Level 1 [Member]

$ 10,275

$ 10,630

$ 11,755

Fair value of the company's long-term borrowings, including long-term debt due within one year

2,129

2,444

Fair Value, Inputs, Level 3 [Member]

5,711

5,761

Fair Value Measured at Net Asset Value Per Share

162

121

Fair Value, Inputs, Level 1, Level 2, and Level 3

2,490

2,546

Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV

7,914

8,367

Defined Benefit Plan, Cash | Fair Value, Inputs, Level 1 [Member]

Defined Benefit Plan, Cash | Fair value of the company's long-term borrowings, including long-term debt due within one year

876

1,030

Defined Benefit Plan, Cash | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan, Cash | Fair Value, Inputs, Level 1, Level 2, and Level 3

Defined Benefit Plan, Equity Securities, US | Fair Value, Inputs, Level 1 [Member]

876

1,030

Defined Benefit Plan, Equity Securities, US | Fair value of the company's long-term borrowings, including long-term debt due within one year

836

^[1]

1,026

^[2]

Defined Benefit Plan, Equity Securities, US | Fair Value, Inputs, Level 3 [Member]

^[1]

^[2]

Defined Benefit Plan, Equity Securities, US | Fair Value Measured at Net Asset Value Per Share

^[1]

^[2]

Defined Benefit Plan, Equity Securities, US | Fair Value, Inputs, Level 1, Level 2, and Level 3

Defined Benefit Plan, Equity Securities, Non-US | Fair Value, Inputs, Level 1 [Member]

837

^[1]

1,030

^[2]

Defined Benefit Plan, Equity Securities, Non-US | Fair value of the company's long-term borrowings, including long-term debt due within one year

417

388

Defined Benefit Plan, Equity Securities, Non-US | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan, Equity Securities, Non-US | Fair Value Measured at Net Asset Value Per Share

Defined Benefit Plan, Equity Securities, Non-US | Fair Value, Inputs, Level 1, Level 2, and Level 3

US Treasury and Government [Member] | Fair Value, Inputs, Level 1 [Member]

417

389

US Treasury and Government [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

US Treasury and Government [Member] | Fair Value, Inputs, Level 3 [Member]

1,540

1,628

US Treasury and Government [Member] | Fair Value Measured at Net Asset Value Per Share

US Treasury and Government [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]

1,540

1,628

Corporate Debt Securities [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]

3,728

3,540

Corporate Debt Securities [Member] | Fair Value Measured at Net Asset Value Per Share

Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]

3,728

3,540

Asset-backed Securities [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]

440

590

Asset-backed Securities [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

Hedge Funds [Member] | Fair Value, Inputs, Level 1 [Member]

440

590

Hedge Funds [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]

Hedge Funds [Member] | Fair Value Measured at Net Asset Value Per Share

Hedge Funds [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

Private Market Securities [Member] | Fair Value, Inputs, Level 1 [Member]

Private Market Securities [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]

Private Market Securities [Member] | Fair Value Measured at Net Asset Value Per Share

Private Market Securities [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

1,750

1,810

Real Estate [Member] | Fair Value, Inputs, Level 1 [Member]

Real Estate [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]

Real Estate [Member] | Fair Value Measured at Net Asset Value Per Share

101

Real Estate [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

647

642

Other Investments [Member] | Fair Value, Inputs, Level 1 [Member]

101

Other Investments [Member] | Fair value of the company's long-term borrowings, including long-term debt due within one year

Other Investments [Member] | Fair Value, Inputs, Level 3 [Member]

Other Investments [Member] | Fair Value, Inputs, Level 1, Level 2, and Level 3

$ 55

Pension trust receivables | Other Reconciling Items

Pension trust payables | Other Reconciling Items

^[3]

^[4]

$ (208)

^[5]

$ (362)

^[6]

Common Stock [Member]

Amount of Employer and Related Party Securities Included in Plan Assets, Percent

1.00%

Common Stock [Member] | Defined Benefit Plan, Equity Securities, US

Amount of Employer and Related Party Securities Included in Plan Assets

$ 132

[1]	The Corteva pension plans directly held no Corteva, Inc. common stock at December 31, 2025.
[2]	The Corteva pension plans directly held $132 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2024.
[3]	Primarily receivables for investment securities sold.
[4]	Primarily receivables for investments securities sold.
[5]	Primarily payables for investment securities purchased.
[6]	Primarily payables for investment securities purchased.

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Inventory [Line Items]
Finished products	$ 2,956	$ 2,649
Semi-finished products	2,276	2,297
Raw materials and supplies	435	486
Total inventories	$ 5,667	$ 5,432

Commitments and Contingent Liabilities - New Jersey (Details)	12 Months Ended
	Dec. 31, 2025 USD ($)	Aug. 03, 2025 USD ($)
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29.00%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71.00%
NEW JERSEY \| New Jersey Statewide Settlement [Member]
Loss Contingencies [Line Items]
New Jersey Statewide Settlement Reserve Fund	$ 475,000,000
NEW JERSEY \| Chemours [Member]
Loss Contingencies [Line Items]
Purchase of Chemours' Future Interest in Insurance Proceeds		$ 150,000,000
Litigation Settlement, Purchase of Chemours' Future Interest in Insurance Proceeds, Fee Threshold I		35,000,000
Litigation Settlement, Purchase of Chemours' Future Interest in Insurance Proceeds, Fee Threshold II		$ 3,000,000
Purchase of Chemours' Future Interest in Insurance Proceeds, Fee Interest Rate		2.00%
NEW JERSEY \| Corteva [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Purchase of Chemours' Future Interest in Insurance Proceeds		$ 44,000,000
NEW JERSEY \| DuPont de Nemours [Member] \| Chemours [Member]
Loss Contingencies [Line Items]
Purchase of Chemours' Future Interest in Insurance Proceeds		$ 106,000,000
NEW JERSEY \| Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	4
NEW JERSEY \| PFAS [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	2
NEW JERSEY \| New Jersey Statewide Settlement [Member]
Loss Contingencies [Line Items]
Litigation Settlement Amount	$ 875,000,000
Litigation Settlement, Amount Awarded to Other Party, Period	25 years
Litigation Settlement, Amount Awarded to Other Party, Present value	$ 500,000,000
Litigation Settlement, Amount Awarded to Other Party, Discount Rate	8.00%
Litigation Settlement, Amount Allocated to Statewide NRD	$ 16,000,000
Litigation Settlement, Percentage of Allocated Statewide NRD for Alleged Statewide AFFF Contamination	25.00%
(Loss) Income from Discontinued Operation, before Income Tax	$ 72,000,000
Discontinued Operation, Income (Loss) from Discontinued Operation, after Income Tax	$ 58,000,000
NEW JERSEY \| New Jersey Statewide Settlement [Member] \| DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Historical DuPont Operating Sites	4

Commitments and Contingent Liabilities- Supplier Finance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Supplier Finance Program, Obligation, Current	$ 121	$ 88	$ 115
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]	Accounts Payable
Supplier Finance Program, Obligation [Roll Forward]
Invoices confirmed during the year (Supplier Finance Program, Obligation, Addition)	$ 690	571
Confirmed invoices paid during the year (Supplier Finance Program, Obligation, Period Increase (Decrease))	$ (657)	$ (598)

Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligations	$ 11,806	$ 11,995
Fair value of plan assets	$ 10,027	$ 10,414

Fair Value Measures Fair Value Measurement Nonrecurring Basis (Details) - Fair Value, Nonrecurring [Member] - Crop Protection Strategy Operations Program [Member] - Fair Value, Inputs, Level 3 [Member] $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis Associated with Restructuring [Line Items]
Operating Lease, Impairment Loss Associated with Restructuring	$ 92
Impairment of Property, Plant, and Equipment to be Disposed of Associated with Restructuring	60
Restructuring Costs and Asset Impairment Charges	$ 152

Leases Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating cash outflows from operating leases	$ 166	$ 188	$ 169
Financing cash outflows from finance leases	$ 0	$ 1	$ 1

Earnings Per Share of Common Stock EPS Calculation - Basic (Details) - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ 1.75	$ 1.23	$ 1.31
Basic earnings (loss) per share of common stock from discontinued operations	(0.15)	0.08	(0.27)
Basic earnings (loss) per share of common stock	$ 1.60	$ 1.31	$ 1.04

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(13))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Revenue from Contract with Customer [Abstract]

Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment	$ 9,551	$ 9,074
Accumulated Depreciation	(5,331)	(4,975)
Property, Plant and Equipment, Net	4,220	4,099	$ 4,287
Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment	449	425
Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment	1,867	1,715
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment	6,849	6,472
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment	$ 386	$ 462

Accounting Policies	12 Months Ended
Accounting Policies	Dec. 31, 2025
Insider Trading Policies and Procedures:
Insider Trading Policies and Procedures Adopted	true

Revenue (Notes)

12 Months Ended

Dec. 31, 2025

Revenue

REVENUE

Revenue Recognition

Products

Substantially all of Corteva's revenue is derived from product sales, which consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property

Corteva enters into licensing arrangements with customers to license its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $150 million and $139 million at December 31, 2025 and December 31, 2024, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over a period of six years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.


Contract Balances	December 31, 2025		December 31, 2024
(In millions)
Accounts and notes receivable - trade 1	$	5,034	$	4,615
Contract assets - current 2	34		30
Contract assets - noncurrent 3	83		74
Deferred revenue - current	3,579		3,287
Deferred revenue - noncurrent 4	125		114

1.Included in accounts and notes receivable - net in the Consolidated Balance Sheets.

2.Included in other current assets in the Consolidated Balance Sheets.

3.Included in other assets in the Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the Consolidated Balance Sheets.

Revenue recognized during the years ended December 31, 2025, 2024 and 2023 from amounts included in deferred revenue at the beginning of the period was $3,247 million, $3,359 million and $3,342 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified into two operating segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Corn	$	7,002	$	6,496	$	6,447
Soybean	1,878		1,927		1,858
Other oilseeds	644		653		708
Other	374		469		459
Seed	9,898		9,545		9,472
Herbicides	3,730		3,599		4,034
Insecticides	1,669		1,715		1,598
Fungicides	1,140		1,081		1,112
Biologicals	519		476		491
Other	445		492		519
Crop Protection	7,503		7,363		7,754
Total	$	17,401	$	16,908	$	17,226

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:


Seed	For the Year Ended December 31,
(In millions)	2025		2024		2023
North America 1	$	6,271	$	6,033	$	5,768
EMEA 2	1,560		1,581		1,622
Latin America	1,614		1,523		1,637
Asia Pacific	453		408		445
Total	$	9,898	$	9,545	$	9,472


Crop Protection	For the Year Ended December 31,
(In millions)	2025		2024		2023
North America 1	$	2,753	$	2,627	$	2,822
EMEA 2	1,550		1,543		1,745
Latin America	2,314		2,253		2,269
Asia Pacific	886		940		918
Total	$	7,503	$	7,363	$	7,754

1.Represents U.S. & Canada.

2.Europe, Middle East, and Africa ("EMEA").

Refer to Note 21 - Geographic Information, to the Consolidated Financial Statements, for the breakout of consolidated net sales by geographic area.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

Award Timing Disclosure	12 Months Ended
Award Timing Disclosure	Dec. 31, 2025
Award Timing Disclosures [Line Items]
Award Timing MNPI Disclosure	nformation relating to executive compensation and the company's equity compensation plans is incorporated herein by reference to the definitive Proxy Statement for the 2026 Annual Meeting of Stockholders of Corteva, Inc., including information within "Compensation Discussion and Analysis," "Compensation of Executive Officers, "Director Compensation," "Compensation Committee Interlocks and Insider Participation" and "Compensation Committee Report."
Award Timing MNPI Considered	true

Supplementary Information Other Income (Expense) - Net (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Equity in earnings (losses) of affiliates - net

$ 136

$ 132

$ 283

Net gain (loss) on sales of businesses and other assets

Non-operating pension and other post-employment benefit credits (costs)

^[1]

(181)

(284)

(397)

^[2]

(23)

(144)

(119)

Miscellaneous income (expenses) - net

^[3]

(556)

(36)

(247)

Other income (expense) - net

$ (570)

$ (300)

$ (448)

Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]

Other income (expense) - net

Argentina, Pesos

$ (34)

$ (66)

$ (284)

[1]	Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.
[2]	Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).
[3]	Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2025 includes a charge related to the Bayer resolution offset by the receipt of insurance proceeds. The year ended December 31, 2024 includes the receipt of insurance proceeds and an indemnification payment negotiated with the prior Stoller owners. The years ended December 31, 2024 and 2023 also include estimated settlement reserves. The year ended December 31, 2023 also includes an Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on significant items.

Amount of income (loss) for proportionate share of equity method investee's income (loss).

Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 310
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479255/942-310-S50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 310
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.H.2.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478116/942-310-S99-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column E)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column E)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 45
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477346/946-830-45-39

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

SEC Schedule, 12-09, Allowance, Credit Loss [Member]

Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Award Vesting Period	3 years
OIP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	1.05%	1.18%	0.96%
Expected Volatility	34.09%	32.17%	31.07%
Risk Free Interest Rate	4.40%	4.20%	4.10%
Expected life of stock options granted during period	6 years	6 years	6 years
OIP [Member] \| Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value	$ 23.83	$ 18.80	$ 21.42
Grants between June 2019 and 2020 [Member] \| OIP [Member] \| Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option, Expiration Period	10 years

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]

Balance at beginning of period

$ 179

$ 205

$ 194

Additions charged to expenses

132

Deductions from reserves

^[1]

(70)

(81)

(13)

Balance at end of period

241

179

205

SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]

SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]

Balance at beginning of period

666

510

342

Additions charged to expenses

283

301

225

Purchase Accounting Adjustments

Deductions from reserves

^[2]

(62)

(145)

(65)

Balance at end of period

$ 887

$ 666

$ 510

[1]	Deductions include write-offs, recoveries collected and currency translation adjustments.
[2]	Deductions include amounts recorded to other comprehensive income and currency translation adjustments.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Subsection 09
-Paragraph Column E
-Publisher SEC

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Subsection 09
-Paragraph Column D
-Publisher SEC

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Subsection 09
-Paragraph Column C
-Subparagraph (1)
-Publisher SEC

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Subsection 09
-Paragraph Column C
-Subparagraph (2)
-Publisher SEC

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Subsection 09
-Paragraph Column B
-Publisher SEC

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09(Column C)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09(Column C)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09(Column E))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09(Column D))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4

Supplementary Information [Abstract]

Supplementary Information

12 Months Ended

Dec. 31, 2025

Additional Financial Information Disclosure [Text Block]

SUPPLEMENTARY INFORMATION


Other Income (Expense) - Net	For the Year Ended December 31,
(In millions)	2025		2024		2023
Interest income	$	136	$	132	$	283
Equity in earnings (losses) of affiliates - net	13		15		10
Net gain (loss) on sales of businesses and other assets	41		17		22
Net exchange gains (losses) 1	(181)		(284)		(397)
Non-operating pension and other post-employment benefit credits (costs) 2	(23)		(144)		(119)
Miscellaneous income (expenses) - net 3	(556)		(36)		(247)
Other income (expense) - net	$	(570)	$	(300)	$	(448)

1. Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.

2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).

3. Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2025 includes a charge related to the Bayer resolution offset by the receipt of insurance proceeds. The year ended December 31, 2024 includes the receipt of insurance proceeds and an indemnification payment negotiated with the prior Stoller owners. The years ended December 31, 2024 and 2023 also include estimated settlement reserves. The year ended December 31, 2023 also includes an Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). See Note 22 - Segment Information, to the Consolidated Financial Statements, for additional information on significant items.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States, whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)	$	(254)	$	(152)	$	(371)
Local tax (expenses) benefits	11		11		55
Net after-tax impact from subsidiary exchange gain (loss)	$	(243)	$	(141)	$	(316)

Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	73	$	(132)	$	(26)
Tax (expenses) benefits	(8)		26		7
Net after-tax impact from hedging program exchange gain (loss)	$	65	$	(106)	$	(19)

Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	(181)	$	(284)	$	(397)
Tax (expenses) benefits	3		37		62
Net after-tax exchange gain (loss)	$	(178)	$	(247)	$	(335)

Noncontrolling interest adjustment	—		1		—

Net after-tax exchange gain (loss) attributable to Corteva	$	(178)	$	(246)	$	(335)

Cash, Cash Equivalents and Restricted Cash Equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.


(In millions)	December 31, 2025		December 31, 2024
Cash and cash equivalents	$	4,521	$	3,106
Restricted cash equivalents	204		316
Total cash, cash equivalents and restricted cash equivalents	$	4,725	$	3,422

Restricted cash equivalents primarily relates to a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. During the second quarter of 2024, the company's previously-restricted cash in the Water District Settlement Fund, which was established by Corteva, EIDP, Inc., DuPont and Chemours in September 2023 under the Nationwide Water District Settlement, was released. All of the company's restricted cash equivalents are classified as current as of December 31, 2025 and 2024, except for the $15 million MOU Escrow Account balance at December 31, 2024.

Accounts Payable

Accounts payable was $4,398 million and $4,039 million at December 31, 2025 and 2024, respectively. Accounts payable - trade, which is a component of accounts payable, was $2,871 million and $2,632 million at December 31, 2025 and 2024, respectively. Included in accounts payable – trade was seed grower compensation of approximately $420 million and $410 million at December 31, 2025 and 2024, respectively, which is measured at fair value using Level 2 inputs. Accrued discounts and rebates, which is a component of accounts payable, was $1,328 million and $1,207 million at December 31, 2025 and 2024, respectively. No other components of accounts payable were more than five percent of total current liabilities.

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ 53	$ (55)	$ 101
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	51	(35)	60
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	7	(8)	(9)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	(5)	(12)	50
Unrealized (gain) loss on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ 0	$ 0	$ 0

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480870/815-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480870/815-30-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480870/815-30-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480870/815-30-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-4

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Amount of tax expense (benefit) allocated to other comprehensive income (loss).

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 12
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-12

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-11

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 71	$ 64
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	5	4
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 234	$ 223

Revenue (Tables)

12 Months Ended

Dec. 31, 2025

Contract Balances [Table Text Block]


Contract Balances	December 31, 2025		December 31, 2024
(In millions)
Accounts and notes receivable - trade 1	$	5,034	$	4,615
Contract assets - current 2	34		30
Contract assets - noncurrent 3	83		74
Deferred revenue - current	3,579		3,287
Deferred revenue - noncurrent 4	125		114

1.Included in accounts and notes receivable - net in the Consolidated Balance Sheets.

2.Included in other current assets in the Consolidated Balance Sheets.

3.Included in other assets in the Consolidated Balance Sheets.

4.Included in other noncurrent obligations in the Consolidated Balance Sheets.

Geography [Member]

Disaggregation of Revenue [Table Text Block]


Seed	For the Year Ended December 31,
(In millions)	2025		2024		2023
North America 1	$	6,271	$	6,033	$	5,768
EMEA 2	1,560		1,581		1,622
Latin America	1,614		1,523		1,637
Asia Pacific	453		408		445
Total	$	9,898	$	9,545	$	9,472


Crop Protection	For the Year Ended December 31,
(In millions)	2025		2024		2023
North America 1	$	2,753	$	2,627	$	2,822
EMEA 2	1,550		1,543		1,745
Latin America	2,314		2,253		2,269
Asia Pacific	886		940		918
Total	$	7,503	$	7,363	$	7,754

1.Represents U.S. & Canada.

2.Europe, Middle East, and Africa ("EMEA").

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Accounts and Notes Receivables, Net

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) - Other Post Employment Benefits Plan	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount Rate	5.14%	5.50%
Net Periodic Benefit, Discount Rate	5.50%	4.92%	5.09%

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2025
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Philadelphia, Pennsylvania
Auditor Firm ID	238

Accounts and Notes Receivable, Net

12 Months Ended

Dec. 31, 2025

Receivables [Abstract]

ACCOUNTS AND NOTES RECEIVABLE - NET


(In millions)	December 31, 2025		December 31, 2024
Accounts receivable – trade 1	$	4,881	$	4,448
Notes receivable – trade 1,2	153		167
Other 3	1,337		1,061
Total accounts and notes receivable - net	$	6,371	$	5,676

1.Accounts and notes receivable – trade are net of allowances of $241 million and $179 million at December 31, 2025 and 2024, respectively.

2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and crop protection products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2025 and 2024, there were no significant impairments related to current loan agreements.

3.Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $117 million and $144 million as of December 31, 2025 and 2024, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the years ended December 31, 2024 and 2025, respectively:


(In millions)
Balance at December 31, 2023	$	205
Net provision for credit losses	39
Other - net of write-offs charged against allowance	(65)
Balance at December 31, 2024	$	179
Net provision for credit losses	104
Other - net of write-offs charged against allowance	(42)
Balance at December 31, 2025	$	241

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Balance Sheets.

Trade receivables sold under these agreements were $166 million, $131 million, and $112 million for the years ended December 31, 2025, 2024 and 2023, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of December 31, 2025 and 2024 were $17 million and $15 million, respectively. The net proceeds received were included in cash provided by (used for) operating activities, in the Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense) - net in the Consolidated Statements of Operations. The loss on sale of receivables were $5 million, $9 million and $17 million for the years ended December 31, 2025, 2024 and 2023, respectively. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information on the company’s guarantees.

Stockholders' Equity

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

STOCKHOLDERS' EQUITY

Common Stock

Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2025, 2024, and 2023:


Shares of common stock			Issued



Balance at December 31, 2022			713,419,000
Issued			1,965,000
Repurchased and retired			(14,124,000)
Balance at December 31, 2023			701,260,000
Issued			2,244,000
Repurchased and retired			(17,909,000)
Balance at December 31, 2024			685,595,000
Issued			2,701,000
Repurchased and retired			(16,133,000)
Balance at December 31, 2025			672,163,000

Share Buyback Plan

On November 19, 2024, Corteva, Inc. announced that its Board of Directors authorized a $3 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2024 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2024 Share Buyback Plan, the company repurchased and retired 8,318,000 shares in the open market for a cost (excluding excise taxes) of $571 million during the year ended December 31, 2025.

On September 13, 2022, Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2022 Share Buyback Plan"). The company completed the 2022 Share Buyback Plan during the second quarter of 2025 and repurchased and retired 7,815,000, 17,909,000 and 10,026,000 shares in the open market and through privately-negotiated transactions for a cost (excluding excise taxes) of $500 million, $1 billion and $500 million during the years ended December 31, 2025, 2024 and 2023, respectively. Included within the shares repurchased during the years ended December 31, 2025 and 2024 were $145 million and $125 million, respectively, of shares from the master trust fund of the principal U.S. pension plan, as part of the Pension Investment Committee's periodic portfolio rebalancing process. Shares were repurchased by the company at the prevailing market rate authorized and agreed to by a third-party independent fiduciary for the plan.

On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The company completed the 2021 Share Buyback Plan during the first quarter of 2023 and repurchased and retired 4,098,000, 17,425,000 and 5,572,000 shares in the open market for a total cost of $250 million, $1 billion and $250 million during the years ended December 31, 2023, 2022 and 2021, respectively.

Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital ("APIC"). When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest

Corteva, Inc. owns 100 percent of the outstanding common shares of EIDP. However, EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's Consolidated Balance Sheets. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution.

Below is a summary of the EIDP Preferred Stock at December 31, 2025 and 2024 which is classified as noncontrolling interests in the Corteva Consolidated Balance Sheets.


(Shares in thousands)			Number of Shares
Authorized			23,000
$4.50 Series, callable at $120			1,673
$3.50 Series, callable at $102			700

Other Comprehensive Income (Loss)

The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below:


(In millions)	Cumulative Translation Adjustment1		Derivative Instruments		Pension Benefit Plans		Other Benefit Plans		Unrealized Gain (Loss) on Investments		Total
2023
Balance at January 1, 2023	$	(2,883)	$	80	$	(163)	$	160	$	—	$	(2,806)
Other comprehensive income (loss) before reclassifications	425		(123)		(188)		38		—		152
Amounts reclassified from accumulated other comprehensive income (loss)	—		(12)		(2)		(9)		—		(23)
Net other comprehensive income (loss)	$	425	$	(135)	$	(190)	$	29	$	—	$	129
Balance at December 31, 2023	$	(2,458)	$	(55)	$	(353)	$	189	$	—	$	(2,677)
2024
Other comprehensive income (loss) before reclassifications	(1,014)		27		127		40		(6)		(826)
Amounts reclassified from accumulated other comprehensive income (loss)	—		44		—		(10)		—		34
Net other comprehensive income (loss)	$	(1,014)	$	71	$	127	$	30	$	(6)	$	(792)

Balance at December 31, 2024	$	(3,472)	$	16	$	(226)	$	219	$	(6)	$	(3,469)
2025
Other comprehensive income (loss) before reclassifications	867		(65)		(149)		(12)		6		647
Amounts reclassified from accumulated other comprehensive income (loss)	—		42		(3)		(14)		—		25
Net other comprehensive income (loss)	$	867	$	(23)	$	(152)	$	(26)	$	6	$	672
Balance at December 31, 2025	$	(2,605)	$	(7)	$	(378)	$	193	$	—	$	(2,797)

1.The cumulative translation adjustment gain for the year ended December 31, 2025 was primarily driven by the weakening of the U.S. Dollar ("USD") against the Euro ("EUR"), Brazilian Real ("BRL"), South African Rand (“ZAR”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the year ended December 31, 2024 was primarily driven by the strengthening of the U.S. Dollar against the Brazilian Real, Euro, Swiss Franc ("CHF") and Mexican Peso. The cumulative translation adjustment gain for the year ended December 31, 2023 was primarily driven by the weakening of the U.S. Dollar against the Swiss Franc, Brazilian Real and Euro.

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Derivative instruments	$	(5)	$	(12)	$	50
Pension benefit plans - net	51		(35)		60
Other benefit plans - net	7		(8)		(9)
Unrealized gains (losses) on investments	—		—		—
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	53	$	(55)	$	101

A summary of the reclassifications out of accumulated other comprehensive income (loss) is provided as follows:


(In millions)	For the Year Ended December 31,
	2025		2024		2023
Derivative instruments: 1	$	66	$	65	$	(8)
Tax (benefit) expense 2	(24)		(21)		(4)
After-tax	$	42	$	44	$	(12)
Amortization of pension benefit plans:
Prior service (benefit) cost 3,4	$	(4)	$	(4)	$	(3)
Actuarial (gains) losses 3,4	—		1		—

Settlement (gain) loss 3,4	—		2		—
Total before tax	$	(4)	$	(1)	$	(3)
Tax (benefit) expense 2	1		1		1
After-tax	$	(3)	$	—	$	(2)
Amortization of other benefit plans:
Prior service (benefit) cost 3,4	$	(1)	$	(1)	$	(2)
Actuarial (gains) losses 3,4	(17)		(13)		(10)

Total before tax	$	(18)	$	(14)	$	(12)
Tax (benefit) expense 2	4		4		3
After-tax	$	(14)	$	(10)	$	(9)



Total reclassifications for the period, after-tax	$	25	$	34	$	(23)

1.Reflected in cost of goods sold in the Consolidated Statements of Operations.

2.Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.

3.These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 17 - Pension Plans and Other Post-Employment Benefits, to the Consolidated Financial Statements, for additional information.

4.Reflected in other income (expense) - net in the Consolidated Statements of Operations.

The entire disclosure for equity.

Segment Reporting, Asset Reconciling Item [Line Items]

Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Contingency [Line Items]
Unrecognized Tax Benefits, Beginning Balance	$ 263	$ 390	$ 357
Decreases related to positions taken on items from prior years	(1)	(4)	0
Increases related to positions taken on items from prior years	94	13	23
Increases related to positions taken in the current year	9	12	16
Settlement of uncertain tax positions with tax authorities	(24)	(140)	(4)
Decreases due to expiration of statutes of limitations	(5)	(5)	(2)
Exchange (gain) loss	(1)	(3)	0
Unrecognized Tax Benefits, Ending Balance	335	263	390
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	243	176	173
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	(9)	(4)	1
Total accrual (receivable) for interest and penalties associated with unrecognized tax benefits	(15)	(2)	$ 11
Tax, Advance deposits made to foreign taxing authority	95	$ 100
Undistributed Earnings of Foreign Subsidiaries	$ 4,158

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Receivables [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current Beginning Balance	$ 179	$ 205
Net provision for credit losses	104	39
Other deductions against allowance	(42)	(65)
Accounts Receivable, Allowance for Credit Loss, Current Ending Balance	$ 241	$ 179

Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income (loss) from Continuing Operations before Income Taxes	$ 1,688	$ 1,275	$ 1,093
Provision for (benefit from) income taxes on continuing operations	484	412	152
Income (loss) from continuing operations after income taxes	1,204	863	941
Continuing Operations [Member]
Income (loss) from Continuing Operations before Income Taxes, Domestic	325	324	(414)
Income (Loss) from Continuing Operations before Income Taxes, Foreign	1,363	951	1,507
Income (loss) from Continuing Operations before Income Taxes	1,688	1,275	1,093
Current Federal Tax (Benefit) Expense	87	285	143
Current State and Local Tax Expense (Benefit)	26	45	40
Current Foreign Tax Expense (Benefit)	412	447	407
Total current tax expense (benefit)	525	777	590
Deferred Federal Income Tax Expense (Benefit)	(139)	(300)	(326)
Deferred State and Local Income Tax Expense (Benefit)	(24)	(28)	(50)
Deferred Foreign Income Tax Expense (Benefit)	122	(37)	(62)
Total deferred tax expense (benefit)	(41)	(365)	(438)
Provision for (benefit from) income taxes on continuing operations	484	412	152
Income (loss) from continuing operations after income taxes	$ 1,204	$ 863	$ 941

EIDP Basis of Presentation (Details) - $ / shares	12 Months Ended
EIDP Basis of Presentation (Details) - $ / shares	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Feb. 05, 2026	Dec. 31, 2022	Jun. 03, 2019
Common Stock, Shares, Outstanding	672,163,000	685,595,000	701,260,000		713,419,000
Common Stock, Par Value	$ 0.01	$ 0.01		$ 0.01		$ 0.01
EIDP
Common Stock, Shares, Outstanding	200	200
Common Stock, Par Value	$ 0.30	$ 0.30		$ 0.30
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	4.50	4.50	$ 4.50
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividend Rate, Per-Dollar-Amount	3.50	$ 3.50	$ 3.50
Corteva [Member]
Common Stock, Par Value	$ 0.01
Corteva [Member] \| EIDP
Ownership of outstanding common shares in EIDP	100.00%

Insider Trading Arrangements	12 Months Ended
Insider Trading Arrangements	Dec. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Supplementary Information Supplementary Information (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Accounts Payable	$ 4,398	$ 4,039
Accounts Payable, Trade, Current	2,871	2,632
Accounts Payable, Other	1,328	1,207
Seed Grower Compensation
Accounts Payable, Trade, Current	$ 420	$ 410

EIDP Segment FN (Tables)

12 Months Ended

Dec. 31, 2025

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]


Income (loss) from continuing operations after income taxes to segment operating EBITDA	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	863	$	941
Provision for (benefit from) income taxes on continuing operations	484		412		152
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Depreciation and amortization	1,203		1,227		1,211
Interest income	(136)		(132)		(283)
Interest expense	180		233		233
Exchange (gains) losses - net	181		284		397
Non-operating (benefits) costs - net	39		174		151

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	—		—		—
Significant items	658		315		579
Separation costs	35		—		—
Corporate expenses	138		115		110
Segment operating EBITDA	$	3,986	$	3,491	$	3,491

Segment Reporting, Asset Reconciling Item [Line Items]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	For the Year Ended December 31,
	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	893	$	926
Provision for (benefit from) income taxes on continuing operations	484		421		147
Income (loss) from continuing operations before income taxes	$	1,688	$	1,314	$	1,073
Depreciation and amortization	1,203		1,227		1,211
Interest income	(136)		(171)		(283)
Interest expense	180		233		253
Exchange (gains) losses - net	181		284		397
Non-operating (benefits) costs - net	39		174		151
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	—		—		—
Significant items	658		315		579
Separation costs	35		—		—
Corporate expenses	138		115		110
Segment operating EBITDA	$	3,986	$	3,491	$	3,491

Revenue Contract Balances (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]

Accounts and notes receivable - trade

^[1]

$ 5,034

$ 4,615

Contract assets - current

^[2]

Contract assets - noncurrent

^[3]

Deferred Revenue, Current

3,579

3,287

Deferred Revenue. Noncurrent

^[4]

125

114

Deferred Revenue Recognized During the Period

$ 3,247

$ 3,359

$ 3,342

[1]	Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
[2]	Included in other current assets in the Consolidated Balance Sheets.
[3]	Included in other assets in the Consolidated Balance Sheets.
[4]	Included in other noncurrent obligations in the Consolidated Balance Sheets.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Segment Reporting Sig Items Footnote (Details) - 2022 Restructuring Actions - Russia Exit - Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Net Sales	$ 71
Cost of Revenue	$ 53

The aggregate cost of goods produced and sold and services rendered during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Derivative Instruments, Gain (Loss) [Line Items]

Financial Instruments Fair Value of Derivatives (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Derivative Asset, Statement of Financial Position [Extensible Enumeration]

Other current assets

Derivative Asset, Counterparty and Cash Collateral Netting

$ 32

$ 91

^[1]

(21)

(45)

Derivative Liability, Statement of Financial Position [Extensible Enumeration]

$ 11

$ 46

Accrued and other current liabilities

Derivative Liability, Counterparty and Cash Collateral Netting

$ 50

$ 111

^[1]

(21)

(45)

Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

^[1]

(21)

(45)

Derivative Liability, Counterparty and Cash Collateral Netting

104

^[1]

(21)

(45)

Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

Derivative Liability, Counterparty and Cash Collateral Netting

Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

Derivative Liability, Counterparty and Cash Collateral Netting

Designated as Hedging Instrument [Member] | Commodity Contract [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Asset, Counterparty and Cash Collateral Netting

Derivative Liability, Counterparty and Cash Collateral Netting

$ 3

$ 2

[1]

Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

EIDP Segment FN (Notes)

12 Months Ended

Dec. 31, 2025

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

Corteva’s reportable segments reflect the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (Seed and Crop Protection). The company's CODM is the Chief Executive Officer. The primary measure used by Corteva's CODM for purposes of allocating resources to the segments and assessing segment performance is segment operating EBITDA.

Segment operating EBITDA is primarily utilized in the annual planning and monthly forecasting processes. On a monthly basis, the CODM considers variances between comparable prior year actual results and current year actual or forecasted results when evaluating the company's success in delivering its innovative proprietary technology to farmers and monitoring of expected savings from cost and productivity actions. The CODM also utilizes segment operating EBITDA when evaluating the impacts of market-driven trends on segment performance, such as input costs and inflationary and currency impacts.

The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.

Corporate Profile

The company conducts its global operations through the following reportable segments:

Seed

The company's Seed segment is a global leader in developing and supplying commercial seed combining advanced germplasm and traits that offer maximum yield potential for farmers around the world. The segment is a leader in many key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The company offers seed and trait technologies that boost resilience to weather, pests, diseases, and herbicides used to manage weeds. Its digital solutions provide data-driven insights to help farmers optimize yield and profitability.

Crop Protection

The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment offers crop protection solutions and digital solutions that provide farmers tools to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.


(In millions)	Seed		Crop Protection		Total
As of and for the Year Ended December 31, 2025
Net sales	$	9,898	$	7,503	$	17,401
Segment operating EBITDA	2,636		1,350		3,986
Depreciation and amortization	780		423		1,203
Purchases of property, plant and equipment	377		214		591
As of and for the Year Ended December 31, 2024
Net sales	$	9,545	$	7,363	$	16,908
Segment operating EBITDA	2,219		1,272		3,491
Depreciation and amortization	805		422		1,227
Purchases of property, plant and equipment	365		232		597
As of and for the Year Ended December 31, 2023
Net sales	$	9,472	$	7,754	$	17,226
Segment operating EBITDA	2,117		1,374		3,491
Depreciation and amortization	814		397		1,211
Purchases of property, plant and equipment	332		263		595

Reconciliation of Segment Profitability


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2025
Net sales	$	9,898	$	7,503	$	17,401
Cost of goods sold	4,533		4,585		9,118
Other expenses 1	2,729		1,568		4,297
Segment operating EBITDA	$	2,636	$	1,350	$	3,986


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2024
Net sales	$	9,545	$	7,363	$	16,908
Cost of goods sold	4,876		4,636		9,512
Other expenses 1	2,450		1,455		3,905
Segment operating EBITDA	$	2,219	$	1,272	$	3,491


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2023
Net sales	$	9,472	$	7,754	$	17,226
Cost of goods sold	4,982		4,913		9,895
Other expenses 1	2,373		1,467		3,840
Segment operating EBITDA	$	2,117	$	1,374	$	3,491

1. Other expenses consist primarily of selling, general and administrative expenses and research and development expense, net of depreciation add-back.

Reconciliation to Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	863	$	941
Provision for (benefit from) income taxes on continuing operations	484		412		152
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Depreciation and amortization	1,203		1,227		1,211
Interest income	(136)		(132)		(283)
Interest expense	180		233		233
Exchange (gains) losses - net	181		284		397
Non-operating (benefits) costs - net	39		174		151

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	—		—		—
Significant items	658		315		579
Separation costs	35		—		—
Corporate expenses	138		115		110
Segment operating EBITDA	$	3,986	$	3,491	$	3,491

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The years ended December 31, 2025, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2025
Restructuring and asset related charges - net 1	$	(4)	$	(135)	$	(7)	$	(146)


Bayer resolution 2	(610)		—		—		(610)
Gain (loss) on sale of business, assets and equity investments 3,4	—		37		—		37

AltEn facility remediation charges 5	(37)		—		—		(37)
Insurance proceeds 6	—		98		—		98
Total	$	(651)	$	—	$	(7)	$	(658)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2024
Restructuring and asset related charges - net 1	$	(55)	$	(142)	$	(91)	$	(288)
Gain (loss) on sale of business, assets and equity investments 4	4		3		—		7
Inventory write-offs 4	2		—		—		2
Insurance proceeds 6	—		71		—		71
Estimated settlement expense 7	—		(101)		—		(101)





Acquisition-related costs 8	—		(6)		—		(6)
Total	$	(49)	$	(175)	$	(91)	$	(315)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2023
Restructuring and asset related charges - net 1	$	(86)	$	(228)	$	(22)	$	(336)
Gain (loss) on sale of business, assets and equity investments 4	4		10		—		14
Inventory write-offs 4	(7)		—		—		(7)
Spare parts write-off 3	—		(12)		—		(12)
Estimated settlement expense 7	—		(204)		—		(204)
Acquisition-related costs 8	—		(45)		—		(45)
AltEn facility remediation charges 5	(10)		—		—		(10)
Employee Retention Credit	—		3		—		3
Seed sale associated with Russia Exit 4,9	18		—		—		18
Total	$	(81)	$	(476)	$	(22)	$	(579)

1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.

2.Consists of a charge relating to the resolution of litigation with Bayer. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.

3.Incremental gains (losses) associated with activities related to the Crop Protection Operations Strategy Restructuring Program. Within gain (loss) on sale of business, assets and equity investments, a $23 million benefit was recorded for the year ended December 31, 2025.

4.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. Within gain (loss) on sale of business, assets and equity investments, such benefits are $14 million, $7 million and $14 million for the years ended December 31, 2025, 2024 and 2023, respectively.

5.Relates to a charge to increase the remediation accrual at the AltEn facility relating to Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.

6.Includes proceeds received related to prior significant items.

7.Consists of estimated Lorsban® related charges.

8.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up.

9.Includes a benefit of $18 million for the year ended December 31, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the year ended December 31, 2023.

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

There are no differences in reporting structure or segments between Corteva, Inc. and EIDP. In addition, there are no differences between Corteva, Inc. and EIDP segment net sales, segment operating EBITDA or significant items by segment; refer to page F-65 of the Corteva, Inc. Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EIDP.

Reconciliation to Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions)	For the Year Ended December 31,
	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	893	$	926
Provision for (benefit from) income taxes on continuing operations	484		421		147
Income (loss) from continuing operations before income taxes	$	1,688	$	1,314	$	1,073
Depreciation and amortization	1,203		1,227		1,211
Interest income	(136)		(171)		(283)
Interest expense	180		233		253
Exchange (gains) losses - net	181		284		397
Non-operating (benefits) costs - net	39		174		151
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	—		—		—
Significant items	658		315		579
Separation costs	35		—		—
Corporate expenses	138		115		110
Segment operating EBITDA	$	3,986	$	3,491	$	3,491

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Marketable Securities [Member]

EIDP Related Party (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
EIDP Related Party (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 09, 2025
Related Party Transaction [Line Items]
Other Assets		$ 2,044	$ 1,810
Accrued and other current liabilities		3,099	2,103
Dividends Paid to stockholders		475	458	$ 439
EIDP
Related Party Transaction [Line Items]
Other Assets		2,044	1,810
Accrued and other current liabilities		3,223	2,096
Dividend to Parent			1,750
EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Interest Expense				20
Interest Paid on Related Party Long-Term Debt				40
Interest Income, Other	$ 38
EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Due from Parent		0	129
Dividend to Parent		1,815
Dividends, Cash		1,815	1,750
Dividends Paid to stockholders		1,682	1,750	$ 0
Dividends Payable, Current		133			$ 195
Accrued and Other Current Liabilities [Member] \| EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Accrued and other current liabilities		27	9
Other Noncurrent Obligations [Member] \| EIDP \| Corteva [Member]
Related Party Transaction [Line Items]
Accounts Payable and Accrued Liabilities, Noncurrent		$ 154	$ 149

EIDP Income Taxes Geographic Allocation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income (loss) from Continuing Operations before Income Taxes	$ 1,688	$ 1,275	$ 1,093
Provision for (benefit from) income taxes on continuing operations	484	412	152
Income (Loss) from Continuing Operations After Taxes	1,204	863	941
Continuing Operations [Member]
Income (loss) from Continuing Operations before Income Taxes, Domestic	325	324	(414)
Income (Loss) from Continuing Operations before Income Taxes, Foreign	1,363	951	1,507
Income (loss) from Continuing Operations before Income Taxes	1,688	1,275	1,093
Current Federal Tax (Benefit) Expense	87	285	143
Current State and Local Tax Expense (Benefit)	26	45	40
Current Foreign Tax Expense (Benefit)	412	447	407
Total current tax expense (benefit)	525	777	590
Deferred Federal Income Tax Expense (Benefit)	(139)	(300)	(326)
Deferred State and Local Income Tax Expense (Benefit)	(24)	(28)	(50)
Deferred Foreign Income Tax Expense (Benefit)	122	(37)	(62)
Total deferred tax expense (benefit)	(41)	(365)	(438)
Provision for (benefit from) income taxes on continuing operations	484	412	152
Income (Loss) from Continuing Operations After Taxes	1,204	863	941
EIDP
Income (loss) from Continuing Operations before Income Taxes	1,688	1,314	1,073
Provision for (benefit from) income taxes on continuing operations	484	421	147
Income (Loss) from Continuing Operations After Taxes	1,204	893	926
EIDP \| Continuing Operations [Member]
Income (loss) from Continuing Operations before Income Taxes, Domestic	325	363	(434)
Income (Loss) from Continuing Operations before Income Taxes, Foreign	1,363	951	1,507
Income (loss) from Continuing Operations before Income Taxes	1,688	1,314	1,073
Current Federal Tax (Benefit) Expense	87	292	138
Current State and Local Tax Expense (Benefit)	26	47	40
Current Foreign Tax Expense (Benefit)	412	447	407
Total current tax expense (benefit)	525	786	585
Deferred Federal Income Tax Expense (Benefit)	(139)	(300)	(326)
Deferred State and Local Income Tax Expense (Benefit)	(24)	(28)	(50)
Deferred Foreign Income Tax Expense (Benefit)	122	(37)	(62)
Total deferred tax expense (benefit)	(41)	(365)	(438)
Provision for (benefit from) income taxes on continuing operations	484	421	147
Income (Loss) from Continuing Operations After Taxes	$ 1,204	$ 893	$ 926

Debt Security - Available for sale (Details) - Foreign Government Bonds [Member] - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Debt Securities, Available-for-sale [Line Items]

Available-for-sale securities

^[1]

$ 8

$ 0

Other Assets [Member]

Debt Securities, Available-for-sale [Line Items]

Debt Securities, AFS, Fair Value, Maturity after year one to five years

^[2]

$ 22

$ 97

[1]	Maturity at time of purchase was more than three months to less than one year.
[2]	Maturity at time of purchase was more than one year.

Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-SubTopic 10
-Topic 825
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482881/825-10-55-10

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482881/825-10-55-12

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 103
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-103

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481830/320-10-45-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479130/326-30-45-1

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2025

Property, Plant and Equipment Disclosure [Text Block]

PROPERTY, PLANT AND EQUIPMENT


(In millions)	December 31, 2025		December 31, 2024
Land and land improvements	$	449	$	425
Buildings	1,867		1,715
Machinery and equipment	6,849		6,472
Construction in progress	386		462
Total property, plant and equipment	$	9,551	$	9,074
Accumulated depreciation	(5,331)		(4,975)
Total property, plant and equipment - net	$	4,220	$	4,099

Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 2 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 2 to 7 years.


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Depreciation expense	$	559	$	542	$	528

Earnings Per Share of Common Stock (Tables)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock Reconciliation


Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	863	$	941
Net income (loss) attributable to continuing operations noncontrolling interests	11		12		12

Income (loss) from continuing operations available to Corteva common stockholders	$	1,193	$	851	$	929


Income (loss) from discontinued operations available to Corteva common stockholders	(99)		56		(194)
Net income (loss) available to common stockholders	$	1,094	$	907	$	735

Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Basic	For the Year Ended December 31,
(Dollars per share)	2025		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	1.75	$	1.23	$	1.31
Earnings (loss) per share of common stock from discontinued operations	(0.15)		0.08		(0.27)
Earnings (loss) per share of common stock	$	1.60	$	1.31	$	1.04

Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]


Earnings (Loss) Per Share Calculations - Diluted	For the Year Ended December 31,
(Dollars per share)	2025		2024		2023
Earnings (loss) per share of common stock from continuing operations	$	1.75	$	1.22	$	1.30
Earnings (loss) per share of common stock from discontinued operations	(0.15)		0.08		(0.27)
Earnings (loss) per share of common stock	$	1.60	$	1.30	$	1.03

Share Count Information [Table Text Block]


Share Count Information	For the Year Ended December 31,
(Shares in millions)	2025	2024	2023
Weighted-average common shares - basic	680.0	693.7	709.0
Plus dilutive effect of equity compensation plans 1	1.4	2.3	2.9

Weighted-average common shares - diluted	681.4	696.0	711.9
Potential shares of common stock excluded from EPS calculations 2	2.3	3.1	2.3

performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details)	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	100.00%	100.00%
Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	67.00%	67.00%
Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	0.00%	0.00%
Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	13.00%	12.00%
Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	7.00%	7.00%
Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	0.00%	0.00%
UNITED STATES \| Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	8.00%	9.00%
Non-US [Member] \| Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	5.00%	5.00%

Geographic Information Revenue by Country (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues from External Customers and Long-Lived Assets [Line Items]

$ 17,401

$ 16,908

$ 17,226

UNITED STATES

Revenues from External Customers and Long-Lived Assets [Line Items]

8,269

7,866

7,783

CANADA

Revenues from External Customers and Long-Lived Assets [Line Items]

755

794

807

EMEA

Revenues from External Customers and Long-Lived Assets [Line Items]

3,110

3,124

3,367

Asia Pacific

Revenues from External Customers and Long-Lived Assets [Line Items]

1,339

1,348

1,363

Latin America

Revenues from External Customers and Long-Lived Assets [Line Items]

^[1]

3,928

3,776

3,906

BRAZIL

$ 2,900

$ 2,618

$ 2,523

[1]	Net sales for Brazil for the years ended December 31, 2025, 2024 and 2023 were $2,900 million, $2,618 million and $2,523 million, respectively.

EIDP Related Party (Notes)	12 Months Ended
EIDP Related Party (Notes)	Dec. 31, 2025
EIDP
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva EIDP and Corteva, including certain consolidated subsidiaries (collectively the “Participating Companies”), are party to a Master In-House Banking Agreement, which established banking arrangements to facilitate the management of the cash and liquidity needs of the Participating Companies. Historically, in periods where EIDP had a net amount due from Corteva, Inc., EIDP classified the amount within other assets given Corteva, Inc. had both the ability and intent to repay the amounts due. Beginning in the fourth quarter of 2024, Corteva, Inc.'s intent to repay the amounts due changed and therefore, borrowings under this agreement are now classified within equity of EIDP. Through the third quarter of 2024, EIDP earned interest income from Corteva, Inc. of $38 million under this agreement, which is reflected as other income (expense) - net in EIDP's Consolidated Statements of Operations. As of December 31, 2025 and 2024, EIDP had a due from parent of $— million and $129 million, respectively, classified within the equity section of EIDP’s Consolidated Balance Sheets. In December 2025, the Board of Directors of EIDP authorized and declared a dividend of $195 million to Corteva, Inc., from which the proceeds are intended to be used to fund Corteva, Inc. share repurchases and common stock dividends during the first quarter of 2026. At December 31, 2025, EIDP had a dividend payable to Corteva, Inc. of $133 million. EIDP declared cash dividends of $1,815 million and $1,750 million for the years ended December 31, 2025 and 2024, respectively. Cash dividends paid to Corteva, Inc. during the years ended December 31, 2025 and 2024 were $1,682 million and $1,750 million, respectively. In the second quarter of 2019, EIDP entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. EIDP repaid the outstanding related party revolving loan balance during the fourth quarter of 2023. EIDP incurred interest expense of $20 million and paid interest of $40 million for the year ended December 31, 2023 associated with the related party loan to Corteva, Inc., net of interest income earned from the Master In-House Banking Agreement. As of December 31, 2025 and 2024, EIDP had payables to Corteva, Inc. of $27 million and $9 million, included in accrued and other current liabilities, respectively, and $154 million and $149 million included in other noncurrent obligations, respectively, in the Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements for further details of the Separation Agreements).

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Accounts, Notes, Loans and Financing Receivable [Line Items]

Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Accounts receivable - trade

^[1]

$ 4,881

$ 4,448

Notes receivable - trade

^[1],[2]

153

167

Other

^[3]

1,337

1,061

Total accounts and notes receivable - net

6,371

5,676

A/R trade and notes receivable - trade, allowance

$ 241

179

$ 205

Other Receivable, Total Current Assets, Percentage

5.00%

Nonconsolidated Affiliates [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Nontrade Receivables, Current

$ 117

$ 144

[1]	Accounts and notes receivable – trade are net of allowances of $241 million and $179 million at December 31, 2025 and 2024, respectively.
[2]	Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and crop protection products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2025 and 2024, there were no significant impairments related to current loan agreements.
[3]	Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $117 million and $144 million as of December 31, 2025 and 2024, respectively.

Goodwill and Other Intangible Assets Amortization Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 644	$ 685	$ 683
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
2025	637
2026	576
2027	555
2028	531
2029	$ 521

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-11

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-24

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-12

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-6

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 24: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 26: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 27: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 28: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483154/926-20-50-5

Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details) $ in Millions	Dec. 31, 2025 USD ($)
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2025	$ 1,199
2026	1,162
2027	1,126
2028	1,088
2029	1,048
2030-2034	4,644
Total	10,267
Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2025	98
2026	91
2027	85
2028	79
2029	73
2030-2034	293
Total	$ 719

Leases Maturity of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Leases [Abstract]
Operating Lease, Year One	$ 136
Operating Lease, Year Two	95
Operating Lease, Year Three	71
Operating Lease, Year Four	51
Operating Lease, Year Five	33
Operating Lease, Due After Year Five	87
Operating Lease, Total Payments	473
Operating Lease, Interest	58
Total operating lease liabilities	$ 415	$ 476

Restructuring and Asset Related Charges - Crop Protection Operations Strategy (Details) - USD ($)
$ in Millions

12 Months Ended

26 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2025

Crop Protection Strategy Operations Program [Member]

$ 146

$ 288

$ 336

Restructuring and Related Cost, Cost Incurred to Date

611

$ 611

(113)

(61)

(177)

^[1]

150

232

217

150

232

(13)

(101)

Crop Protection Strategy Operations Program [Member] | Minimum [Member]

Anticipated Cash Payments

650

330

Crop Protection Strategy Operations Program [Member] | Maximum [Member]

Anticipated Cash Payments

700

360

Crop Protection Strategy Operations Program [Member] | Employee Severance [Member]

Restructuring and Related Cost, Cost Incurred to Date

102

(49)

(21)

^[2]

Crop Protection Strategy Operations Program [Member] | Employee Severance [Member] | Minimum [Member]

Crop Protection Strategy Operations Program [Member] | Employee Severance [Member] | Maximum [Member]

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member]

105

Restructuring and Related Cost, Cost Incurred to Date

340

^[3],[4]

101

214

^[5]

101

(13)

(101)

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Minimum [Member]

Crop Protection Strategy Operations Program [Member] | Asset Related Charges [Member] | Maximum [Member]

320

Crop Protection Strategy Operations Program [Member] | Decommissioning and Demolition

340

Restructuring and Related Cost, Cost Incurred to Date

(52)

(10)

^[4]

Crop Protection Strategy Operations Program [Member] | Contract Termination [Member]

Restructuring and Related Cost, Cost Incurred to Date

(12)

(30)

^[4]

Crop Protection Strategy Operations Program [Member] | Contract Termination [Member] | Minimum [Member]

$ 0

Crop Protection Strategy Operations Program [Member] | Contract Termination [Member] | Maximum [Member]

245

Goodwill and Intangible Asset Disclosure [Abstract]

$ 255

[1]	This amount excludes charges relating to spare parts write-offs included in cost of goods sold for the year ended December 31, 2023, in the company's Consolidated Statement of Operations.
[2]	Reflects corporate related charges.
[3]	Asset-related charges includes impairment charges related to operating lease assets and property, plant and equipment.
[4]	Reflects charges which are substantially all associated with the Crop Protection segment.
[5]	Asset-related charges includes impairment charges related to operating lease assets and property, plant and equipment.

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Long-Term Debt and Available Credit Facilities Long Term Debt (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Debt Instrument [Line Items]
Finance Lease, Liability, Noncurrent	$ 0	$ 0
Unamortized debt discount and issuance costs	16,000,000	12,000,000
Long-term debt payable within one year	782,000,000	500,000,000
Long-term Debt	1,686,000,000	1,953,000,000
Long-Term Debt, Maturities, Repayments of Principal in Next Rolling 12 Months	782,000,000
Long-Term Debt, Maturities, Repayments of Principal in Rolling Year Five	500,000,000
Line of Credit Facility, Remaining Borrowing Capacity	5,500,000,000
Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	86,000,000
Medium-Term Note [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 102,000,000	$ 104,000,000
Long-term Debt, Weighted Average Interest Rate	3.76%	4.41%
Senior Notes [Member] \| Notes Maturing 2025 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 0	$ 500,000,000
Long-term Debt, Weighted Average Interest Rate	0.00%	1.70%
Senior Notes [Member] \| Notes Maturing 2026 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600,000,000	$ 600,000,000
Long-term Debt, Weighted Average Interest Rate	4.50%	4.50%
Senior Notes [Member] \| Notes Maturing 2030 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500,000,000	$ 500,000,000
Long-term Debt, Weighted Average Interest Rate	2.30%	2.30%
Senior Notes [Member] \| Notes Maturing 2033 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 600,000,000	$ 600,000,000
Long-term Debt, Weighted Average Interest Rate	4.80%	4.80%
Senior Notes [Member] \| Notes Maturing 2032 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500,000,000	$ 0
Long-term Debt, Weighted Average Interest Rate	5.125%	0.00%
Foreign Currency Loans [Member] \| Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 182,000,000	$ 161,000,000
Long-term Debt, Weighted Average Interest Rate	12.70%	12.70%
Fair value of the company's long-term borrowings, including long-term debt due within one year
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 2,462,000,000	$ 2,366,000,000

Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details) $ in Millions	1 Months Ended		12 Months Ended	13 Months Ended	36 Months Ended		60 Months Ended
	May 31, 2023 USD ($)	Feb. 28, 2023 USD ($)	Dec. 31, 2025 USD ($)	Feb. 26, 2024	Jun. 03, 2027	May 03, 2025	Jun. 03, 2029	May 03, 2027	Feb. 20, 2026 USD ($)	Feb. 20, 2025 USD ($)	Feb. 20, 2024 USD ($)	Jul. 20, 2023 USD ($)	Jan. 20, 2023 USD ($)	May 03, 2022 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 5,500
Line of Credit Facility, Remaining Borrowing Capacity			5,500
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]				Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]				Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			1,900											$ 3,000
Line of Credit Facility, Remaining Borrowing Capacity			1,900
Debt Instrument, Term					3 years			5 years
364-day Revolving Credit Facility
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			750
Line of Credit Facility, Remaining Borrowing Capacity			$ 750
Debt Instrument, Term				364 days
Ratio of Indebtedness to Net Capital			0.60
Adjusted Term SOFR				0.10%
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital			0.60
Adjusted Term SOFR			0.10%
Revolving Credit Facilities due 2029
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 2,850
Line of Credit Facility, Remaining Borrowing Capacity			$ 2,850
Debt Instrument, Term							5 years
Revolving Credit Facilities due 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity														$ 2,000
Debt Instrument, Term						3 years
364-day Revolving Credit Facilities due 2024
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity												$ 500	$ 1,000
Proceeds from Lines of Credit		$ 1,000
Repayments of Lines of Credit	$ 1,000
364-day Revolving Credit Facilities due 2026
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity										$ 750
364-day Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity									$ 1,250
364-day Revolving Credit Facilities due 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity											$ 1,000

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Goodwill


(In millions)	Seed		Crop Protection		Total




Balance at December 31, 2023	$	5,422	$	5,183	$	10,605
Currency translation adjustment	(96)		(139)		(235)
Other goodwill adjustments 1	—		38		38
Balance at December 31, 2024	$	5,326	$	5,082	$	10,408
Currency translation adjustment	(14)		71		57

Balance at December 31, 2025	$	5,312	$	5,153	$	10,465

1.Includes measurement period adjustments related to the acquisitions of Stoller and Symborg, which were not material.

^[1]

Other Intangible Assets


	December 31, 2025						December 31, 2024
(In millions)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Intangible assets subject to amortization (finite-lived):
Germplasm	$	6,291	$	(1,587)	$	4,704	$	6,291	$	(1,336)	$	4,955
Customer-related	2,394		(1,024)		1,370		2,350		(863)		1,487
Developed technology	1,860		(1,283)		577		1,838		(1,161)		677
Trademarks/trade names	2,056		(466)		1,590		2,056		(380)		1,676

Other 1	368		(313)		55		388		(312)		76
Total other intangible assets with finite lives	$	12,969	$	(4,673)	$	8,296	$	12,923	$	(4,052)	$	8,871

Intangible assets not subject to amortization (indefinite-lived):
In-process research and development	5		—		5		5		—		5
Total other intangible assets with indefinite lives	5		—		5		5		—		5
Total other intangible assets	$	12,974	$	(4,673)	$	8,301	$	12,928	$	(4,052)	$	8,876

1.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense


(In millions)
2026	$	637
2027	576
2028	555
2029	531
2030	521

[1]	Includes measurement period adjustments related to the acquisitions of Stoller and Symborg, which were not material.

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]


Significant Other Observable Inputs	December 31, 2025		December 31, 2024
(In millions)	Level 2 1		Level 2 1
Assets at fair value:
Marketable securities	$	1	$	63
Debt securities:
Foreign government bonds 2	30		97
Derivatives relating to: 3
Foreign currency	28		71
Commodity contracts	4		20

Total assets at fair value	$	63	$	251
Liabilities at fair value:
Derivatives relating to: 3
Foreign currency	$	41	$	104
Commodity contracts	9		7
Total liabilities at fair value	$	50	$	111

1.Reflects significant other observable inputs.

2.Represents the company's investments in debt securities that are classified as available-for-sale, which are included in the Consolidated Balance Sheets.

3.See Note 19 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.

Financial Instruments Effect of Derivative Instruments (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Derivative Instruments, Gain (Loss) [Line Items]

(Loss) Gain on Derivative Instruments, Net, Pretax

^[1]

$ (96)

$ (208)

$ (115)

Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

(Loss) Gain on Hedging Activity

^[1]

$ (66)

$ (65)

$ 8

Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]

Cost of Goods Sold

Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net

^[1]

$ (30)

$ (143)

$ (123)

Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]

Derivative Instruments, Gain (Loss) [Line Items]

(Loss) Gain on Hedging Activity

^[1],[2]

(41)

Foreign Exchange Contract [Member] | Cost of Goods Sold | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net

^[1],[2]

(103)

(77)

Foreign Exchange Contract [Member] | Other Income (Expense) - net | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net

^[1],[3]

(130)

(28)

Commodity Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]

Derivative Instruments, Gain (Loss) [Line Items]

(Loss) Gain on Hedging Activity

^[1],[2]

(72)

(74)

Commodity Contract [Member] | Cost of Goods Sold | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net

^[1],[2],[4]

(34)

(20)

Commodity Contract [Member] | Other Income (Expense) - net | Not Designated as Hedging Instrument [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net

^[3]

$ 0

$ (2)

$ 2

[1]	For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
[2]	Recorded in cost of goods sold, in the Consolidated Statement of Operations.
[3]	Recognized in other income (expense) - net, in the Consolidated Statement of Operations. Note that the net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the Consolidated Financial Statements for additional information.
[4]	The net gain (loss) relating to commodity contracts that are not designated as hedging instruments that were recorded in cost of goods sold, in the Consolidated Statement of Operations, are mostly offset by the related net gain (loss) on third-party grower contracts denominated as liabilities.

Recent Accounting Guidance	12 Months Ended
Recent Accounting Guidance	Dec. 31, 2025
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for annual periods beginning after December 15, 2024 on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The company adopted this guidance on a prospective basis and has included enhanced income tax related disclosures in Note 7 - Income Taxes, to the Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU includes amendments that expand the existing reportable segment disclosure requirements and requires disclosure of (i) significant expense categories and amounts by reportable segment as well as the segment’s profit or loss measure(s) that are regularly provided to the chief operating decision maker (the “CODM”) to allocate resources and assess performance; (ii) how the CODM uses each reported segment profit or loss measure to allocate resources and assess performance; (iii) the nature of other segment balances contributing to reported segment profit or loss that are not captured within segment revenues or expenses; and (iv) the title and position of the individual or name of the group or committee identified as the CODM. This guidance requires retrospective application to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The company adopted this guidance and has included enhanced disclosures relating to its reportable segments. See Note 22 - Segment Information, to the Consolidated Financial Statements, for the company's updated disclosure. Accounting Guidance Issued But Not Adopted as of December 31, 2025 In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU includes amendments that require entities to bifurcate specified expense line items on the income statement into underlying components, including purchases of inventory, employee compensation, depreciation, intangible asset amortization and depletion, as applicable. Qualitative descriptions of the remaining components are required. These enhanced disclosures are required for both interim and annual periods. Selling expenses must also be separately disclosed for both interim and annual periods, along with an annual qualitative description of the composition of selling expenses. In January 2025, the FASB subsequently issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, to provide clarification on the ASU's effective date. The new standard is effective for fiscal years beginning after December 15, 2026 on a prospective basis with the option to apply it retrospectively, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The adoption of this guidance will result in the company being required to include enhanced disclosures around income statement expenses.

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476173/280-10-65-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org/250/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Schedule of Inventory, Current [Table Text Block]

Inventories (Tables)

12 Months Ended

Dec. 31, 2025

Inventory Disclosure [Abstract]


(In millions)	December 31, 2025		December 31, 2024
Finished products	$	2,956	$	2,649
Semi-finished products	2,276		2,297
Raw materials and supplies	435		486
Total inventories	$	5,667	$	5,432

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Foreign Currency Exchange Gain (Loss) [Line Items]

Tax benefits (expenses) on exchange (loss) gain

^[1]

$ (181)

$ (284)

$ (397)

Noncontrolling Interest [Member]

(178)

(247)

(335)

Foreign Currency Exchange Gain (Loss) [Line Items]

Foreign Currency Exchange Gain (Loss) [Line Items]

Corteva [Member]

Subsidiary Monetary Position

(178)

(246)

(335)

Foreign Currency Exchange Gain (Loss) [Line Items]

Tax benefits (expenses) on exchange (loss) gain

(254)

(152)

(371)

Foreign Currency Exchange Gain (Loss) [Line Items]

(243)

(141)

(316)

Hedging Program [Member]

Tax benefits (expenses) on exchange (loss) gain

(132)

(26)

(8)

$ 65

$ (106)

$ (19)

[1]	Includes net pre-tax exchange gains (losses) of $(34) million, $(66) million and $(284) million, associated with impacts from the devaluation of the Argentine peso for the years ended December 31, 2025, 2024 and 2023, respectively.

Leases Narrative (Details) $ in Millions	12 Months Ended
Leases Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($)
Residual Value Guarantee	$ 183
Minimum [Member]
Remaining Lease Term	1 year
Maximum [Member]
Remaining Lease Term	37 years

Property, Plant, and Equipment Useful Life (Details)	Dec. 31, 2025
Minimum [Member]
Property, Plant and Equipment [Line Items]
Definite-Lived Intangible Asset, Useful Life	2 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Definite-Lived Intangible Asset, Useful Life	25 years
Computer Software, Intangible Asset [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Definite-Lived Intangible Asset, Useful Life	2 years
Computer Software, Intangible Asset [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Definite-Lived Intangible Asset, Useful Life	7 years
Building [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Building [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	25 years

Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details) - PFOA Matters: Drinking Water Actions [Member]	12 Months Ended	108 Months Ended
	Dec. 31, 2004 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2025 USD ($)	Jan. 01, 2012
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size	80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment				6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold	$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date		$ 2,000,000
Escrow Balance			$ 1,000,000

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Income Tax Disclosure [Text Block]

Leases Lease Term and Discount Rate (Details)	Dec. 31, 2025	Dec. 31, 2024
Operating Lease, Weighted Average Remaining Lease Term	6 years 2 months 12 days	6 years 5 months 8 days
Finance Lease, Weighted Average Remaining Lease Term	0 years	4 months 17 days
Operating Lease, Weighted Average Discount Rate, Percent	3.85%	3.32%
Finance Lease, Weighted Average Discount Rate, Percent	0.00%	3.29%

Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2026
Defined Benefit and Contribution Disclosures [Line Items]
Pre-tax cash requirements to cover actual net claims costs and related administrative expenses	$ 96	$ 101	$ 97
Trust Asset	$ 204	316
U.S. Retirement Savings Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer Matching Contribution, Percent of Match	100.00%
Employer Matching Contribution, Percent of Employees' Gross Pay	6.00%
Employer Discretionary Contribution Percent	3.00%
Defined Contribution Plan, Employer Contribution	$ 99	100	101
Employers Discretionary Contribution, Vesting Period	3 years
Trust Agreement [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Trust Asset Distribution	$ 37	48
Trust Asset	147	176
Corteva Other Contribution Plans [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution	51	46	45
Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement	0	(2)	0
Actuarial (gain) loss	(383)	580
Employer contributions	40	50
Other Post Employment Benefits Plan
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement	0	0	0
Actuarial (gain) loss	(15)	51
Employer contributions	96	101
Other Post Employment Benefits Plan \| Forecast [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Expected Future Employer Contributions, Next Fiscal Year				$ 100
Other Pension Plan [Member]
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Employer contributions	$ 40	$ 50	$ 52
Other Pension Plan [Member] \| Forecast [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Expected Future Employer Contributions, Next Fiscal Year				$ 40

Income Taxes

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

INCOME TAXES

Domestic and foreign components of income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	324	$	(414)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Current tax expense (benefit)
Federal	$	87	$	285	$	143
State and local	26		45		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	777	$	590
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		412		152
Net income (loss) from continuing operations after taxes	$	1,204	$	863	$	941


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2025
($ In millions)	$		%
U.S. Federal statutory tax rate	$	354	21.0	%
State and local income tax, net of federal (national) income tax effect 1	5		0.3	%
Foreign tax effects
Argentina
Statutory tax rate differential	(17)		(1.0)	%
Withholding tax	18		1.1	%
Exchange gains/losses	(31)		(1.8)	%
Changes in valuation allowances	73		4.3	%
Other	(3)		(0.2)	%
Brazil

Withholding tax	37		2.2	%
Changes in valuation allowances 2	153		9.1	%
Other	(4)		(0.2)	%
India
Statutory tax rate differential	17		1.0	%
Agriculture exemption	(41)		(2.4)	%
Withholding tax	31		1.8	%
Other	1		0.1	%
Switzerland
Statutory tax rate differential	(91)		(5.4)	%
Cantonal income tax, net	59		3.5	%
Other	(1)		(0.1)	%
Other foreign jurisdictions	49		2.9	%
Effect of cross-border tax laws (net of related foreign tax credits)
Global Intangible Low-Taxed Income (GILTI)	24		1.4	%
Other	12		0.7	%
Tax credits
U.S. research and development credit	(47)		(2.8)	%
Other foreign tax credits	(52)		(3.1)	%
Changes in valuation allowances 3	74		4.4	%
Nontaxable or nondeductible items	31		1.8	%
Changes in unrecognized tax benefits	(19)		(1.1)	%
Other
Capital loss 3	(77)		(4.6)	%
Legal entity tax characterization 4	(49)		(2.9)	%
Other	(22)		(1.3)	%
Effective tax rate	$	484	28.7	%

1.State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.

3.For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.

4.For the year ended December 31, 2025, a U.S. federal deferred tax benefit was recorded associated with a change in a legal entity's U.S. tax characterization in the amount of $(49) million.


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.8		(1.8)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.7)		(5.9)
Exchange gains/losses 3	1.7		2.0
State and local incomes taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(7.9)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.5)
Tax settlements and expiration of statute of limitations	(1.7)		(0.3)

Impact of Brazil valuation allowance 6	9.4		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	0.1		(0.1)
Effective tax rate on income from continuing operations	32.3	%	13.9	%

2. Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

Significant jurisdictions in which income taxes were paid (net of refunds received) are shown below:


Income Taxes Paid, Net	For the Year Ended December 31,
(In millions)	2025
US Federal	$	195
US State and Local	49
Brazil	72
India	42
Switzerland, Federal	59
Switzerland, Geneva	46
Other Foreign	287
Total	$	750

Significant components of the company's net deferred tax asset (liability) were attributable to:


Deferred Tax Balances	December 31, 2025				December 31, 2024
(In millions)	Assets		Liabilities		Assets		Liabilities
Property	$	—	$	347	$	—	$	278
Operating loss and tax credit carryforwards 1	631		—		552		—
Accrued employee benefits	678		—		671		—
Other accruals and reserves	767		—		590		—
Intangibles	—		1,828		—		1,950
Inventory	275		—		184		—
Research and development capitalization	689		—		761		—
Investments	53		—		69		—
Unrealized exchange gains/losses	—		4		—		50
Other – net	42		—		40		—
Subtotal	$	3,135	$	2,179	$	2,867	$	2,278
Valuation allowances 2	(887)		—		(666)		—
Total	$	2,248	$	2,179	$	2,201	$	2,278
Net deferred tax asset (liability)	$	69			$	(77)

1. Primarily related to tax loss and credit carryforwards from operations in the United States, Argentina, Brazil, Switzerland, and Spain.

Details of the company’s operating loss and tax credit carryforwards are shown in the following table:


Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	December 31, 2025		December 31, 2024
Operating loss carryforwards
Expire within 5 years	$	290	$	222
Expire after 5 years or indefinite expiration	213		226
Total operating loss carryforwards	$	503	$	448
Tax credit carryforwards
Expire within 5 years	$	25	$	13
Expire after 5 years or indefinite expiration	103		91
Total tax credit carryforwards	$	128	$	104
Total operating loss and tax credit carryforwards	$	631	$	552

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:


Total Gross Unrecognized Tax Benefits	For the Year Ended December 31,
(In millions)	2025		2024		2023
Total unrecognized tax benefits as of beginning of period	$	263	$	390	$	357
Decreases related to positions taken on items from prior years	(1)		(4)		—
Increases related to positions taken on items from prior years	94		13		23
Increases related to positions taken in the current year	9		12		16
Settlement of uncertain tax positions with tax authorities	(24)		(140)		(4)
Decreases due to expiration of statutes of limitations	(5)		(5)		(2)
Exchange (gain) loss	(1)		(3)		—
Total unrecognized tax benefits as of end of period	$	335	$	263	$	390
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	243	$	176	$	173
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations	$	(9)	$	(4)	$	1
Total accrual (receivable) for interest and penalties associated with unrecognized tax benefits at end of period	$	(15)	$	(2)	$	11

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:


Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2025			Earliest Open Year
Jurisdiction
Argentina			2018
Brazil			2018
Canada			2017
China			2015
France			2023
India			2023
Italy			2019
Spain			2020
Switzerland			2020
United States:
Federal income tax			2012
State and local income tax			2012

The entire disclosure for income tax.

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

$ 24,030

$ 25,279

$ 25,541

672

(792)

129

Cumulative Translation Adjustment

24,386

24,030

25,279

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

(3,472)

(2,458)

(2,883)

^[1]

867

(1,014)

425

Amounts Reclassified from Accumulated Other Comprehensive Income

867

(1,014)

425

Accumulated Other Comprehensive Income (Loss) [Line Items]

(2,605)

(3,472)

(2,458)

Derivative Instruments

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

(55)

(65)

(123)

Amounts Reclassified from Accumulated Other Comprehensive Income

(12)

(23)

(135)

Unrealized (gain) loss on investments

(7)

(55)

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

(6)

(6)

Amounts Reclassified from Accumulated Other Comprehensive Income

(6)

Accumulated Other Comp Loss

(6)

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

(3,469)

(2,677)

(2,806)

647

(826)

152

Amounts Reclassified from Accumulated Other Comprehensive Income

(23)

672

(792)

129

Accumulated Other Comprehensive Income (Loss) [Line Items]

(2,797)

(3,469)

(2,677)

Pension Plan

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

(226)

(353)

(163)

(149)

127

(188)

Amounts Reclassified from Accumulated Other Comprehensive Income

(3)

(2)

(152)

127

(190)

Accumulated Other Comprehensive Income (Loss) [Line Items]

(378)

(226)

(353)

Other Benefit Plans

Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

219

189

160

(12)

Amounts Reclassified from Accumulated Other Comprehensive Income

(14)

(10)

(9)

(26)

Cash Equivalents [Member] | Time Deposits and Money Market Funds [Member]

$ 193

$ 219

$ 189

[1]

The cumulative translation adjustment gain for the year ended December 31, 2025 was primarily driven by the weakening of the U.S. Dollar ("USD") against the Euro ("EUR"), Brazilian Real ("BRL"), South African Rand (“ZAR”) and Mexican Peso ("MXN"). The cumulative translation adjustment loss for the year ended December 31, 2024 was primarily driven by the strengthening of the U.S. Dollar against the Brazilian Real, Euro, Swiss Franc ("CHF") and Mexican Peso. The cumulative translation adjustment gain for the year ended December 31, 2023 was primarily driven by the weakening of the U.S. Dollar against the Swiss Franc, Brazilian Real and Euro.

Debt Securities - Held-to-Maturity (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

Schedule of Held-to-maturity Securities [Line Items]

Held-to-maturity securities

^[1]

$ 3,431

$ 2,179

Marketable Securities [Member] | Bank Time Deposits

Schedule of Held-to-maturity Securities [Line Items]

Held-to-maturity securities

^[2]

$ 1

$ 8

[1]	Maturity at time of purchase was three months or less.
[2]	Maturity at time of purchase was more than three months to less than one year.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-5

Geographic Allocation of Income and Provision for Income Taxes

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	324	$	(414)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Current tax expense (benefit)
Federal	$	87	$	285	$	143
State and local	26		45		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	777	$	590
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		412		152
Net income (loss) from continuing operations after taxes	$	1,204	$	863	$	941

Reconciliation to US Statutory Rate


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2025
($ In millions)	$		%
U.S. Federal statutory tax rate	$	354	21.0	%
State and local income tax, net of federal (national) income tax effect 1	5		0.3	%
Foreign tax effects
Argentina
Statutory tax rate differential	(17)		(1.0)	%
Withholding tax	18		1.1	%
Exchange gains/losses	(31)		(1.8)	%
Changes in valuation allowances	73		4.3	%
Other	(3)		(0.2)	%
Brazil

Withholding tax	37		2.2	%
Changes in valuation allowances 2	153		9.1	%
Other	(4)		(0.2)	%
India
Statutory tax rate differential	17		1.0	%
Agriculture exemption	(41)		(2.4)	%
Withholding tax	31		1.8	%
Other	1		0.1	%
Switzerland
Statutory tax rate differential	(91)		(5.4)	%
Cantonal income tax, net	59		3.5	%
Other	(1)		(0.1)	%
Other foreign jurisdictions	49		2.9	%
Effect of cross-border tax laws (net of related foreign tax credits)
Global Intangible Low-Taxed Income (GILTI)	24		1.4	%
Other	12		0.7	%
Tax credits
U.S. research and development credit	(47)		(2.8)	%
Other foreign tax credits	(52)		(3.1)	%
Changes in valuation allowances 3	74		4.4	%
Nontaxable or nondeductible items	31		1.8	%
Changes in unrecognized tax benefits	(19)		(1.1)	%
Other
Capital loss 3	(77)		(4.6)	%
Legal entity tax characterization 4	(49)		(2.9)	%
Other	(22)		(1.3)	%
Effective tax rate	$	484	28.7	%

1.State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.

3.For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.

4.For the year ended December 31, 2025, a U.S. federal deferred tax benefit was recorded associated with a change in a legal entity's U.S. tax characterization in the amount of $(49) million.


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.8		(1.8)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.7)		(5.9)
Exchange gains/losses 3	1.7		2.0
State and local incomes taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(7.9)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.5)
Tax settlements and expiration of statute of limitations	(1.7)		(0.3)

Impact of Brazil valuation allowance 6	9.4		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	0.1		(0.1)
Effective tax rate on income from continuing operations	32.3	%	13.9	%

2. Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

Income Taxes Paid


Income Taxes Paid, Net	For the Year Ended December 31,
(In millions)	2025
US Federal	$	195
US State and Local	49
Brazil	72
India	42
Switzerland, Federal	59
Switzerland, Geneva	46
Other Foreign	287
Total	$	750

Deferred Tax Balances


Deferred Tax Balances	December 31, 2025				December 31, 2024
(In millions)	Assets		Liabilities		Assets		Liabilities
Property	$	—	$	347	$	—	$	278
Operating loss and tax credit carryforwards 1	631		—		552		—
Accrued employee benefits	678		—		671		—
Other accruals and reserves	767		—		590		—
Intangibles	—		1,828		—		1,950
Inventory	275		—		184		—
Research and development capitalization	689		—		761		—
Investments	53		—		69		—
Unrealized exchange gains/losses	—		4		—		50
Other – net	42		—		40		—
Subtotal	$	3,135	$	2,179	$	2,867	$	2,278
Valuation allowances 2	(887)		—		(666)		—
Total	$	2,248	$	2,179	$	2,201	$	2,278
Net deferred tax asset (liability)	$	69			$	(77)

1. Primarily related to tax loss and credit carryforwards from operations in the United States, Argentina, Brazil, Switzerland, and Spain.

Operating Loss and Tax Credit Carryforwards


Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	December 31, 2025		December 31, 2024
Operating loss carryforwards
Expire within 5 years	$	290	$	222
Expire after 5 years or indefinite expiration	213		226
Total operating loss carryforwards	$	503	$	448
Tax credit carryforwards
Expire within 5 years	$	25	$	13
Expire after 5 years or indefinite expiration	103		91
Total tax credit carryforwards	$	128	$	104
Total operating loss and tax credit carryforwards	$	631	$	552

Total Gross Unrecognized Tax Benefits


Total Gross Unrecognized Tax Benefits	For the Year Ended December 31,
(In millions)	2025		2024		2023
Total unrecognized tax benefits as of beginning of period	$	263	$	390	$	357
Decreases related to positions taken on items from prior years	(1)		(4)		—
Increases related to positions taken on items from prior years	94		13		23
Increases related to positions taken in the current year	9		12		16
Settlement of uncertain tax positions with tax authorities	(24)		(140)		(4)
Decreases due to expiration of statutes of limitations	(5)		(5)		(2)
Exchange (gain) loss	(1)		(3)		—
Total unrecognized tax benefits as of end of period	$	335	$	263	$	390
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	243	$	176	$	173
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations	$	(9)	$	(4)	$	1
Total accrual (receivable) for interest and penalties associated with unrecognized tax benefits at end of period	$	(15)	$	(2)	$	11

Tax Year Subject to Examination


Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2025			Earliest Open Year
Jurisdiction
Argentina			2018
Brazil			2018
Canada			2017
China			2015
France			2023
India			2023
Italy			2019
Spain			2020
Switzerland			2020
United States:
Federal income tax			2012
State and local income tax			2012

Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount

$ 354

Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount

21.00%

^[1]

$ 5

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

^[1]

0.30%

^[2]

$ 74

Effective Income Tax Rate Reconciliation, GILTI, Amount

^[2]

4.40%

$ 24

Effective Income Tax Rate Reconciliation, GILTI, Percent

1.40%

Effective Income Tax Rate Reconciliation, Cross-Border, Other, Amount

$ 12

Effective Income Tax Rate Reconciliation, Cross-Border, Other, Percent

0.70%

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

$ (47)

Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount

(2.80%)

$ 31

Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent

1.80%

Unrecognized Tax Benefits

$ (19)

Unrecognized Tax Benefits, Period Increase (Decrease), Percent

(1.10%)

Effective Income Tax Rate Reconciliation, Capital Loss, Amount

^[2]

$ (77)

Effective Income Tax Rate Reconciliation, Capital Loss, Percent

^[2]

(4.60%)

Effective Income Tax Rate Reconciliation, Legal Entity Tax Characterization, Amount

^[3]

$ (49)

Effective Income Tax Rate Reconciliation, Legal Entity Tax Characterization, Percent

^[3]

(2.90%)

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

$ (22)

Provision for (benefit from) income taxes on continuing operations

(1.30%)

$ 484

$ 412

$ 152

Effective Income Tax Rate Reconciliation, Percent

28.70%

Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent

32.30%

13.90%

Continuing Operations [Member]

21.00%

Effective tax rates on international operations - net

1.30%

0.90%

^[4]

4.80%

(1.80%)

^[5]

1.70%

2.00%

^[6]

9.40%

0.00%

(4.70%)

(5.90%)

Provision for (benefit from) income taxes on continuing operations

0.10%

(0.10%)

$ 484

$ 412

$ 152

Acquisitions, divestitures, and ownership restructuring activities

^[7]

(1.10%)

3.60%

Impact of Swiss Tax Changes

^[8]

0.00%

(7.90%)

Excess tax benefits (tax deficiency) from stock-compensation

(0.20%)

(0.50%)

Tax settlements and expiration of statue of limitations

(1.70%)

(0.30%)

Repatriation of Foreign Earnings

^[9]

1.70%

2.90%

Deferred Other Tax Expense (Benefit)

$ (62)

Continuing Operations [Member] | Tax Currency Change

Continuing Operations [Member] | Intellectual Property Realigment

(24)

Continuing Operations [Member] | Brazil Valuation Allowance [Member] | Seed [Member]

Continuing Operations [Member] | Brazil Valuation Allowance [Member] | Crop Protection [Member]

$ 120

Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount

132

ARGENTINA

$ (17)

Effective tax rates on international operations - net

(1.00%)

Effective Income Tax Rate Reconciliaiton, Witholding Tax, Amount

$ 18

Effective Income Tax Rate Reconciliation, Withholding Tax, Percent

1.10%

Effective Income Tax Rate Reconciliation, Foreign Currency Exchange Gains (Losses), Amount

$ (31)

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

(1.80%)

$ 73

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

4.30%

$ (3)

Effective Income Tax Rate Reconciliaiton, Witholding Tax, Amount

(0.20%)

BRAZIL

$ 37

Effective Income Tax Rate Reconciliation, Withholding Tax, Percent

2.20%

Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

^[10]

$ 153

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

^[10]

9.10%

$ (4)

Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount

(0.20%)

INDIA

$ 17

Effective tax rates on international operations - net

1.00%

Effective Income Tax Rate Reconciliaiton, Witholding Tax, Amount

$ 31

Effective Income Tax Rate Reconciliation, Withholding Tax, Percent

1.80%

Effective Income Tax Rate Reconciliaiton, Agriculture Exemption, Amount

$ (41)

Effective Income Tax Rate Reconciliation, Agriculture Exemption, Percent

(2.40%)

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

$ 1

Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount

0.10%

SWITZERLAND

$ (91)

Effective tax rates on international operations - net

(5.40%)

Effective Income Tax Rate Reconciliation, Cantonal Income Tax, Amount

$ 59

Effective Income Tax Rate Reconciliation, Cantonal Income Tax, Percent

3.50%

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

$ (1)

Foreign Tax Jurisdiction, Other

(0.10%)

Effective Income Tax Rate Reconciliation, Tax Credit, Amount

$ (52)

Effective Income Tax Rate Reconciliation, Tax Credit, Percent

(3.10%)

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

$ 49

Effective Income Tax Rate Reconciliation, Capital Loss, Amount

2.90%

UNITED STATES

$ 27

Effective Income Tax Rate Reconciliation, Legal Entity Tax Characterization, Amount

$ 49

[1]	State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.
[2]	For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.
[3]	For the year ended December 31, 2025, a U.S. federal deferred tax benefit was recorded associated with a change in a legal entity's U.S. tax characterization in the amount of $(49) million.
[4]	Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results.
[5]	Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, to the Consolidated Financial Statements, under the heading "Foreign Currency Risk."
[6]	For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position ofa legal entity in Brazil (Seed business).
[7]	Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.
[8]	Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.
[9]	Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.
[10]	For the year ended December 31, 2025, the company established a valuation allowance recorded against the net deferred tax asset position of a legal entity in Brazil (Crop Protection business) in the amount of $132 million.

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Cash and Cash Equivalents	$ 4,521	$ 3,106
Restricted Cash	204	316
Cash, Cash Equivalents, and Restricted Cash	$ 4,725	$ 3,422

Segment Reporting (Notes)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

SEGMENT INFORMATION

Corporate Profile

The company conducts its global operations through the following reportable segments:

Seed

Crop Protection


(In millions)	Seed		Crop Protection		Total
As of and for the Year Ended December 31, 2025
Net sales	$	9,898	$	7,503	$	17,401
Segment operating EBITDA	2,636		1,350		3,986
Depreciation and amortization	780		423		1,203
Purchases of property, plant and equipment	377		214		591
As of and for the Year Ended December 31, 2024
Net sales	$	9,545	$	7,363	$	16,908
Segment operating EBITDA	2,219		1,272		3,491
Depreciation and amortization	805		422		1,227
Purchases of property, plant and equipment	365		232		597
As of and for the Year Ended December 31, 2023
Net sales	$	9,472	$	7,754	$	17,226
Segment operating EBITDA	2,117		1,374		3,491
Depreciation and amortization	814		397		1,211
Purchases of property, plant and equipment	332		263		595

Reconciliation of Segment Profitability


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2025
Net sales	$	9,898	$	7,503	$	17,401
Cost of goods sold	4,533		4,585		9,118
Other expenses 1	2,729		1,568		4,297
Segment operating EBITDA	$	2,636	$	1,350	$	3,986


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2024
Net sales	$	9,545	$	7,363	$	16,908
Cost of goods sold	4,876		4,636		9,512
Other expenses 1	2,450		1,455		3,905
Segment operating EBITDA	$	2,219	$	1,272	$	3,491


(In millions)	Seed		Crop Protection		Total
For the Year Ended December 31, 2023
Net sales	$	9,472	$	7,754	$	17,226
Cost of goods sold	4,982		4,913		9,895
Other expenses 1	2,373		1,467		3,840
Segment operating EBITDA	$	2,117	$	1,374	$	3,491

1. Other expenses consist primarily of selling, general and administrative expenses and research and development expense, net of depreciation add-back.

Reconciliation to Consolidated Financial Statements


Income (loss) from continuing operations after income taxes to segment operating EBITDA	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations after income taxes	$	1,204	$	863	$	941
Provision for (benefit from) income taxes on continuing operations	484		412		152
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Depreciation and amortization	1,203		1,227		1,211
Interest income	(136)		(132)		(283)
Interest expense	180		233		233
Exchange (gains) losses - net	181		284		397
Non-operating (benefits) costs - net	39		174		151

Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges	—		—		—
Significant items	658		315		579
Separation costs	35		—		—
Corporate expenses	138		115		110
Segment operating EBITDA	$	3,986	$	3,491	$	3,491

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA

The years ended December 31, 2025, 2024 and 2023, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2025
Restructuring and asset related charges - net 1	$	(4)	$	(135)	$	(7)	$	(146)


Bayer resolution 2	(610)		—		—		(610)
Gain (loss) on sale of business, assets and equity investments 3,4	—		37		—		37

AltEn facility remediation charges 5	(37)		—		—		(37)
Insurance proceeds 6	—		98		—		98
Total	$	(651)	$	—	$	(7)	$	(658)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2024
Restructuring and asset related charges - net 1	$	(55)	$	(142)	$	(91)	$	(288)
Gain (loss) on sale of business, assets and equity investments 4	4		3		—		7
Inventory write-offs 4	2		—		—		2
Insurance proceeds 6	—		71		—		71
Estimated settlement expense 7	—		(101)		—		(101)





Acquisition-related costs 8	—		(6)		—		(6)
Total	$	(49)	$	(175)	$	(91)	$	(315)


(In millions)	Seed		Crop Protection		Corporate		Total
For the Year Ended December 31, 2023
Restructuring and asset related charges - net 1	$	(86)	$	(228)	$	(22)	$	(336)
Gain (loss) on sale of business, assets and equity investments 4	4		10		—		14
Inventory write-offs 4	(7)		—		—		(7)
Spare parts write-off 3	—		(12)		—		(12)
Estimated settlement expense 7	—		(204)		—		(204)
Acquisition-related costs 8	—		(45)		—		(45)
AltEn facility remediation charges 5	(10)		—		—		(10)
Employee Retention Credit	—		3		—		3
Seed sale associated with Russia Exit 4,9	18		—		—		18
Total	$	(81)	$	(476)	$	(22)	$	(579)

2.Consists of a charge relating to the resolution of litigation with Bayer. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.

6.Includes proceeds received related to prior significant items.

7.Consists of estimated Lorsban® related charges.

Deferred Tax Assets, Property, Plant and Equipment

Income Taxes Income Taxes - Deferred Tax Balances (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2024

Dec. 31, 2025

Assets

$ 0

Total Operating Loss and Tax Credit Carryforwards

552

631

^[1]

Deferred Tax Assets, Accrued Employee Benefits

671

^[1]

678

Deferred Tax Assets, Other Accruals and Reversals

590

767

Deferred Tax Assets, Inventory

184

275

Deferred Tax Assets, Research and Development Capitalization

761

689

Deferred Tax Assets, Investments

Unrealized Exchange Gains / Losses

Deferred Tax Assets, Other

Deferred Tax Assets, Gross

2,867

3,135

Deferred Tax Assets, Valuation Allowance

^[2]

(666)

(887)

Deferred Tax Assets, Net of Valuation Allowance

2,201

2,248

Deferred Tax Assets, Net

Liabilities

Deferred Tax Liabilities, Property

278

347

Deferred Tax Liabilities, Intangible Assets

1,950

1,828

Deferred Tax Liabilities, Unrealized Exchange Gains/Losses

Deferred Tax Liabilities, Other

Deferred Tax Liabilities, Gross

2,278

$ 2,179

Net Deferred Tax Liability

(77)

Seed [Member] | Continuing Operations [Member] | Brazil Valuation Allowance [Member]

Liabilities

$ 120

[1]

1. Primarily related to tax loss and credit carryforwards from operations in the United States, Argentina, Brazil, Switzerland, and Spain.

[2]

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
Cybersecurity Risk Management and Strategy Disclosure	Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes Integrated [Text Block]	CYBERSECURITY Risk Management and Strategy. The company’s risk management programs for cybersecurity are integrated into the company’s enterprise risk management and general compliance programs and processes. Our cybersecurity program utilizes a layered, defense-in-depth strategy to identify and mitigate cybersecurity threats. The company’s information security team is responsible for the day-to-day management of the company’s global information security program, which includes defining policies and procedures to safeguard our information systems and data, conducting vulnerability, threat and third-party information security assessments, information security event management (i.e., responding to ransomware and other cyber-attacks, business continuity and recovery), evaluating external cyber intelligence, supporting industry cybersecurity efforts and working with governmental agencies. The global information security team also develops training for personnel (e.g., employees and contractors) with access to Corteva’s system to support adherence to the company’s policies and procedures, along with increasing awareness of cyber-related risk. The personnel training includes, but is not limited to, mandatory onboarding training, phishing simulations with automated remediation training, table-top incident response exercises, and educational intranet posting and email campaigns. Our Enterprise Risk Management Committee, which includes the company’s Chief Information Officer (“CIO”) and Chief Information Security Officer (“CISO”), independently assesses and monitors the effectiveness of the company’s cybersecurity risk management programs and strategies. The company’s internal audit function also performs independent reviews and validation of the various programs, including policies and procedures as determined by their annual risk assessment. The company leverages the U.S. Department of Commerce’s National Institute of Standards and Technology (“NIST”) Cybersecurity Framework (“Framework”) as the foundation of its global information security program. The NIST Framework provides standards, guidelines, and practices for organizations to better manage and reduce cybersecurity risk and is designed to foster risk and cybersecurity management communications amongst both internal and external organizational stakeholders. The company’s information security team works with independent, third-party consultants annually to assess the maturity of the company’s cybersecurity program within the NIST Framework and to develop strategic areas of focus for the company’s programs commensurate with the company’s business objectives. As part of the company’s global information security program, we leverage both internal and external assessments and partnerships with industry leaders to help approach information security company-wide. Additionally, the company maintains a comprehensive program that defines standards for the planning, sourcing, management, and oversight of third-party relationships and third-party access to its system, facilities, and/or confidential or proprietary data. Cybersecurity incidents may create risk to the company that may impact its reputation, financial performance, ability to operate safely or at all, and the value of its intellectual property. Like most major corporations, the company is the target of industrial espionage, including cyberattacks, from time to time. The company has determined that these incidents have resulted, and could result in the future, in unauthorized parties gaining access to certain confidential business information. However, to date, Corteva has not experienced any known cybersecurity incidents that have materially affected the company, including the company's results of operations and financial condition, changes in the competitive environment, business operations and strategy. Although management does not believe that Corteva has experienced any material losses to date related to cybersecurity incidents, there can be no assurance that Corteva will not suffer such losses in the future. For more information on potential risk related to cybersecurity incidents, including intellectual property theft and operational disruption, please see “Item 1A – Risk Factors” of this report. Governance. The company’s Audit Committee and Governance and Compliance Committee provide board oversight of company cybersecurity risks. The Audit Committee conducts a minimum of two cybersecurity program updates per year, including a review of capital spend, budget, and staffing, as well as quarterly reports on cybersecurity threats and key risk indicators related to the company’s progress on risk mitigation activities. The Governance and Compliance Committee, as part of its oversight for the enterprise risk management program company-wide, reviews the company’s oversight and governance structure related to company risks, including cybersecurity risks, remains appropriate and that risks are appropriately managed. The company’s CIO oversees the company’s information technology programs and investments. The company’s CISO reports to the CIO and oversees the company’s information security programs. The company’s CIO has over 30 years of information technology experience, including 10 years in various information technology leadership roles. Our CIO holds a bachelor of science and master of science degrees in organizational communications as well as an M.B.A. in information technology. The company’s CISO has over 30 years of experience in information security and is a Certified Information Security Manager® (CISM®), a Certified Data Privacy Solutions Engineer™ (CDPSE®), as well as being Certified in Risk and Information Systems Control® (CRISC®). Our CISO holds a bachelor of science degree in electric engineering as well as an M.B.A. in operations, technology. Both the CIO and CISO regularly report to the Audit Committee, and Board, on the company’s identification, prevention, detection, mitigation and remediation of cybersecurity risks and incidents. In 2025, the Board reviewed the company’s cybersecurity program and maturity assessment, while the Audit Committee provided regular oversight of cybersecurity risks, with cybersecurity discussions and dashboard reviews of key performance indicators and risks at four committee meetings during the course of the year. With respect to specific incidents, the company leverages an incident response framework to elevate and evaluate specific incidents to the CIO and CISO, along with the company’s senior leadership, including the finance and legal functions. In the event of a potentially material cybersecurity incident, the Audit Committee would be immediately notified and briefed.

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

(Income) Loss from Discontinued Operations, after income taxes

$ 1,105

$ 919

$ 747

(56)

194

Depreciation and amortization

1,203

1,227

1,211

Provision for (benefit from) deferred income tax

(41)

(365)

(438)

Net periodic pension and OPEB (benefit) cost, net

160

138

Pension and OPEB contributions

(136)

(151)

(149)

Net (gain) loss on sales of property, businesses, consolidated companies and investments

(41)

(17)

(22)

Accounts and Notes Receivable

146

288

336

Other net loss

545

383

578

(261)

(705)

358

Inventories

(35)

1,110

Accounts Payable

231

(115)

(663)

Deferred Revenue

270

(86)

(11)

Other Assets and Liabilities

336

(296)

(527)

Cash Provided by (Used for) Operating Activities - Continuing Operations

3,457

2,296

1,809

Cash Provided by (Used for) Operating Activities - Discontinued Operations

(51)

(151)

(40)

Cash provided by (used for) operating activities

3,406

2,145

1,769

Capital expenditures

(591)

(597)

(595)

Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested

Acquisitions of businesses - Net of Cash Acquired

(1,456)

Investments in and loans to nonconsolidated affiliates

(20)

(7)

(32)

Purchases of investments

(144)

(148)

Proceeds from Sale and Maturities of Investments

135

130

147

Payments for (Proceeds from) Hedge, Investing Activities

(83)

Other investing activities - net

(38)

(39)

(2)

Cash provided by (used for) investing activities

(543)

(589)

(1,987)

Net Change in borrowings (less than 90 days)

(6)

Proceeds from Debt

1,730

3,072

3,429

Payments on Debt

(1,871)

(2,885)

(2,309)

Repurchase of Common Stock

(1,071)

(1,009)

(756)

Proceeds from Exercise of Stock Options

Dividends Paid to stockholders

(475)

(458)

(439)

Other financing activities, net

(45)

(32)

(49)

Cash provided by (used for) financing activities

(1,644)

(1,199)

(99)

Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents

(93)

(143)

Increase (decrease) on cash, cash equivalents and restricted cash

1,303

264

(460)

Cash, cash equivalents and restricted cash equivalents at beginning of period

3,422

^[1]

3,158

^[1]

3,618

Cash, cash equivalents and restricted cash equivalents at end of period

^[1]

4,725

3,422

3,158

Supplemental Cash Flow Information [Abstract]

Interest, net of amounts capitalized

191

244

234

Income Taxes

750

707

535

(Income) Loss from Discontinued Operations, after income taxes

1,105

949

732

(56)

194

Depreciation and amortization

1,203

1,227

1,211

Provision for (benefit from) deferred income tax

(41)

(365)

(438)

Net periodic pension and OPEB (benefit) cost, net

160

138

Pension and OPEB contributions

(136)

(151)

(149)

Net (gain) loss on sales of property, businesses, consolidated companies and investments

(41)

(17)

(22)

Accounts and Notes Receivable

146

288

336

Other net loss

545

383

578

(261)

(705)

358

Inventories

(35)

1,110

Accounts Payable

231

(115)

(663)

Deferred Revenue

270

(86)

(11)

Other Assets and Liabilities

336

(284)

(553)

Cash Provided by (Used for) Operating Activities - Continuing Operations

3,457

2,338

1,768

Cash Provided by (Used for) Operating Activities - Discontinued Operations

(51)

(151)

(40)

Cash provided by (used for) operating activities

3,406

2,187

1,728

Capital expenditures

(591)

(597)

(595)

Net payment from (advances to) Parent on in-house banking arrangement

361

Net payment from (advances to) Parent on in-house banking arrangement

(20)

Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested

Acquisitions of businesses - Net of Cash Acquired

(1,456)

Investments in and loans to nonconsolidated affiliates

(20)

(7)

(32)

Purchases of investments

(144)

(148)

Proceeds from Sale and Maturities of Investments

135

130

147

Payments for (Proceeds from) Hedge, Investing Activities

(83)

Other investing activities - net

(38)

(39)

(2)

Cash provided by (used for) investing activities

(543)

(228)

(2,007)

Net Change in borrowings (less than 90 days)

(6)

Net payment from (advances to) Parent on in-house banking arrangement

129

Net payment from (advances to) Parent on in-house banking arrangement

(129)

Repayments of Related Party Debt

(1,129)

Proceeds from Debt

1,730

3,072

3,429

Payments on Debt

(1,871)

(2,885)

(2,309)

Proceeds from Exercise of Stock Options

Other financing activities, net

(38)

(23)

(54)

Cash provided by (used for) financing activities

(1,644)

(1,602)

(38)

Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents

(93)

(143)

Increase (decrease) on cash, cash equivalents and restricted cash

1,303

264

(460)

Cash, cash equivalents and restricted cash equivalents at beginning of period

3,422

3,158

3,618

Cash, cash equivalents and restricted cash equivalents at end of period

4,725

3,422

3,158

Supplemental Cash Flow Information [Abstract]

Interest, net of amounts capitalized

^[2]

191

244

234

Income Taxes

750

707

535

EIDP | Corteva [Member]

Dividends Paid to stockholders

$ (1,682)

$ (1,750)

$ 0

[1]	See page F-22 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.
[2]	Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements.

Consolidated Statements of Equity (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Common Stock, Dividends, Per Share, Declared	$ 0.66	$ 0.62
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share	3.50	3.50
Preferred Stock, Dividend Rate, Per-Dollar-Amount	3.50	3.50
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share	4.50	4.50
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$ 4.50	$ 4.50

Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 11,821	$ 12,094
Fair Value of plan assets	$ 10,028	$ 10,500

Goodwill and Other Intangible Assets Goodwill by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Goodwill [Line Items]
Goodwill Beginning Balance	$ 10,408	$ 10,605
Currency Translation Adjustment	57	(235)
Other goodwill adjustments		38
Goodwill Ending Balance	10,465	10,408
Accumulated impairment losses on goodwill	4,503
Crop Protection [Member]
Goodwill [Line Items]
Goodwill Beginning Balance	5,082	5,183
Currency Translation Adjustment	71	(139)
Other goodwill adjustments		38
Goodwill Ending Balance	5,153	5,082
Seed [Member]
Goodwill [Line Items]
Goodwill Beginning Balance	5,326	5,422
Currency Translation Adjustment	(14)	(96)
Other goodwill adjustments		0
Goodwill Ending Balance	$ 5,312	$ 5,326

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Consolidated Statements of Income - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

$ 17,401

$ 16,908

$ 17,226

Research and Development Expense

9,172

9,529

9,920

1,474

1,402

1,337

Selling, General and Administrative Expense

3,492

3,196

3,176

Amortization of Intangibles

644

685

683

Restructuring and asset related charges - net

^[1]

146

288

336

Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]

$ 35

$ 0

Other income (expense) - net

$ (570)

$ (300)

$ (448)

Income (loss) from continuing operations before income taxes

180

233

1,688

1,275

1,093

Provision for (benefit from) income taxes on continuing operations

484

412

152

Income (loss) from continuing operations after income taxes

1,204

863

941

Income (loss) from discontinued operations after income taxes

(99)

(194)

Net income (loss) attributable to noncontrolling interests

1,105

919

747

Net Income (Loss) attributable to Company

$ 1,094

$ 907

$ 735

Basic earnings (loss) per share of common stock from continuing operations

$ 1.75

$ 1.23

$ 1.31

Basic earnings (loss) per share of common stock from discontinued operations

(0.15)

0.08

(0.27)

Basic earnings (loss) per share of common stock

1.60

1.31

1.04

Diluted earnings (loss) per share of common stock from continuing operations

1.75

1.22

1.30

Diluted earnings (loss) per share of common stock from discontinued operations

(0.15)

0.08

(0.27)

Diluted earnings (loss) per share of common stock

$ 1.60

$ 1.30

$ 1.03

$ 17,401

$ 16,908

$ 17,226

Research and Development Expense

9,172

9,529

9,920

1,474

1,402

1,337

Selling, General and Administrative Expense

3,492

3,196

3,176

Amortization of Intangibles

644

685

683

Restructuring and asset related charges - net

146

288

336

Other income (expense) - net

(570)

(261)

(448)

Income (loss) from continuing operations before income taxes

180

233

253

1,688

1,314

1,073

Provision for (benefit from) income taxes on continuing operations

484

421

147

Income (loss) from continuing operations after income taxes

1,204

893

926

Income (loss) from discontinued operations after income taxes

(99)

(194)

Net income (loss) attributable to noncontrolling interests

1,105

949

732

Net Income (Loss) attributable to Company

$ 1,104

$ 947

$ 730

[1]	Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.

Goodwill and Other Intangible Assets Other Intangible Assets (Details) - USD ($)
$ in Millions

Dec. 31, 2025

Dec. 31, 2024

$ 12,969

$ 12,923

(4,673)

(4,052)

Indefinite-lived Intangible Assets

8,296

8,871

Total Intangible Assets, Gross

12,974

12,928

Total intangible assets - net

8,301

8,876

IPR&D [Member]

Indefinite-lived Intangible Assets

Germplasm [Member]

6,291

(1,587)

(1,336)

4,704

4,955

2,394

2,350

(1,024)

(863)

Developed Technology Rights [Member]

1,370

1,487

1,860

1,838

(1,283)

(1,161)

Trademarks and Trade Names [Member]

577

677

2,056

(466)

(380)

Other Intangible Assets [Member]

1,590

1,676

^[1]

368

388

^[1]

(313)

(312)

Geographic Allocation of Income and Provision for Income Taxes

^[1]

$ 55

$ 76

[1]	Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

EIDP Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	324	$	(414)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,275	$	1,093
Current tax expense (benefit)
Federal	$	87	$	285	$	143
State and local	26		45		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	777	$	590
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		412		152
Net income (loss) from continuing operations after taxes	$	1,204	$	863	$	941

Reconciliation to US Statutory Rate


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2025
($ In millions)	$		%
U.S. Federal statutory tax rate	$	354	21.0	%
State and local income tax, net of federal (national) income tax effect 1	5		0.3	%
Foreign tax effects
Argentina
Statutory tax rate differential	(17)		(1.0)	%
Withholding tax	18		1.1	%
Exchange gains/losses	(31)		(1.8)	%
Changes in valuation allowances	73		4.3	%
Other	(3)		(0.2)	%
Brazil

Withholding tax	37		2.2	%
Changes in valuation allowances 2	153		9.1	%
Other	(4)		(0.2)	%
India
Statutory tax rate differential	17		1.0	%
Agriculture exemption	(41)		(2.4)	%
Withholding tax	31		1.8	%
Other	1		0.1	%
Switzerland
Statutory tax rate differential	(91)		(5.4)	%
Cantonal income tax, net	59		3.5	%
Other	(1)		(0.1)	%
Other foreign jurisdictions	49		2.9	%
Effect of cross-border tax laws (net of related foreign tax credits)
Global Intangible Low-Taxed Income (GILTI)	24		1.4	%
Other	12		0.7	%
Tax credits
U.S. research and development credit	(47)		(2.8)	%
Other foreign tax credits	(52)		(3.1)	%
Changes in valuation allowances 3	74		4.4	%
Nontaxable or nondeductible items	31		1.8	%
Changes in unrecognized tax benefits	(19)		(1.1)	%
Other
Capital loss 3	(77)		(4.6)	%
Legal entity tax characterization 4	(49)		(2.9)	%
Other	(22)		(1.3)	%
Effective tax rate	$	484	28.7	%

1.State taxes in Minnesota made up the majority (greater than 50%) of the tax effect in this category.

3.For the year ended December 31, 2025, a U.S. federal tax benefit of $(27) million, net of valuation allowance, was recorded to recognize a capital loss in a wholly owned foreign investment.

4.For the year ended December 31, 2025, a U.S. federal deferred tax benefit was recorded associated with a change in a legal entity's U.S. tax characterization in the amount of $(49) million.


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.8		(1.8)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.7)		(5.9)
Exchange gains/losses 3	1.7		2.0
State and local incomes taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(7.9)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.5)
Tax settlements and expiration of statute of limitations	(1.7)		(0.3)

Impact of Brazil valuation allowance 6	9.4		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	0.1		(0.1)
Effective tax rate on income from continuing operations	32.3	%	13.9	%

2. Includes net tax charge of $46 million for the year ended December 31, 2023, associated with intellectual property realignment.

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

Geographic Allocation of Income and Provision for Income Taxes


Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes	For the Year Ended December 31,
(In millions)	2025		2024		2023
Income (loss) from continuing operations before income taxes
Domestic	$	325	$	363	$	(434)
Foreign	1,363		951		1,507
Income (loss) from continuing operations before income taxes	$	1,688	$	1,314	$	1,073
Current tax expense (benefit)
Federal	$	87	$	292	$	138
State and local	26		47		40
Foreign	412		447		407
Total current tax expense (benefit)	$	525	$	786	$	585
Deferred tax expense (benefit)
Federal	$	(139)	$	(300)	$	(326)
State and local	(24)		(28)		(50)
Foreign	122		(37)		(62)
Total deferred tax expense (benefit)	$	(41)	$	(365)	$	(438)
Provision for (benefit from) income taxes on continuing operations	484		421		147
Net income (loss) from continuing operations	$	1,204	$	893	$	926

Reconciliation to US Statutory Rate


Reconciliation to U.S. Statutory Rate	For the Year Ended December 31,
	2024		2023
Statutory U.S. federal income tax rate	21.0	%	21.0	%
Effective tax rates on international operations - net 1	4.6		(1.9)
Acquisitions, divestitures and ownership restructuring activities 2	(1.1)		3.6
U.S. research and development credit	(4.5)		(6.0)
Exchange gains/losses 3	1.7		2.0
State and local income taxes - net	1.3		0.9
Impact of Swiss Tax Changes 4	—		(8.0)
Excess tax benefits/deficiencies from stock compensation	(0.2)		(0.6)
Tax settlements and expiration of statute of limitations	(1.6)		(0.4)
Impact of Brazil valuation allowance 6	9.1		—
Repatriation of foreign earnings 5	1.7		2.9
Other – net	—		0.2
Effective tax rate	32.0	%	13.7	%

2. Includes a tax charge of $46 million for the year ended December 31, 2023 associated with intellectual property realignment.

4. Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.

5. Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.

6. For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of

a legal entity in Brazil (Seed business).

Short-Term Borrowings (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Short-term Debt [Line Items]
Long-term debt payable within one year	$ 782	$ 500
Finance lease obligations payable within one year	0	0
Short-term borrowings and finance lease obligations	894	750
Other loans - various currencies
Short-term Debt [Line Items]
Short-term borrowings and finance lease obligations	112	250
364-day Revolving Credit Facility \| 364-day Revolving Credit Facility
Short-term Debt [Line Items]
Short-term borrowings and finance lease obligations	$ 0	$ 0

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) - Pension Plan

Dec. 31, 2025

Dec. 31, 2024

Rate of increase in future compensation levels

Discount Rate

5.31%

5.59%

^[1]

2.82%

2.87%

[1]	The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Inventory Disclosure [Text Block]

Inventories

12 Months Ended

Dec. 31, 2025

Inventory Disclosure [Abstract]

INVENTORIES


(In millions)	December 31, 2025		December 31, 2024
Finished products	$	2,956	$	2,649
Semi-finished products	2,276		2,297
Raw materials and supplies	435		486
Total inventories	$	5,667	$	5,432

Accounts and Notes Receivable, Net (Tables)

12 Months Ended

Dec. 31, 2025

Receivables [Abstract]

Schedule of Accounts and Notes Receivable


(In millions)	December 31, 2025		December 31, 2024
Accounts receivable – trade 1	$	4,881	$	4,448
Notes receivable – trade 1,2	153		167
Other 3	1,337		1,061
Total accounts and notes receivable - net	$	6,371	$	5,676

1.Accounts and notes receivable – trade are net of allowances of $241 million and $179 million at December 31, 2025 and 2024, respectively.

Accounts Receivable, Allowance for Credit Loss


(In millions)
Balance at December 31, 2023	$	205
Net provision for credit losses	39
Other - net of write-offs charged against allowance	(65)
Balance at December 31, 2024	$	179
Net provision for credit losses	104
Other - net of write-offs charged against allowance	(42)
Balance at December 31, 2025	$	241

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 13	$ 16	$ 18
Interest Cost	627	648	690
Expected return on plan assets	(622)	(531)	(605)
Amortization of unrecognized loss (gain)	0	1	0
Amortization of prior service benefit	(4)	(4)	(3)
Settlement loss	0	2	0
Net periodic benefit cost (credit)	14	132	100
Net loss (gain)	(199)	164	(255)
Amortization of unrecognized (loss) gain	0	1	0
Prior service cost (benefit)	(1)	0	0
Amortization of prior service benefit	(4)	(4)	(3)
Settlement loss	0	2	0
Effect of foreign exchange rates	1	(1)	8
Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva	(203)	162	(250)
Total recognized in net periodic benefit cost and other comprehensive (income) loss	(217)	30	(350)
Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	0	0	1
Interest Cost	40	42	49
Expected return on plan assets	0	0	0
Amortization of unrecognized loss (gain)	(17)	(13)	(10)
Amortization of prior service benefit	(1)	(1)	(2)
Settlement loss	0	0	0
Net periodic benefit cost (credit)	22	28	38
Net loss (gain)	(15)	51	49
Amortization of unrecognized (loss) gain	(17)	(13)	(10)
Prior service cost (benefit)	0	1	0
Amortization of prior service benefit	(1)	(1)	(2)
Settlement loss	0	0	0
Effect of foreign exchange rates	0	0	1
Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva	(33)	38	38
Total recognized in net periodic benefit cost and other comprehensive (income) loss	$ (55)	$ 10	$ 0

Revenue Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining Performance Obligation	$ 150	$ 139
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining Performance Obligation, Expected Timing of Satisfaction	6 years

Leases (Notes)

12 Months Ended

Dec. 31, 2025

Leases [Abstract]

Leases

LEASES

The company has operating and finance leases for real estate, transportation, certain machinery and equipment, and information technology assets. The company’s leases have remaining lease terms of approximately 1 to 37 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee generally declines over the course of the lease term. The portion of residual value guarantees that are probable of payment are included in the related lease liability. At December 31, 2025, the company has future maximum payments for residual value guarantees in operating leases of $183 million with final expirations through 2035. The company's lease agreements do not contain any material restrictive covenants.

The components of lease cost for the years ended December 31, 2025, 2024 and 2023 were as follows:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Operating lease cost	$	161	$	176	$	169
Finance lease cost
Amortization of right-of-use assets	—		1		1

Total finance lease cost	$	—	$	1	$	1
Short-term lease cost	37		27		23
Variable lease cost	7		8		11

Total lease cost	$	205	$	212	$	204

Supplemental cash flow information related to leases for the years ended December 31, 2025, 2024 and 2023 was as follows:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	166	$	188	$	169

Financing cash outflows from finance leases	$	—	$	1	$	1

New leases entered into during the years ended December 31, 2025 and 2024 were not material, on an individual basis.

Supplemental balance sheet information related to leases is as follows:


(In millions)	December 31, 2025		December 31, 2024
Operating Leases
Operating lease right-of-use assets 1	$	411	$	414
Current operating lease liabilities 2	122		134
Noncurrent operating lease liabilities 3	293		342
Total operating lease liabilities	$	415	$	476

Finance Leases
Property, plant, and equipment, gross	$	14	$	14
Accumulated depreciation	(14)		(14)
Property, plant, and equipment, net	$	—	$	—
Short-term borrowings and finance lease obligations	—		—
Long-term debt	—		—
Total finance lease liabilities	$	—	$	—

1.Included in other assets in the Consolidated Balance Sheets.

2. Included in accrued and other current liabilities in the Consolidated Balance Sheets.

3. Included in other noncurrent obligations in the Consolidated Balance Sheets.

The company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.


Lease Term and Discount Rate	December 31, 2025		December 31, 2024
Weighted-average remaining lease term (years)
Operating leases	6.20		6.44
Finance leases	0		0.38
Weighted average discount rate
Operating leases	3.85	%	3.32	%
Finance leases	—	%	3.29	%

Maturities of lease liabilities are as follows:


Maturity of Lease Liabilities at December 31, 2025	Operating Leases
(In millions)
2026	$	136
2027	95
2028	71
2029	51
2030	33
2031 and thereafter	87
Total lease payments	$	473
Less: Interest	58
Present value of lease liabilities	$	415

Leases

LEASES

The components of lease cost for the years ended December 31, 2025, 2024 and 2023 were as follows:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Operating lease cost	$	161	$	176	$	169
Finance lease cost
Amortization of right-of-use assets	—		1		1

Total finance lease cost	$	—	$	1	$	1
Short-term lease cost	37		27		23
Variable lease cost	7		8		11

Total lease cost	$	205	$	212	$	204

Supplemental cash flow information related to leases for the years ended December 31, 2025, 2024 and 2023 was as follows:


	For the Year Ended December 31,
(In millions)	2025		2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	166	$	188	$	169

Financing cash outflows from finance leases	$	—	$	1	$	1

New leases entered into during the years ended December 31, 2025 and 2024 were not material, on an individual basis.

Supplemental balance sheet information related to leases is as follows:


(In millions)	December 31, 2025		December 31, 2024
Operating Leases
Operating lease right-of-use assets 1	$	411	$	414
Current operating lease liabilities 2	122		134
Noncurrent operating lease liabilities 3	293		342
Total operating lease liabilities	$	415	$	476

Finance Leases
Property, plant, and equipment, gross	$	14	$	14
Accumulated depreciation	(14)		(14)
Property, plant, and equipment, net	$	—	$	—
Short-term borrowings and finance lease obligations	—		—
Long-term debt	—		—
Total finance lease liabilities	$	—	$	—

1.Included in other assets in the Consolidated Balance Sheets.

2. Included in accrued and other current liabilities in the Consolidated Balance Sheets.

3. Included in other noncurrent obligations in the Consolidated Balance Sheets.

The company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.


Lease Term and Discount Rate	December 31, 2025		December 31, 2024
Weighted-average remaining lease term (years)
Operating leases	6.20		6.44
Finance leases	0		0.38
Weighted average discount rate
Operating leases	3.85	%	3.32	%
Finance leases	—	%	3.29	%

Maturities of lease liabilities are as follows:


Maturity of Lease Liabilities at December 31, 2025	Operating Leases
(In millions)
2026	$	136
2027	95
2028	71
2029	51
2030	33
2031 and thereafter	87
Total lease payments	$	473
Less: Interest	58
Present value of lease liabilities	$	415

Segment Reporting (Details) - USD ($) $ in Millions	12 Months Ended
Segment Reporting (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net Sales	$ 17,401	$ 16,908	$ 17,226
Depreciation and amortization	1,203	1,227	1,211
Segments
Segment Reporting Information [Line Items]
Net Sales	17,401	16,908	17,226
Segment Operating EBITDA	3,986	3,491	3,491
Depreciation and amortization	1,203	1,227	1,211
Purchases of property, plant and equipment	591	597	595
Seed [Member] \| Segments
Segment Reporting Information [Line Items]
Net Sales	9,898	9,545	9,472
Segment Operating EBITDA	2,636	2,219	2,117
Depreciation and amortization	780	805	814
Purchases of property, plant and equipment	377	365	332
Crop Protection [Member] \| Segments
Segment Reporting Information [Line Items]
Net Sales	7,503	7,363	7,754
Segment Operating EBITDA	1,350	1,272	1,374
Depreciation and amortization	423	422	397
Purchases of property, plant and equipment	$ 214	$ 232	$ 263

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.